GLP-1 Market
LLY $1354.00 ▼ -0.8% NVO $40.31 ▲ +0.0% PFE $29.39 ▼ -1.6% VKTX $26.84 ▲ +4.1% KLRA $12.97 ▲ +6.6% GPCR $20.35 ▲ +6.7% RHHBY $59.37 ▼ -0.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Hormonal therapy

Company
University of Colorado, Denver
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
241 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

241 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 9, 2026

Find a Clinical Trial Near Me

See recruiting studies for Hormonal therapy and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01072825

    A European Network for the Investigation of Gender Incongruence

    University Hospital, Ghent 125 participants Est. completion 2030-12-31 4 sites
    Other conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
    View official trial listing →
  • Recruiting NCT NCT02476786

    Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

    Not yet reported Washington University School of Medicine 50 participants Est. completion 2032-07-31 1 site
    Other conditions: Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the Breast
    View official trial listing →
  • Recruiting NCT NCT02535221

    Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

    Not yet reported Peking University 234 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT02641769

    Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.

    Not yet reported, Not yet reported Stem Cells Arabia 600 participants Est. completion 2031-01 1 site
    Other conditions: Non-obstructive Azoospermia
    View official trial listing →
  • Recruiting NCT NCT03621904

    PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

    Radboud University Medical Center 150 participants Est. completion 2027-09-01 1 site
    Other conditions: Endometrial Cancer Stage III, Endometrial Cancer Stage IV, Endometrial Cancer Recurrent
    View official trial listing →
  • Recruiting NCT NCT03675893

    RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

    Not yet reported Dana-Farber Cancer Institute 110 participants Est. completion 2031-08-01 3 sites Stand-alone
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT03808337

    Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

    Not yet reported Memorial Sloan Kettering Cancer Center 145 participants Est. completion 2027-01 12 sites
    Other conditions: Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer, Metastatic Non-Small Cell Lung Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04158843

    Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis

    Not yet reported xuexin he 183 participants Est. completion 2026-12-31 4 sites
    Other conditions: Breast Cancer, Oligometastasis
    View official trial listing →
  • Recruiting NCT NCT04174352

    FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

    Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2027-12 2 sites
    Other conditions: ERα+ Breast Cancer, ESR1 Gene Mutation
    View official trial listing →
  • Recruiting NCT NCT04221542

    Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Amgen 479 participants Est. completion 2032-03-21 57 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT04293796

    Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)

    Not yet reported N.N. Petrov National Medical Research Center of Oncology 60 participants Est. completion 2028-12-10 1 site
    Other conditions: Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
    View official trial listing →
  • Recruiting NCT NCT04297020

    Brain Health in Breast Cancer Survivors

    Jonsson Comprehensive Cancer Center 120 participants Est. completion 2028-03-15 1 site
    Other conditions: Cognitive Impairment, Cognitive Function
    View official trial listing →
  • Recruiting NCT NCT04362046

    Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

    Not yet reported Vancouver Coastal Health Research Institute 30 participants Est. completion 2028-07 1 site
    Other conditions: Endometrial Hyperplasia, Endometrial Cancer, Gynecologic Cancer
    View official trial listing →
  • Recruiting NCT NCT04457895

    Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.

    Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 108 participants Est. completion 2028-08 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04476485

    Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

    Shengjing Hospital 1000 participants Est. completion 2026-12-31 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04483804

    Application of Radiomics in Breast Cancer

    Second Affiliated Hospital, Zhejiang University, School of Medicine 2000 participants Est. completion 2028-12 1 site
    Other conditions: Breast Cancer, Ultrasound, Elastography, Pathology, Radiomics
    View official trial listing →
  • Recruiting NCT NCT04606446

    Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    Not yet reported Pfizer 320 participants Est. completion 2029-08-27 43 sites
    Other conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT04666961

    Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

    Not yet reported Institut Cancerologie de l'Ouest 262 participants Est. completion 2033-08-01 8 sites
    Other conditions: Ductal Carcinoma in Situ, Extensive Disease, Mastectomy
    View official trial listing →
  • Recruiting NCT NCT04740697

    Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

    Not yet reported Institut Claudius Regaud 200 participants Est. completion 2028-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04775355

    Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

    City of Hope Medical Center 30 participants Est. completion 2026-12-01 1 site
    Other conditions: Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Cancer AJCC v7
    View official trial listing →
  • Recruiting NCT NCT04794075

    Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

    Not yet reported Centre Hospitalier Emile Roux 300 participants Est. completion 2029-08 9 sites
    Other conditions: Neoplasm of Breast
    View official trial listing →
  • Recruiting NCT NCT04799535

    Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

    Mayo Clinic 550 participants Est. completion 2027-11-29 1 site
    Other conditions: Breast Carcinoma, Breast Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04819243

    PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study

    Not yet reported Samsung Medical Center 178 participants Est. completion 2027-12-31 1 site
    Other conditions: Premenopausal HR+/HER2- Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04838249

    Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System

    University of Leipzig 80 participants Est. completion 2026-05 1 site
    Other conditions: Transsexualism, Transgenderism, Adiposity, Eating Behavior, Arterial Stiffness, Microangiopathy
    View official trial listing →
  • Recruiting NCT NCT04852887

    De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    Not yet reported NRG Oncology 1670 participants Est. completion 2041-07 832 sites
    Other conditions: Stage I Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04886531

    Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

    Not yet reported Ruth O'Regan 30 participants Est. completion 2027-12-21 4 sites
    Other conditions: Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04921137

    Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

    Not yet reported Ottawa Hospital Research Institute 500 participants Est. completion 2036-05 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04923542

    SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 31 participants Est. completion 2027-12 2 sites
    Other conditions: Brain Metastases, HR+ Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04935164

    Comparative Study of Gender Identity Disorder Versus Control

    Centre Hospitalier Henri Laborit 120 participants Est. completion 2029-12 1 site
    Other conditions: Gender Dysphoria, Adult
    View official trial listing →
  • Recruiting NCT NCT04968964

    Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

    Not yet reported Washington University School of Medicine 55 participants Est. completion 2030-09-30 1 site
    Other conditions: Breast Cancer, Cancer of the Breast
    View official trial listing →
  • Recruiting NCT NCT04985058

    Real-world Data in Patients With Breast Cancer Treated With Abemaciclib

    Hellenic Cooperative Oncology Group 108 participants Est. completion 2027-07-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04985266

    A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

    Not yet reported Royal Marsden NHS Foundation Trust 1100 participants Est. completion 2030-09-01 49 sites
    Other conditions: ER+ Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05063136

    Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

    Not yet reported Henan Cancer Hospital 1979 participants Est. completion 2028-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05071105

    SBRT in Early Breast Cancer in Elderly Women

    Not yet reported University of Rome Tor Vergata 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Recruiting NCT NCT05169112

    Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy

    Not yet reported Ottawa Hospital Research Institute 72 participants Est. completion 2028-11 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT05169762

    Feminizing Treatment in Transgender Women and Non-binary Persons

    Odense University Hospital 100 participants Est. completion 2035-09-01 1 site
    Other conditions: Transgenderism
    View official trial listing →
  • Recruiting NCT NCT05212454

    Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 400 participants Est. completion 2029-12 1 site
    Other conditions: Breast Cancer, Chemotherapy Effect
    View official trial listing →
  • Recruiting NCT NCT05267912

    Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 152 participants Est. completion 2029-01-18 11 sites Stand-alone
    Other conditions: Advanced, Pretreated Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05280028

    HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

    Far Eastern Memorial Hospital 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Recruiting NCT NCT05304962

    FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

    Not yet reported Regor Pharmaceuticals Inc. 64 participants Est. completion 2027-03-31 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05335317

    Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser

    Not yet reported MeLSyTech, Ltd 120 participants Est. completion 2025-12-01 1 site
    Other conditions: Postmenopausal Period, Vaginal Atrophy, Vaginal Prolapse
    View official trial listing →
  • Recruiting NCT NCT05345860

    Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300 participants Est. completion 2027-03-24 3 sites
    Other conditions: Early-stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05362760

    Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

    Not yet reported Prof. Wolfgang Janni 300 participants Est. completion 2029-04 54 sites
    Other conditions: Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05417308

    Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Endocrine Therapy-Induced Alopecia, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05442463

    Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

    University of Calgary 200 participants Est. completion 2025-11-30 1 site
    Other conditions: Hormone Therapy
    View official trial listing →
  • Recruiting NCT NCT05448547

    Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

    Not yet reported Sven Löffeler 980 participants Est. completion 2036-12-31 26 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT05467891

    Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

    Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sites
    Other conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05472792

    Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

    Not yet reported UNC Lineberger Comprehensive Cancer Center 90 participants Est. completion 2032-04-15 1 site
    Other conditions: Breast Cancer, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT05534321

    Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

    Not yet reported, Not yet reported Baptist Health South Florida 74 participants Est. completion 2028-09 1 site
    Other conditions: Spine Metastases
    View official trial listing →
  • Recruiting NCT NCT05587751

    Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

    Not yet reported Mayo Clinic 44 participants Est. completion 2027-07 1 site
    Other conditions: Hormonal Gender-Affirming Therapy
    View official trial listing →
  • Recruiting NCT NCT05603078

    A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2028-07 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05621564

    Pre-operative Therapy in Breast Cancer

    RenJi Hospital 6032 participants Est. completion 2030-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05649605

    Early Mental Response - The EMRE Study

    Not yet reported Karolinska University Hospital 70 participants Est. completion 2026-12-30 1 site
    Other conditions: Gender Dysphoria, Gender Identity, Gender Issues
    View official trial listing →
  • Recruiting NCT NCT05693766

    Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

    Not yet reported Sonya Reid 64 participants Est. completion 2037-08-31 4 sites
    Other conditions: Invasive Mammary Carcinoma, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05717166

    A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

    Not yet reported David Palma 180 participants Est. completion 2029-04 5 sites
    Other conditions: Metastatic Tumor
    View official trial listing →
  • Recruiting NCT NCT05720260

    Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

    Not yet reported National Taiwan University Hospital 42 participants Est. completion 2027-01-31 1 site
    Other conditions: Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05726292

    A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

    Not yet reported University of Chicago 90 participants Est. completion 2028-04-01 4 sites
    Other conditions: Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05759546

    PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

    Not yet reported Fudan University 200 participants Est. completion 2027-06-01 1 site
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT05774951

    A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

    Not yet reported AstraZeneca 4300 participants Est. completion 2036-05-29 709 sites
    Other conditions: Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05800535

    JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients

    Hospices Civils de Lyon 100 participants Est. completion 2029-02-10 1 site
    Other conditions: Cancer, Sarcopenia
    View official trial listing →
  • Recruiting NCT NCT05819853

    Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

    Not yet reported University of Colorado, Denver 80 participants Est. completion 2028-06-30 1 site Added to GLP-1
    Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese
    View official trial listing →
  • Recruiting NCT NCT05860465

    Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 254 participants Est. completion 2026-12-30 22 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05872347

    Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

    Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 52 participants Est. completion 2026-12-31 25 sites
    Other conditions: Breast Cancer Brain Metastases
    View official trial listing →
  • Recruiting NCT NCT05878314

    Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer

    University Hospital Tuebingen 504 participants Est. completion 2035-04 1 site
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05879926

    Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    Not yet reported NRG Oncology 3960 participants Est. completion 2034-07 1261 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05891093

    Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

    Not yet reported Fudan University 766 participants Est. completion 2031-05-31 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05904964

    Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 288 participants Est. completion 2030-03-01 3 sites
    Other conditions: HR Positive/HER2 Low Expression Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05914116

    A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    Not yet reported, Not yet reported DualityBio Inc. 862 participants Est. completion 2028-05 107 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05919329

    Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

    Not yet reported OHSU Knight Cancer Institute 80 participants Est. completion 2030-09-01 1 site Stand-alone
    Other conditions: Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05949541

    Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer

    Not yet reported Fudan University 265 participants Est. completion 2028-01 1 site
    Other conditions: Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05953090

    VALOR: Vaginal Atrophy & Long-term Observation of Recovery

    Not yet reported Stratpharma AG 2000 participants Est. completion 2028-12 14 sites Stand-alone
    Other conditions: Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)
    View official trial listing →
  • Recruiting NCT NCT05983107

    Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2027-07-15 1 site
    Other conditions: HR+/HER2- Advanced Breast Cancer, Targeted Therapy
    View official trial listing →
  • Recruiting NCT NCT06033287

    Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

    Hunan Cancer Hospital 300 participants Est. completion 2025-12-31 1 site
    Other conditions: Breast Cancer, Endocrine Therapy, CDK4/6 Inhibitors, Subsequent Treatment
    View official trial listing →
  • Recruiting NCT NCT06044623

    Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

    Not yet reported Region Örebro County 495 participants Est. completion 2029-05-31 12 sites
    Other conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life, Toxicity, Older Patients
    View official trial listing →
  • Recruiting NCT NCT06075953

    DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

    Not yet reported QuantumLeap Healthcare Collaborative 400 participants Est. completion 2033-11 30 sites
    Other conditions: Ductal Carcinoma in Situ
    View official trial listing →
  • Recruiting NCT NCT06083766

    Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People

    Mayo Clinic 24 participants Est. completion 2030-07 1 site
    Other conditions: Effects of GAHT, on Skeletal Muscle in TGD
    View official trial listing →
  • Recruiting NCT NCT06106477

    Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

    Not yet reported Medical College of Wisconsin 20 participants Est. completion 2027-07-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06106529

    REDucing Hot FLASHes in Women Using Endocrine Therapy.

    Not yet reported Reinier de Graaf Groep 260 participants Est. completion 2029-01-01 1 site
    Other conditions: Breast Cancer, Hot Flash Due to Medication
    View official trial listing →
  • Recruiting NCT NCT06111313

    The University of Miami Adapt (UAdapt) Trial

    Not yet reported University of Miami 130 participants Est. completion 2033-11-30 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06127979

    A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

    Not yet reported Memorial Sloan Kettering Cancer Center 42 participants Est. completion 2028-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06130995

    Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

    Not yet reported University of Oklahoma 46 participants Est. completion 2030-01 1 site Stand-alone
    Other conditions: Androgen Deprivation Therapy, Locally Advanced Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06135714

    Metastasis-directed Therapy for Oligometastases of Breast Cancer

    Not yet reported Tokyo Medical and Dental University 146 participants Est. completion 2035-10-31 1 site
    Other conditions: Breast Cancer, Oligometastasis, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06149130

    Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer

    Not yet reported Tongji Hospital 82 participants Est. completion 2026-11-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06162559

    Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study

    Not yet reported The Netherlands Cancer Institute 30 participants Est. completion 2036-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06176534

    Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

    Not yet reported Henan Cancer Hospital 240 participants Est. completion 2026-12-20 1 site
    Other conditions: Advanced Breast Cancer, Treatment, HR Low/HER2 Negative
    View official trial listing →
  • Recruiting NCT NCT06195709

    ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

    Not yet reported Institut Curie 300 participants Est. completion 2030-09-27 21 sites
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06207734

    Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 120 participants Est. completion 2028-07-10 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06218303

    Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

    Not yet reported Finn, Olivera, PhD 50 participants Est. completion 2029-12-31 1 site
    Other conditions: Ductal Carcinoma in Situ
    View official trial listing →
  • Recruiting NCT NCT06242509

    Intestinal Akkermansia Muciniphila in Prostate Cancer

    Assistance Publique - Hôpitaux de Paris 52 participants Est. completion 2027-01-20 1 site
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06245681

    Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content

    Medical University of Vienna 40 participants Est. completion 2028-10-20 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Recruiting NCT NCT06280560

    Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation

    Fundación IVI 60 participants Est. completion 2026-12-30 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Recruiting NCT NCT06291675

    Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

    Medical University of Vienna 50 participants Est. completion 2033-03-03 1 site
    Other conditions: Gender Dysphoria, Hormone Therapy Induced Morphologic Change
    View official trial listing →
  • Recruiting NCT NCT06306612

    CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

    Not yet reported RenJi Hospital 192 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06331676

    Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care

    Not yet reported Hospices Civils de Lyon 90 participants Est. completion 2028-03-21 2 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06341894

    Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 1163 participants Est. completion 2029-06 1 site
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06350825

    Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 200 participants Est. completion 2028-12-31 1 site
    Other conditions: Metastatic Prostate Cancer, Therapy, Directly Observed
    View official trial listing →
  • Recruiting NCT NCT06361940

    Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

    Not yet reported Medical College of Wisconsin 185 participants Est. completion 2028-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06369285

    A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

    Not yet reported Puma Biotechnology, Inc. 225 participants Est. completion 2029-06-30 53 sites
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06375798

    Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer

    Hebei Medical University Fourth Hospital 620 participants Est. completion 2026-11-19 1 site
    Other conditions: Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06377852

    The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

    Not yet reported American Society of Clinical Oncology 500 participants Est. completion 2028-09-01 92 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06382948

    Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

    Not yet reported MedSIR 300 participants Est. completion 2028-04 104 sites
    Other conditions: Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
    View official trial listing →
  • Recruiting NCT NCT06383026

    Individuals on Hormone Therapy Breast Cancer Screening Pilot

    Medical College of Wisconsin 130 participants Est. completion 2028-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06413381

    Risk Factors for Non-response to Hormonal Medical Therapy in Patients With Endometriosis

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 250 participants Est. completion 2029-11-28 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06417801

    Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.

    AstraZeneca 170 participants Est. completion 2027-12-30 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06439290

    Voice Outcome of Glottoplasty, Cricothyroid Approximation, Thyroplasty, and Chondrolaryngoplasty

    Not yet reported University Ghent 290 participants Est. completion 2027-12 2 sites
    Other conditions: Surgery, Larynx, Transgenderism, Gender Dysphoria
    View official trial listing →
  • Recruiting NCT NCT06446401

    The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

    Uppsala University 1400 participants Est. completion 2031-12-31 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06461650

    Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction

    Not yet reported University of Florida 20 participants Est. completion 2029-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06461793

    Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)

    Not yet reported Samsung Medical Center 33 participants Est. completion 2033-12-31 1 site
    Other conditions: High Risk Prostate Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06480513

    Cancer Of the BReast Asanas Study (COBRA)

    Not yet reported UMC Utrecht 140 participants Est. completion 2027-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06486883

    Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

    Not yet reported MedSIR 200 participants Est. completion 2028-01 79 sites
    Other conditions: Advanced Breast Cancer, Advanced Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06500169

    Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

    Not yet reported University of Southern California 20 participants Est. completion 2027-12-31 2 sites
    Other conditions: Localized Prostate Carcinoma, Locally Advanced Prostate Carcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06517212

    Tirzepatide Weight Loss for MRD+ Early Breast Cancer

    Not yet reported Baylor Research Institute 48 participants Est. completion 2030-12-31 1 site
    Other conditions: Breast Cancer, Breast Neoplasms, Breast Cancers
    View official trial listing →
  • Recruiting NCT NCT06530459

    The MUSE Study for Menopausal Arthralgia

    Not yet reported, Not yet reported National University Hospital, Singapore 100 participants Est. completion 2028-04 1 site
    Other conditions: Arthralgia, Menopause, Perimenopausal Disorder, Joint Pain, Postmenopausal Disorder
    View official trial listing →
  • Recruiting NCT NCT06548919

    Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer

    SciClone Pharmaceuticals 450 participants Est. completion 2027-12-31 1 site
    Other conditions: ESR1 Gene Mutation, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06590857

    Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

    Not yet reported, Not yet reported RayzeBio, Inc. 64 participants Est. completion 2033-11 31 sites
    Other conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06637150

    Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer

    Not yet reported Fudan University 1388 participants Est. completion 2030-09-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06670053

    Puberty, Testosterone, and Brain Development

    University of Colorado, Denver 100 participants Est. completion 2029-01 1 site
    Other conditions: Gender Identity, Gender Dysphoria in Adolescents and Adults, Headache, Transgender
    View official trial listing →
  • Recruiting NCT NCT06680596

    Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

    Not yet reported UNICANCER 80 participants Est. completion 2029-08-01 40 sites
    Other conditions: Breast Cancer Metastatic, Breast Cancer Stage IV
    View official trial listing →
  • Recruiting NCT NCT06702995

    Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported, Not yet reported Evopoint Biosciences Inc. 307 participants Est. completion 2027-07-13 2 sites
    Other conditions: Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)
    View official trial listing →
  • Recruiting NCT NCT06704516

    COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

    Not yet reported University of Oxford 10 participants Est. completion 2026-01-01 1 site
    MASLD Other conditions: Menopause
    View official trial listing →
  • Recruiting NCT NCT06726148

    Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals 280 participants Est. completion 2028-09-25 33 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06757634

    Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

    Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 239 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06774053

    Swiss ProspectivE Cohort of TRAnsgender and Gender Diverse Individuals - The SPECTRA Study

    University Hospital, Basel, Switzerland 600 participants Est. completion 2046-01 3 sites
    Other conditions: Transgender Individuals, Gender Incongruence
    View official trial listing →
  • Recruiting NCT NCT06776458

    Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

    University of Toronto 112 participants Est. completion 2026-09-30 1 site
    Other conditions: Breast Cancer Females
    View official trial listing →
  • Recruiting NCT NCT06781762

    Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

    University of Toronto 40 participants Est. completion 2026-12-30 1 site
    Other conditions: Breast Cancer Females
    View official trial listing →
  • Recruiting NCT NCT06781996

    A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 180 participants Est. completion 2026-12-15 1 site
    Other conditions: Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06792201

    Evaluation of Sarcopenia in Women in Different Stages of Life and in Hormonal Therapy or Not

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-06-14 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Recruiting NCT NCT06795243

    Efficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates.

    Not yet reported University of Seville 32 participants Est. completion 2026-07-01 1 site
    Other conditions: Endometriosis, Endometriosis Related Pain, Endometriosis, Pain, Endometriosis-related Pain, Pain, Pain Intensity Assessment, Pain Management, Pain, Chronic Disease, Pain Score, Therapeutic Exercise, Exercise Adherence, Adherence, Treatment, Treatment Adherence and Compliance, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT06806930

    Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

    Not yet reported George Washington University 90 participants Est. completion 2028-10 1 site
    Other conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Carcinoma, Breast
    View official trial listing →
  • Recruiting NCT NCT06807580

    Progesterone in Gender Affirming Hormone Therapy Study

    Not yet reported Emory University 40 participants Est. completion 2027-02 1 site
    Other conditions: Transgender Women
    View official trial listing →
  • Recruiting NCT NCT06818682

    Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial

    Not yet reported Tata Memorial Centre 206 participants Est. completion 2035-01-01 1 site
    Other conditions: Prostate Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06830720

    A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

    Novartis Pharmaceuticals 3250 participants Est. completion 2030-06-30 287 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06843967

    A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2028-08-19 7 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT06856174

    Menopausal HT for Women Living With HIV (HoT)

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 105 participants Est. completion 2027-09-20 23 sites
    Other conditions: HIV Infection, Menopause
    View official trial listing →
  • Recruiting NCT NCT06864533

    Adjuvant Chemotherapy for High Malignant Prostate Cancer

    Peking University First Hospital 315 participants Est. completion 2031-09-01 3 sites
    Other conditions: Prostate Cancer, Radiation Therapy, Chemotherapy, Gleason Score
    View official trial listing →
  • Recruiting NCT NCT06897488

    EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

    Not yet reported M.D. Anderson Cancer Center 300 participants Est. completion 2030-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06914440

    Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

    Not yet reported Xijing Hospital 27 participants Est. completion 2030-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06917313

    FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

    Not yet reported Yale University 92 participants Est. completion 2028-03 2 sites
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06931340

    Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    Not yet reported Alliance for Clinical Trials in Oncology 1260 participants Est. completion 2039-05-08 214 sites
    Other conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06939257

    Pain Outcomes Associated With Exogenous Hormone Therapy in Adults

    University of Kansas Medical Center 200 participants Est. completion 2029-09-16 1 site
    Other conditions: Pain, Gender Minority Individuals
    View official trial listing →
  • Recruiting NCT NCT06953882

    Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

    Not yet reported Yale University 140 participants Est. completion 2030-09 1 site
    Other conditions: HER2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06970912

    ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

    Not yet reported Peking University People's Hospital 393 participants Est. completion 2029-12-31 1 site
    Other conditions: Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer, ctDNA Monitoring, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites Stand-alone
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT06979596

    A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06998407

    ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 380 participants Est. completion 2030-08 16 sites
    Other conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07010939

    A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients

    FangYi 3000 participants Est. completion 2028-12-31 3 sites
    Other conditions: Breast Neoplasms, Quality of Life (QOL), Toxicities, Breast Diseases
    View official trial listing →
  • Recruiting NCT NCT07012720

    Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer

    Not yet reported Xijing Hospital 71 participants Est. completion 2027-04-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07019363

    CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

    Not yet reported Fudan University 1903 participants Est. completion 2033-04-15 1 site
    Other conditions: Breast Cancer, Adjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT07024173

    A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 240 participants Est. completion 2027-12 2 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07032506

    Intrauterine Stent Placement Following Hysteroscopic Septum Resection

    Not yet reported Weill Medical College of Cornell University 320 participants Est. completion 2031-12-31 3 sites Stand-alone
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Recruiting NCT NCT07062965

    A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

    Not yet reported Pfizer 400 participants Est. completion 2030-11-04 433 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07071038

    Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

    Not yet reported Dartmouth-Hitchcock Medical Center 62 participants Est. completion 2027-08-05 1 site
    Other conditions: Breast Cancer, Adjuvant Treatment, Early Stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07071337

    A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

    Not yet reported Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430 participants Est. completion 2031-02 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07077876

    Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100 participants Est. completion 2026-01-20 1 site
    Other conditions: Endometrial Adenocarcinoma, Endometrial Hyperplasia, Fertility Preservation, Conservative Treatment Therapy
    View official trial listing →
  • Recruiting NCT NCT07084558

    ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness

    Not yet reported Austrian Breast & Colorectal Cancer Study Group 350 participants Est. completion 2033-06-30 14 sites
    Other conditions: Early and Locally Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07106112

    Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy

    Not yet reported Saint Petersburg State University, Russia 110 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07106632

    Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests

    Not yet reported UNICANCER 3380 participants Est. completion 2038-08-15 105 sites
    Other conditions: Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07125950

    SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

    Not yet reported Henan Cancer Hospital 30 participants Est. completion 2028-01-31 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07137871

    Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

    Not yet reported The University of Texas Health Science Center at San Antonio 35 participants Est. completion 2028-10 1 site Stand-alone
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT07148921

    Perception of Pain During Gender Affirming Hormone Therapy

    Medical University of Vienna 40 participants Est. completion 2026-03 1 site
    Other conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex Hormones
    View official trial listing →
  • Recruiting NCT NCT07151911

    Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients

    Azienda Ospedaliero-Universitaria di Modena 100 participants Est. completion 2031-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07152340

    The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

    Not yet reported Shanghai Changzheng Hospital 64 participants Est. completion 2030-05-01 2 sites
    Other conditions: Thyroid Associated Ophthalmopathies
    View official trial listing →
  • Recruiting NCT NCT07152366

    Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

    Not yet reported Shanghai Changzheng Hospital 96 participants Est. completion 2035-04-15 1 site
    Other conditions: Thyroid Associated Ophthalmopathies
    View official trial listing →
  • Recruiting NCT NCT07162987

    Prehabilitation to Patients With Prostate Cancer

    Not yet reported Odense University Hospital 20 participants Est. completion 2026-11 3 sites
    Other conditions: Prostate Cancer (Diagnosis)
    View official trial listing →
  • Recruiting NCT NCT07174336

    A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    Not yet reported Eli Lilly and Company 800 participants Est. completion 2033-05 364 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Recruiting NCT NCT07180056

    Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer

    Wenjin Yin 229 participants Est. completion 2033-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07190443

    Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

    Not yet reported Japanese Foundation for Cancer Research 290 participants Est. completion 2035-02-06 1 site
    Other conditions: Breast Cancer, Locoregional Recurrence, Abemaciclib, Endocrine Therapy
    View official trial listing →
  • Recruiting NCT NCT07205822

    A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

    Not yet reported AstraZeneca 100 participants Est. completion 2028-02-02 40 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07214532

    Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

    Not yet reported Natera, Inc. 725 participants Est. completion 2037-12-30 49 sites
    Other conditions: Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)
    View official trial listing →
  • Recruiting NCT NCT07222215

    PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

    Not yet reported Kristina A. Fanucci 297 participants Est. completion 2030-10-01 1 site
    Other conditions: Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2- Breast Cancer, ESR1 Gene Mutation, ER Wildtype, Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07235176

    Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 300 participants Est. completion 2031-12-30 1 site
    Other conditions: Advanced ER+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07237269

    Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

    Not yet reported University of Nebraska 140 participants Est. completion 2033-04-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07242118

    Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

    Not yet reported University of Kansas Medical Center 18 participants Est. completion 2027-10 2 sites Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Recruiting NCT NCT07242391

    Menopausal Hormone Therapy And Left Ventricular Function

    Mayo Clinic 50 participants Est. completion 2027-12 1 site
    Other conditions: Menopause, Left Ventricular Dysfunction
    View official trial listing →
  • Recruiting NCT NCT07243002

    Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

    Novartis Pharmaceuticals 3000 participants Est. completion 2030-04-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07243834

    Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise

    Not yet reported Royal Marsden NHS Foundation Trust 160 participants Est. completion 2030-04-28 1 site
    Other conditions: Prostate Cancer, Prostate Cancer (Diagnosis)
    View official trial listing →
  • Recruiting NCT NCT07252726

    Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

    Not yet reported Ottawa Hospital Research Institute 50 participants Est. completion 2033-03 3 sites
    Other conditions: Metastatic Breast Cancer, Metastatic Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07288359

    Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals 205 participants Est. completion 2031-05-09 16 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07295457

    Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)

    Not yet reported Hospices Civils de Lyon 182 participants Est. completion 2029-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07330544

    A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy

    Not yet reported Zhejiang Cancer Hospital 118 participants Est. completion 2028-11-26 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07333521

    Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

    Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2034-01-13 1 site
    Other conditions: Isolated Non-acquired Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT07344779

    A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

    Bayer 1600 participants Est. completion 2030-06-30 16 sites
    Other conditions: Metastatic Hormone-Sensitive Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07347600

    A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

    Hoffmann-La Roche 500 participants Est. completion 2029-12-31 32 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07349069

    A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 5500 participants Est. completion 2034-01 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07364071

    Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer

    Not yet reported University of California, San Diego 150 participants Est. completion 2034-04 1 site
    Other conditions: Prostate Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07366112

    CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment

    Not yet reported Peking University People's Hospital 158 participants Est. completion 2029-12-31 1 site
    Other conditions: Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer, ctDNA Monitoring
    View official trial listing →
  • Recruiting NCT NCT07379918

    Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer

    Assistance Publique - Hôpitaux de Paris 1000 participants Est. completion 2031-06-28 1 site
    Other conditions: Breast Cancer (Early Breast Cancer), Breast Cancer Survivors, Breast Cancer Prognostic, Early Hormone Receptor-positive (HR-positive), HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07391774

    Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    Not yet reported National Cancer Institute (NCI) 1978 participants Est. completion 2029-07-31 258 sites
    Other conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07395804

    How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany

    Bayer 500 participants Est. completion 2031-02-15 1 site
    Other conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
    View official trial listing →
  • Recruiting NCT NCT07400419

    Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2028-04-01 1 site
    Other conditions: Muscle Mass and Strength
    View official trial listing →
  • Recruiting NCT NCT07401381

    A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

    Not yet reported Rovi Pharmaceuticals Laboratories 120 participants Est. completion 2028-10 21 sites
    Other conditions: Hormone Receptor Positive Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07406412

    Hormonal Regulation of Cardiometabolic Health Study

    University of Jyvaskyla 120 participants Est. completion 2028-12-15 7 sites
    Other conditions: Menopause Surgical
    View official trial listing →
  • Recruiting NCT NCT07407439

    Real-world Studies of CDK4/6 Inhibitors

    Tianjin Medical University Cancer Institute and Hospital 245 participants Est. completion 2027-06-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07407920

    Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

    Not yet reported M.D. Anderson Cancer Center 120 participants Est. completion 2028-09-30 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2-Positive Breast Carcinoma, Early Stage Triple-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07410039

    Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

    Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2029-06-30 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorder Attack
    View official trial listing →
  • Recruiting NCT NCT07429773

    Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP

    Not yet reported Centre Hospitalier Universitaire de Nice 120 participants Est. completion 2028-04 1 site
    Other conditions: Endometriosis, Chronic Pelvic Pain Syndrome
    View official trial listing →
  • Recruiting NCT NCT07432178

    CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon)

    Not yet reported Fudan University 2288 participants Est. completion 2034-03-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07443774

    Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

    University Hospital, Grenoble 81 participants Est. completion 2031-12 1 site
    Other conditions: ER+ Breast Cancer, Breast Cancer, Early Breast Cancer, Endocrine Therapy, Abemaciclib, Ribociclib
    View official trial listing →
  • Recruiting NCT NCT07454499

    Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

    Not yet reported Abramson Cancer Center at Penn Medicine 60 participants Est. completion 2027-12-31 1 site
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT07467330

    Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

    Not yet reported Fujian Cancer Hospital 258 participants Est. completion 2032-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07477626

    Radiotherapy After Prostatectomy for Node Positive Prostate Cancer

    Not yet reported Sun Yat-sen University 372 participants Est. completion 2038-12-31 13 sites Stand-alone
    Other conditions: Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy, Lymph Node Positive
    View official trial listing →
  • Recruiting NCT NCT07483307

    A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 176 participants Est. completion 2030-03-13 7 sites
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER+ Breast Cancer, Lobular Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07483658

    Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

    Not yet reported CHU de Quebec-Universite Laval 434 participants Est. completion 2036-02 4 sites Stand-alone
    Other conditions: Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy), Prostate Cancer, Prostatic Neoplasms, Neoplasm Recurrence, Local, Biochemical Recurrence of Malignant Neoplasm of Prostate
    View official trial listing →
  • Recruiting NCT NCT07490938

    Electroacupuncture vs. Auricular Acupressure vs. Waitlist Control for Breast Cancer Endocrine Therapy-Related Joint Pain

    Not yet reported First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 200 participants Est. completion 2027-12 6 sites
    Other conditions: Breast Cancer Survivors, Endocrine Therapy-Induced Joint Pain
    View official trial listing →
  • Recruiting NCT NCT07502820

    The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

    Not yet reported Karolinska Institutet 1100 participants Est. completion 2036-08 4 sites
    Other conditions: Breast Cancer, Adjuvant Drug Therapy
    View official trial listing →
  • Recruiting NCT NCT07506876

    Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

    Not yet reported Legacy Health System 30 participants Est. completion 2027-12 4 sites
    Other conditions: Breast Cancer - Infiltrating Ductal Carcinoma, HER-2 Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07527689

    Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer

    Not yet reported Ruijin Hospital 1950 participants Est. completion 2039-03-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07563621

    Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors

    Jessa Hospital 264 participants Est. completion 2028-08-31 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM), Breast Cancer, Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause
    View official trial listing →
  • Recruiting NCT NCT07578116

    Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

    Not yet reported SWOG Cancer Research Network 562 participants Est. completion 2033-05-31 59 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma, Oligometastatic Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07581834

    Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

    Not yet reported Fujian Cancer Hospital 2000 participants Est. completion 2032-06-30 2 sites
    Other conditions: Breast Diseases, Breast Neoplasms, Dalpiciclib, Endocrine Breast Diseases, CDK4/6 Inhibitor, HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07592403

    Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis

    Not yet reported Beni-Suef University 60 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Endometriosis, Pulsed Electromagnetic Therapy, Trans Perineal Ultrasound
    View official trial listing →
  • Recruiting NCT NCT07594002

    Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy

    Not yet reported University of Kentucky 40 participants Est. completion 2028-08-31 1 site
    Other conditions: Accupuncture, Prostate Cancer, Hormone Therapy, Hot Flashes
    View official trial listing →
  • Recruiting NCT NCT07597993

    BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy

    AstraZeneca 109 participants Est. completion 2029-03-31 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07604571

    Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

    Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2032-06-08 12 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07605728

    Probiotics for Abemaciclib-Induced Abdominal Discomfort.

    Not yet reported Leeuwenhoek Laboratories Co. Ltd. 80 participants Est. completion 2029-12-31 1 site
    Other conditions: Breast Cancer, Chemotherapy-induced Diarrhea
    View official trial listing →
  • Recruiting NCT NCT07610720

    Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 57 participants Est. completion 2029-11-01 1 site
    Other conditions: Advanced/Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07613151

    Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study

    Istituto Oncologico Veneto IRCCS 250 participants Est. completion 2027-12-31 1 site
    Other conditions: Lobular Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07615751

    Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer

    Not yet reported Fudan University 502 participants Est. completion 2029-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07629206

    Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

    Not yet reported IceCure Medical Ltd. 400 participants Est. completion 2034-09 3 sites
    Other conditions: Low-Risk, Early Stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07646171

    EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)

    Tel-Aviv Sourasky Medical Center 19 participants Est. completion 2027-12-31 1 site
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07661927

    Skipping Hormone Therapy in Low-Risk Early Breast Cancer

    Not yet reported UNICANCER 700 participants Est. completion 2033-07-06 41 sites
    Other conditions: Breast Cancer (Early Breast Cancer)
    View official trial listing →
  • Recruiting NCT NCT07666555

    A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.

    Not yet reported Fudan University 98 participants Est. completion 2029-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07671885

    Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)

    Not yet reported Tokyo Women's Medical University 950 participants Est. completion 2039-01-27 49 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07683754

    T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

    Not yet reported Daiichi Sankyo 200 participants Est. completion 2030-08-28 5 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive, HR Positive
    View official trial listing →
  • Recruiting NCT NCT07706127

    mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health

    Not yet reported The University of Texas Health Science Center at San Antonio 159 participants Est. completion 2028-04-30 1 site
    Other conditions: Treatment Adherence
    View official trial listing →
  • Recruiting NCT NCT07708194

    Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure

    Not yet reported, Not yet reported Tianjin Medical University Cancer Institute and Hospital 94 participants Est. completion 2027-02 1 site
    Other conditions: Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-Positive Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07751133

    Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

    Not yet reported University College, London 1500 participants Est. completion 2033-08-01 4 sites
    Other conditions: Prostate Cancer, mHSPC, mCRPC
    View official trial listing →
  • Recruiting NCT NCT07762885

    Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

    Not yet reported Fudan University 636 participants Est. completion 2036-06 1 site
    Other conditions: Ductal Carcinoma In Situ, DCIS
    View official trial listing →
  • Recruiting NCT NCT07762924

    Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery

    Not yet reported Fudan University 234 participants Est. completion 2037-02 1 site
    Other conditions: Ductal Carcinoma In Situ, DCIS
    View official trial listing →
  • Recruiting NCT NCT07796880

    Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80 participants Est. completion 2033-03-15 1 site
    Other conditions: Hormone Receptor-Positive Breast Cancer, HER2 Low Breast Carcinoma, Early-Stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07810959

    Breast and Vascular Effects of Menopausal Hormone Therapy in Postmenopausal Women

    Sanliurfa Mehmet Akif Inan Education and Research Hospital 120 participants Est. completion 2027-05-31 1 site
    Other conditions: Menopause
    View official trial listing →
  • Recruiting NCT NCT07817056

    Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient Adherence

    Tianjin Medical University Cancer Institute and Hospital 100 participants Est. completion 2028-10-31 1 site
    Other conditions: Breast Cancer, Hyperglycemia
    View official trial listing →
  • Recruiting NCT NCT07827573

    A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment

    Not yet reported Hoffmann-La Roche 1500 participants Est. completion 2032-11-30 1 site
    Other conditions: Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07831902

    Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer

    Not yet reported University College, London 600 participants Est. completion 2034-12 12 sites
    Other conditions: Endometrial Cancer, Uterine Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07848438

    Sex Hormones and Aging

    Not yet reported University of Michigan 120 participants Est. completion 2031-08 1 site
    Other conditions: Menopause, Menopausal Hormone Therapy, Aging
    View official trial listing →
  • Recruiting NCT NCT07856225

    Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer

    Fundación Santa Fe de Bogota 370 participants Est. completion 2027-06-01 1 site
    Other conditions: Breast Neoplasms, Triple Negative Breast Neoplasms, HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07861295

    Satavari and Ashoka for Menopause (SAM) Study

    Not yet reported Vidya USA Corporation 50 participants Est. completion 2026-12-15 1 site
    Other conditions: Menopause
    View official trial listing →
  • Recruiting NCT NCT07871110

    Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)

    Not yet reported TransThera Sciences (Nanjing), Inc. 182 participants Est. completion 2029-06-30 16 sites
    Other conditions: Prostate Cancer (CRPC)
    View official trial listing →
  • Recruiting NCT NCT07871435

    GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)

    Not yet reported, Not yet reported GI Innovation, Inc. 107 participants Est. completion 2029-09-30 6 sites
    Other conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)
    View official trial listing →
  • Recruiting NCT NCT07893327

    Evaluation of the Effect of Regular Physical Exercise in Breast Cancer.

    Not yet reported Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares 150 participants Est. completion 2028-12 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT07896772

    Anti-Müllerian Hormone in Breast Cancer Clinical Practice

    Masaryk Memorial Cancer Institute 200 participants Est. completion 2027-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00000399

    Bone Estrogen Strength Training

    Not yet reported University of Arizona 300 participants Est. completion 2001-01 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00000421

    Serologically Active, Clinically Stable Systemic Lupus Erythematosus

    Not yet reported NYU Langone Health 154 participants Est. completion 2003-08 3 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00000601

    Postmenopausal Hormone Therapy in Unstable Angina

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-06
    Cardiovascular disease Other conditions: Angina, Unstable, Coronary Disease, Heart Diseases, Postmenopause
    View official trial listing →
  • Completed NCT NCT00001305

    Growth Hormone Therapy in Osteogenesis Imperfecta

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 42 participants Est. completion 2017-05-19 1 site
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Completed NCT NCT00001752

    Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 30 participants Est. completion 2000-07 1 site
    Other conditions: Hypercholesterolemia, Postmenopause
    View official trial listing →
  • Completed NCT NCT00001890

    Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2001-03 1 site
    Other conditions: Atherosclerosis, Chlamydia Infections, Cytomegalovirus Infections, Pneumonia, Bacterial, Postmenopause
    View official trial listing →
  • Completed NCT NCT00002597

    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 2028 participants Est. completion 2018-05-14 239 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002633

    Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

    Not yet reported NCIC Clinical Trials Group 361 participants Est. completion 2012-01-06 15 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002646

    Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

    Not yet reported Eastern Cooperative Oncology Group 1500 participants 85 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002651

    SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

    Not yet reported SWOG Cancer Research Network 3040 participants Est. completion 2013-06 14 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002855

    Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 306 participants Est. completion 2005-06 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003026

    Hormone Therapy in Treating Patients With Advanced Prostate Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 966 participants 17 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003124

    Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 105 participants Est. completion 2007-01 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003323

    Hormone Therapy in Treating Patients With Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 101 participants Est. completion 2010-03 43 sites
    Other conditions: Prostate Cancer, Sexual Dysfunction and Infertility
    View official trial listing →
  • Completed NCT NCT00003391

    Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Weill Medical College of Cornell University 30 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003428

    Hormone Therapy in Treating Women With Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 114 participants Est. completion 2001-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00003517

    Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

    Not yet reported Burzynski Research Institute 1 site
    Other conditions: Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer, Recurrent Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT00003622

    Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

    Not yet reported James Ahlgren Est. completion 2017-02-22 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003626

    Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy

    Not yet reported Barbara Ann Karmanos Cancer Institute Est. completion 2000-05 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00003645

    Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

    Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2017-03-20 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003653

    Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

    Not yet reported NCIC Clinical Trials Group 1386 participants Est. completion 2013-01-10 29 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003669

    Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer

    Not yet reported Eli Lilly and Company Est. completion 2001-04 10 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00003670

    Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

    Not yet reported Eli Lilly and Company Est. completion 2001-01 4 sites
    Other conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Status unknown NCT NCT00003734

    Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

    Not yet reported St. Luke's Hospital, Ireland 276 participants 12 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004001

    S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported SWOG Cancer Research Network 770 participants Est. completion 2007-01 16 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004054

    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004124

    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

    Not yet reported SWOG Cancer Research Network 983 participants Est. completion 2018-05-01 234 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004205

    Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 8028 participants Est. completion 2016-06-30 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004635

    Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 159 participants Est. completion 2010-03-30 9 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005044

    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 1579 participants Est. completion 2022-05-20 261 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005515

    Mutations, Hormone Therapy (HRT) and Venous Thromboembolism

    University of Washington Est. completion 2003-08
    Cardiovascular disease Other conditions: Venous Thromboembolism, Postmenopause
    View official trial listing →
  • Completed NCT NCT00005627

    Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005805

    St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00005810

    Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005828

    Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 54 participants Est. completion 2008-06 16 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005847

    Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Eastern Cooperative Oncology Group 19 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005848

    R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Fox Chase Cancer Center 7 participants Est. completion 2007-05 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005857

    Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

    Not yet reported City of Hope Medical Center Est. completion 2002-10 4 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005947

    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Dendreon 127 participants Est. completion 2004-09 34 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00005960

    Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Amgen 6 sites
    Other conditions: Pain, Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00005983

    S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer

    Not yet reported SWOG Cancer Research Network 98 participants Est. completion 2005-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00005992

    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Jonsson Comprehensive Cancer Center 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006002

    SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported University of Chicago 36 participants Est. completion 2006-01 18 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006023

    Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Swiss Cancer Institute Est. completion 2001-06 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006044

    Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

    Not yet reported Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00006114

    Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 10 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006143

    Growth Hormone Treatment of Children With HIV-Associated Growth Failure

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 102 participants Est. completion 2002-07 20 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00006313

    Hormone Therapy Effects on CVD Risk Factors

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-06
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Postmenopause
    View official trial listing →
  • Status unknown NCT NCT00009750

    Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported University of California, Davis 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00009945

    Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

    Not yet reported NSABP Foundation Inc 3323 participants Est. completion 2012-12 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00010231

    Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported University of Pittsburgh 22 participants Est. completion 2002-11 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00015977

    Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported University of Chicago 13 participants Est. completion 2005-01 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00016341

    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

    Not yet reported Gynecologic Oncology Group 50 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00016393

    BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported SWOG Cancer Research Network Est. completion 2006-04 28 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00016913

    Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 34 participants Est. completion 2008-05 23 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00017576

    Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported OHSU Knight Cancer Institute 19 participants Est. completion 2006-07 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00021450

    Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 819 participants Est. completion 2016-01 20 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00025116

    ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported NCIC Clinical Trials Group 40 participants Est. completion 2008-09-22 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00027859

    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Eastern Cooperative Oncology Group 98 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00028769

    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

    Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2011-07 91 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00030654

    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 21 participants Est. completion 2005-02-04 78 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00033358

    Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer

    Not yet reported National Cancer Institute (NCI) 52 participants 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00034125

    Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

    Not yet reported Eli Lilly and Company 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT00036621

    A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

    Not yet reported Bristol-Myers Squibb 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00040755

    BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported National Cancer Institute (NCI) 68 participants 1 site
    Other conditions: Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00041301

    Assessing Quality of Life of Patients With Prostate Cancer

    European Organisation for Research and Treatment of Cancer - EORTC 625 participants Est. completion 2005-11 33 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00046826

    Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

    Not yet reported Nuvance Health Est. completion 2009-10 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00049062

    Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2007-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00049257

    Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Jonsson Comprehensive Cancer Center 58 participants Est. completion 2009-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00050011

    Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

    Not yet reported Novartis Pharmaceuticals 602 participants Est. completion 2009-01 44 sites
    Other conditions: Breast Neoplasms, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00055731

    Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

    Not yet reported UNICANCER 413 participants Est. completion 2022-12-31 38 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00063310

    ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation

    Not yet reported Voyager Pharmaceutical Corporation 90 participants Est. completion 2006-02 3 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00065767

    Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

    Not yet reported, Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2005-03 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Terminated NCT NCT00066807

    Premenopausal Endocrine Responsive Chemotherapy Trial

    Not yet reported ETOP IBCSG Partners Foundation 29 participants Est. completion 2006-12 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00067015

    Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00072020

    Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

    Not yet reported University of Sheffield
    Other conditions: Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Status unknown NCT NCT00077168

    Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

    Not yet reported Institute of Cancer Research, United Kingdom 2000 participants 29 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00078585

    PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

    Not yet reported Bavarian Nordic 120 participants Est. completion 2009-01 47 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00083993

    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 1236 participants Est. completion 2006-10 129 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00085293

    Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

    Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2014-05 3 sites
    Other conditions: Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
    View official trial listing →
  • Terminated NCT NCT00097344

    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Active, not recruiting NCT NCT00099437

    Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

    Not yet reported AstraZeneca 736 participants Est. completion 2026-12-31 106 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00102258

    Role of Nutrition and Hormones in Boys With Disordered Growth

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 20 participants Est. completion 2007-10-02 1 site
    Other conditions: Short Stature, Constitutional Delay of Growth and Development, Dwarfism, Pituitary
    View official trial listing →
  • Terminated NCT NCT00103376

    Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

    Not yet reported Medical University of South Carolina 23 participants Est. completion 2011-06 4 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00104715

    Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

    Not yet reported UNICANCER 385 participants Est. completion 2015-12-15 41 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00108290

    Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

    Not yet reported US Department of Veterans Affairs Est. completion 2007-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00109473

    Trial of Growth Hormone Therapy in Pediatric Crohn's Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2009-08 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00110214

    Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported National Cancer Institute (NCI) 1050 participants Est. completion 2011-08 2 sites
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00116220

    Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

    Not yet reported Dana-Farber Cancer Institute 206 participants Est. completion 2015-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00117663

    Radiologic Evaluation and Breast Density (READ)

    Not yet reported Kaiser Permanente 1704 participants Est. completion 2007-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00120497

    Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

    Massachusetts General Hospital 12 participants Est. completion 2011-12 1 site
    Other conditions: Fetal Growth Retardation
    View official trial listing →
  • Terminated NCT NCT00121875

    Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

    Massachusetts General Hospital 1 participants Est. completion 2008-12 1 site
    Other conditions: Turner Syndrome, Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT00124410

    Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

    AHS Cancer Control Alberta 100 participants 1 site
    Other conditions: Prostate Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00128843

    Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

    Not yet reported Spanish Breast Cancer Research Group 103 participants Est. completion 2014-10 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00128934

    Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 744 participants Est. completion 2007-12 83 sites
    Other conditions: Menstruation Disturbances, Premenstrual Syndrome
    View official trial listing →
  • Terminated NCT NCT00131924

    High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

    Not yet reported Northwestern University 1 participants Est. completion 2006-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00134056

    S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

    Not yet reported SWOG Cancer Research Network 1038 participants Est. completion 2016-02 554 sites
    Other conditions: Metastatic Cancer, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00134420

    Growth Hormone and Chromosome 18q- and Abnormal Growth

    Not yet reported The University of Texas Health Science Center at San Antonio 20 participants Est. completion 2005-06 1 site
    Other conditions: Loss of Chromosome 18q, Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00138008

    Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

    Not yet reported Haruhiko Fukuda 200 participants Est. completion 2016-05 34 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00141544

    The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 28 participants Est. completion 2008-03 78 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00141570

    Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 350 participants Est. completion 2007-06 77 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00148772

    Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

    Not yet reported Endeavor Health 29 participants Est. completion 2008-08 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00149604

    AFTER: Altering Fat Through Estrogen and Raloxifene

    Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2006-02 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00165399

    Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

    Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sites
    Other conditions: Adenocarcinoma of the Prostate, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00166543

    Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer

    Not yet reported SRI International 146 participants Est. completion 2008-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00172055

    Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

    Not yet reported Novartis Pharmaceuticals 218 participants Est. completion 2009-07 19 sites
    Other conditions: Cancer Prostate
    View official trial listing →
  • Completed NCT NCT00172224

    Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research

    National Taiwan University Hospital 100 participants 1 site
    Other conditions: Osteoporosis, Fractures, Compression
    View official trial listing →
  • Completed NCT NCT00174408

    Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

    Not yet reported Pfizer 110 participants Est. completion 2005-02
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT00175383

    Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

    Not yet reported University of British Columbia 100 participants Est. completion 2008-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00176631

    Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported Rutgers, The State University of New Jersey 10 participants Est. completion 2008-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00182871

    Testosterone Effects on Bone and Frailty

    Not yet reported National Institute on Aging (NIA) 140 participants Est. completion 2007-07 1 site
    Other conditions: Aging, Frailty, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00183040

    HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

    Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2007-02 2 sites
    Other conditions: Sarcopenia, Muscle Weakness, Frailty
    View official trial listing →
  • Completed NCT NCT00184691

    Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

    Not yet reported Novo Nordisk A/S 78 participants Est. completion 2005-06 13 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00184769

    Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

    Not yet reported Novo Nordisk A/S 16 participants Est. completion 2005-12-21 20 sites
    Chronic kidney disease Other conditions: Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00188760

    Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density

    University Health Network, Toronto 300 participants Est. completion 2010-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00191529

    Growth Hormone Treatment in Short Children Born Small for Gestational Age

    Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-06 1 site
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00193856

    RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

    Not yet reported Trans Tasman Radiation Oncology Group 1071 participants Est. completion 2017-08 24 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00194792

    Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

    Not yet reported University of Washington 28 participants Est. completion 2011-07 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    View official trial listing →
  • Completed NCT NCT00195559

    Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2007-12 51 sites
    Other conditions: Premenstrual Syndrome, Menstruation Disturbances
    View official trial listing →
  • Terminated NCT NCT00206375

    Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism

    Not yet reported Baylor College of Medicine 16 participants Est. completion 2011-11 1 site
    Other conditions: Hypothyroidism
    View official trial listing →
  • Completed NCT NCT00206557

    The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

    Not yet reported The Alfred 60 participants Est. completion 2007-04 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Terminated NCT NCT00209001

    Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer

    Not yet reported Emory University 7 participants Est. completion 2007-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00210223

    Radiofrequency of Breast Cancers in Non Surgical Patients

    Not yet reported Institut Bergonié 21 participants Est. completion 2011-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00216060

    Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

    Not yet reported Christopher Sweeney, MBBS 63 participants Est. completion 2008-03 45 sites
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00223665

    Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

    Not yet reported University of Washington 102 participants Est. completion 2012-09-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00225420

    Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

    Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 23 participants Est. completion 2012-08 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00225758

    Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

    Not yet reported Gary Schwartz 27 participants Est. completion 2011-10 3 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00225914

    Study of Paxil Use in Menopausal Women

    Not yet reported Massachusetts General Hospital 64 participants Est. completion 2006-09 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00231946

    ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

    Not yet reported Voyager Pharmaceutical Corporation 555 participants 59 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Terminated NCT NCT00236301

    Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers

    Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2007-01 1 site
    Other conditions: Healthy Symptomatic Menopausal Women
    View official trial listing →
  • Completed NCT NCT00237198

    Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

    Not yet reported Novartis Pharmaceuticals 47 participants 24 sites
    Other conditions: Postmenopausal Women With Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00240071

    Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

    Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00242931

    Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

    Not yet reported OHSU Knight Cancer Institute Est. completion 2008-03
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00243646

    Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

    Not yet reported Schiffler Cancer Center 6 participants Est. completion 2009-07 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT00244920

    Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

    Not yet reported OHSU Knight Cancer Institute Est. completion 2007-06
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00246753

    Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported UNC Lineberger Comprehensive Cancer Center 29 participants Est. completion 2013-05 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00247650

    Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

    Not yet reported Novartis 190 participants 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00249821

    Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age

    Not yet reported Merck KGaA, Darmstadt, Germany 22 participants Est. completion 2007-09-30
    Other conditions: Small Gestational Age (SGA)
    View official trial listing →
  • Withdrawn NCT NCT00256555

    Growth Hormone Treatment Study in Children With Cystic Fibrosis

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center Est. completion 2018-12-12
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00258388

    Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

    Not yet reported NCIC Clinical Trials Group 82 participants Est. completion 2011-01-18 13 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00267553

    Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 200 participants Est. completion 2006-06 35 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Completed NCT NCT00288080

    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 612 participants Est. completion 2022-05-20 254 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00291759

    ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

    Not yet reported AstraZeneca 3858 participants Est. completion 2009-06 52 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00295620

    Secondary Adjuvant Long Term Study With Arimidex

    Not yet reported AstraZeneca 3484 participants Est. completion 2017-06-30 60 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00304096

    Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

    Not yet reported University of Virginia 12 participants Est. completion 2008-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00305448

    A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

    Not yet reported AstraZeneca 143 participants Est. completion 2012-02 35 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00305747

    Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy

    Not yet reported Barbara Ann Karmanos Cancer Institute 12 participants Est. completion 2010-09 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00309894

    Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

    Not yet reported University of California, San Francisco 49 participants Est. completion 2007-12 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00310180

    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

    Not yet reported National Cancer Institute (NCI) 10273 participants Est. completion 2030-09-30 1222 sites Stand-alone
    Other conditions: Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIB Breast Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00313170

    A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

    Not yet reported AstraZeneca 144 participants Est. completion 2019-03-13 34 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00319072

    Hormone Replacement Therapy (HRT) Website Tool

    Not yet reported National Institute on Aging (NIA) 280 participants Est. completion 2005-12 1 site
    Other conditions: Communication, Menopause, Hormone Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00328614

    Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 32 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00330317

    Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

    Not yet reported Novartis Pharmaceuticals 300 participants Est. completion 2010-11-16 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00334295

    Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

    Not yet reported AstraZeneca 35 participants Est. completion 2011-01 9 sites
    Other conditions: Endometrial Carcinoma
    View official trial listing →
  • Completed NCT NCT00343616

    Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

    Not yet reported ETOP IBCSG Partners Foundation 135 participants Est. completion 2009-05 12 sites
    Other conditions: Breast Cancer, Cognitive/Functional Effects, Fatigue, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Status unknown NCT NCT00348998

    Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

    Not yet reported Virginia Mason Hospital/Medical Center 18 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00351858

    Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer

    Not yet reported Neovii Biotech 40 participants Est. completion 2009-02 1 site
    Other conditions: Breast Neoplasms, Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00354432

    Soy Protein/Effexor Hormone Therapy for Prostate Cancer

    Not yet reported Wake Forest University Health Sciences 120 participants Est. completion 2010-08-01 20 sites
    Other conditions: Hot Flashes, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00355784

    Growth Hormone as a Determinant of Weight Regulation

    Not yet reported University of Michigan 24 participants Est. completion 2015-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT00358098

    Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

    AHS Cancer Control Alberta 51 participants Est. completion 2013-06 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00362973

    PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

    University of Washington 42 participants 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00363285

    Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

    Not yet reported St. Bartholomew's Hospital 900 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00373386

    Growth Hormone and Endothelial Function in Children

    Not yet reported Ohio State University 9 participants Est. completion 2007-12 1 site
    Other conditions: Growth Hormone Deficiency, Panhypopituitarism, Short Stature
    View official trial listing →
  • Terminated NCT NCT00375752

    Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

    Not yet reported Novartis Pharmaceuticals 168 participants Est. completion 2010-12-16 27 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT00379626

    Cognitive and Hormonal Treatment of Sex Offenders

    Not yet reported Norwegian University of Science and Technology 5 participants Est. completion 2010-08 1 site
    Other conditions: Paraphilia
    View official trial listing →
  • Completed NCT NCT00384839

    Vidaza to Restore Hormone Thx Prostate

    Not yet reported US Oncology Research 36 participants Est. completion 2009-11 13 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00388804

    External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 39 participants Est. completion 2011-04 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT00396474

    Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

    Pfizer Est. completion 2012-01
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Withdrawn NCT NCT00403182

    Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

    Not yet reported Technical University of Munich 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00405574

    Study of ATN-224 in Patients With Prostate Cancer

    Not yet reported Attenuon 50 participants Est. completion 2008-09 6 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00407251

    Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

    Not yet reported British Columbia Cancer Agency 73 participants 5 sites
    Other conditions: Hormone Refractory Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00411853

    Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

    Not yet reported Sheba Medical Center 60 participants Est. completion 2012-06 1 site
    Other conditions: Hormone Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00420251

    Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

    Not yet reported Ludwig-Maximilians - University of Munich 50 participants Est. completion 2006-07 1 site
    Other conditions: Juvenile Idiopathic Arthritis, Still Disease, Juvenile-Onset
    View official trial listing →
  • Completed NCT NCT00420654

    Growth Hormone Treatment of Women With Turner Syndrome

    Not yet reported Britta E. Hjerrild 24 participants Est. completion 2011-09 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00433446

    S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported SWOG Cancer Research Network 62 participants Est. completion 2011-07 123 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00433589

    Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 6600 participants Est. completion 2020-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00437359

    Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

    Not yet reported Japan Breast Cancer Research Network 240 participants Est. completion 2020-05 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00450463

    Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 64 participants Est. completion 2017-06-08 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00452140

    Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

    Not yet reported Neovii Biotech 40 participants Est. completion 2009-02 5 sites
    Other conditions: Metastatic Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00452556

    The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

    Not yet reported Nova Scotia Cancer Centre 86 participants Est. completion 2017-02 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00458263

    Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

    Not yet reported Rabin Medical Center 21 participants Est. completion 2011-05 1 site
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT00458991

    rhGH Therapy on Hepatic Drug Metabolism

    University of Louisville 9 participants Est. completion 2008-09 4 sites
    Other conditions: Growth Hormone Deficiency, Dwarfism
    View official trial listing →
  • Completed NCT NCT00460031

    Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported Case Comprehensive Cancer Center 34 participants Est. completion 2010-08-31 6 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00464516

    Preoperative Estetrol in Breast Cancer

    Not yet reported Pantarhei Bioscience 30 participants Est. completion 2010-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00466102

    Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2012-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00471718

    ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 27 participants Est. completion 2009-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00473187

    Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets

    Not yet reported University of Rostock Est. completion 2009-08 1 site
    Other conditions: Hypophosphatemic Rickets, Growth Disorders, Somatropin Therapy
    View official trial listing →
  • Completed NCT NCT00482391

    Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 95 participants Est. completion 2011-07 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00483561

    Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported University of Nebraska 26 participants Est. completion 2010-01 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00486642

    Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported National Cancer Institute (NCI) 23 participants Est. completion 2015-09 6 sites
    Other conditions: Hormone-Resistant Prostate Cancer, Recurrent Prostate Carcinoma
    View official trial listing →
  • Completed NCT NCT00499083

    Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

    Not yet reported University of Nebraska 17 participants Est. completion 2010-01-28 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00512668

    Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 24 participants 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00513071

    AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported National Cancer Institute (NCI) 28 participants Est. completion 2008-10 1 site
    Other conditions: Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00519844

    Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

    Not yet reported Novo Nordisk A/S 5 participants Est. completion 2006-01 1 site
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Terminated NCT NCT00521781

    Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

    Not yet reported The Methodist Hospital Research Institute 14 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Terminated NCT NCT00525161

    Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer

    Not yet reported Suleiman Massarweh 11 participants Est. completion 2015-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00527124

    Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2013-11 4 sites
    Other conditions: Adenocarcinoma of the Prostate, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00530868

    Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

    Not yet reported University of Alabama at Birmingham 75 participants Est. completion 2022-03-31 7 sites
    Other conditions: Breast Cancer, Cancer of the Breast, Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT00535418

    Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

    Not yet reported, Not yet reported Novartis Pharmaceuticals 35 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00537771

    Liver Safety Under Upfront Arimidex vs Tamoxifen

    Not yet reported AstraZeneca 384 participants Est. completion 2011-12 16 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00544167

    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 45 participants Est. completion 2011-04 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00544830

    Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

    Not yet reported City of Hope Medical Center 29 participants Est. completion 2027-02-15 2 sites
    Other conditions: PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7
    View official trial listing →
  • Status unknown NCT NCT00547001

    Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes

    Not yet reported Hartford Hospital 235 participants Est. completion 2009-11 1 site
    Other conditions: Hot Flashes, Night Sweats
    View official trial listing →
  • Completed NCT NCT00553410

    Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 4884 participants Est. completion 2019-05-15 164 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00554918

    Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

    Not yet reported University Hospital Birmingham 300 participants Est. completion 2013-06 16 sites
    Other conditions: Metastatic Cancer, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00555919

    ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

    Not yet reported Bayer 68 participants Est. completion 2011-03 28 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00557336

    Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

    Not yet reported Novo Nordisk A/S 160 participants Est. completion 2005-06-29 37 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Status unknown NCT NCT00561444

    Quality of Life Study for Prostate Cancer Patients

    M.D. Anderson Cancer Center 1051 participants Est. completion 2020-11 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00570258

    Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

    Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00579072

    The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older

    Memorial Sloan Kettering Cancer Center 230 participants Est. completion 2027-12 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00588003

    Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 45 participants Est. completion 2009-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00589420

    Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

    Not yet reported Abramson Cancer Center at Penn Medicine 18 participants Est. completion 2011-02-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00601900

    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 394 participants Est. completion 2024-01-29 522 sites
    Other conditions: Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00602043

    F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2014-09 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00604318

    Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer

    Not yet reported Copenhagen University Hospital at Herlev 56 participants Est. completion 2012-02 1 site
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Completed NCT NCT00604825

    Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

    Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sites
    Other conditions: Menopausal and Female Climacteric States
    View official trial listing →
  • Completed NCT NCT00617942

    Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer

    Not yet reported William Sikov MD 60 participants Est. completion 2015-12 5 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00626106

    QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported NantCell, Inc. 156 participants Est. completion 2011-09-23 60 sites
    Other conditions: Breast Cancer, Breast Tumors, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT00627354

    Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported Groupe D'Etude des Tumeurs Uro-Genitales 90 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00647218

    Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 38 participants Est. completion 2004-11 6 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00651222

    Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy

    Prostate Cancer Foundation of Chicago 1 site
    Other conditions: Prostate Cancer, Cardiovascular Death
    View official trial listing →
  • Terminated NCT NCT00661531

    Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

    Not yet reported Georgetown University 11 participants Est. completion 2015-06 3 sites
    Other conditions: Breast Cancer, Cancer of the Breast, Neoplasms, Breast
    View official trial listing →
  • Terminated NCT NCT00665457

    Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

    Not yet reported University of Nebraska 3 participants Est. completion 2009-07-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00666822

    Compliance to a Hormone Therapy Regimen in Breast Cancer

    Case Comprehensive Cancer Center 178 participants Est. completion 2015-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00667069

    Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

    Not yet reported UNICANCER 424 participants Est. completion 2022-05-24 17 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00668083

    Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

    AstraZeneca 214 participants Est. completion 2008-07 12 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00668603

    Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)

    Not yet reported University of Helsinki 160 participants Est. completion 2008-03 1 site
    Cardiovascular disease Other conditions: Postmenopausal Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00669162

    Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer

    Not yet reported, Not yet reported University of Kansas Medical Center 27 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00681122

    CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)

    AstraZeneca 2600 participants Est. completion 2011-05 164 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00685009

    The Women's Health Initiative Memory Study (The WHIMS Study)

    National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 site
    Other conditions: Dementia Syndromes
    View official trial listing →
  • Terminated NCT NCT00686036

    Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy

    Not yet reported Genzyme, a Sanofi Company 17 participants Est. completion 2010-10 11 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00687739

    Prevention of Obesity in Women Via Estradiol Regulation

    Not yet reported University of Colorado, Denver 79 participants Est. completion 2014-06 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00711061

    Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

    Children's Mercy Hospital Kansas City 24 participants Est. completion 2009-02 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00713440

    Incretin Physiology Associated With Steroid Hormone Treatment

    Not yet reported Glostrup University Hospital, Copenhagen 10 participants Est. completion 2009-01 1 site
    Type 2 diabetes Other conditions: Steroids
    View official trial listing →
  • Completed NCT NCT00726661

    An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)

    Genentech, Inc. 1287 participants Est. completion 2012-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00738205

    Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector

    Merck KGaA, Darmstadt, Germany 834 participants Est. completion 2009-06
    Other conditions: Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Failure, Small for Gestational Age
    View official trial listing →
  • Terminated NCT NCT00743327

    Androgen Deprivation Therapy Study

    National Institute on Aging (NIA) 1 participants Est. completion 2012-08 1 site
    Metabolic syndrome Other conditions: Hypogonadism, Diabetes, Inflammation
    View official trial listing →
  • Completed NCT NCT00745056

    Examining the Relationship Between Hormone Therapy (HT) and Cognitive Function (The WHIMS-ECHO Study)

    Wake Forest University Health Sciences 2922 participants Est. completion 2021-11-04 1 site
    Other conditions: Dementia
    View official trial listing →
  • Terminated NCT NCT00748969

    Clinical Trial of Growth Hormone in MPS I, II, and VI

    Not yet reported, Not yet reported Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 2 participants Est. completion 2013-09 1 site
    Other conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI
    View official trial listing →
  • Completed NCT NCT00757393

    Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis

    Not yet reported The Hospital for Sick Children 21 participants Est. completion 2015-09 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00764166

    A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel

    Not yet reported Assistance Publique - Hôpitaux de Paris 254 participants Est. completion 2010-11 1 site
    Other conditions: Adenocarcinoma of the Prostate
    View official trial listing →
  • Completed NCT NCT00769548

    Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 1322 participants Est. completion 2016-12
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00773695

    A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 150 participants Est. completion 2022-11-09 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00781547

    Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

    Not yet reported Göteborg University 40 participants Est. completion 2005-05 1 site
    Metabolic syndrome Other conditions: Abdominal Obesity, Obesity
    View official trial listing →
  • Completed NCT NCT00784888

    Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

    Pfizer 344 participants Est. completion 2011-12 16 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00796458

    Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

    Not yet reported A.O.U. San Giovanni Battista di Torino, Italy 200 participants 1 site
    Other conditions: Pain, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00808041

    Chemotherapy Monitoring With Breast Computed Tomography (CT)

    Emory University 3 participants Est. completion 2015-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00813189

    Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

    Not yet reported Association REMEDE 30 participants Est. completion 2012-05 1 site
    Other conditions: Chronic Disease, Glucocorticoid Therapy, Response to, Growth Retardation
    View official trial listing →
  • Completed NCT NCT00817739

    Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

    Not yet reported Takeda 341 participants Est. completion 2008-12
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00833248

    Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

    Not yet reported Ferring Pharmaceuticals 246 participants Est. completion 2011-09 66 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00847366

    Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

    Not yet reported AEterna Zentaris 10 participants Est. completion 2012-12
    Other conditions: Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, Sarcomas
    View official trial listing →
  • Completed NCT NCT00849758

    Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients

    Universitaire Ziekenhuizen KU Leuven 110 participants Est. completion 2014-09 2 sites
    Other conditions: Breast Cancer, Elderly
    View official trial listing →
  • Status unknown NCT NCT00867971

    Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

    Assaf-Harofeh Medical Center 100 participants Est. completion 2010-10 1 site
    Other conditions: Growth Hormone Treatment, Glaucoma
    View official trial listing →
  • Status unknown NCT NCT00868868

    Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy

    Groupe de recherche en Urologie de la Mauricie 400 participants Est. completion 2011-09 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00878436

    Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

    Not yet reported, Not yet reported NYU Langone Health 52 participants Est. completion 2015-07 4 sites
    Other conditions: Prostate Cancer, Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00884143

    Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

    AstraZeneca 515 participants Est. completion 2010-01 3 sites
    Other conditions: Post Menopausal, Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00887380

    STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

    Not yet reported Trans Tasman Radiation Oncology Group 2023 participants Est. completion 2024-12 34 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00893061

    Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

    Not yet reported Centre Oscar Lambret 44 participants Est. completion 2014-11-26 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00895310

    Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

    Not yet reported University of California, Davis 30 participants Est. completion 2015-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00895466

    Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

    Not yet reported, Not yet reported Pepscan Therapeutics 12 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00897962

    Blood Glycan Biomarkers in Women With Stage IV Breast Cancer

    University of California, Davis 163 participants Est. completion 2016-01-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00898326

    PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer

    Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 198 participants Est. completion 2016-12-31 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00899288

    Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98

    Not yet reported ETOP IBCSG Partners Foundation 60 participants Est. completion 2007-07
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Active, not recruiting NCT NCT00903591

    Study of Radiation Exposure and Bilateral Breast Cancer

    Memorial Sloan Kettering Cancer Center 1699 participants Est. completion 2027-05 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00912340

    Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer

    Not yet reported Emory University 70 participants Est. completion 2017-07 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00921115

    Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

    Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 site
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00929214

    Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

    Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2027-12-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00929591

    SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

    Not yet reported SWOG Cancer Research Network 1558 participants Est. completion 2010-03
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00932152

    Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

    Not yet reported University of Pittsburgh 3 participants Est. completion 2013-01 1 site
    Other conditions: Non-small Cell Lung Cancer, Postmenopausal Women
    View official trial listing →
  • Completed NCT NCT00943527

    Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

    Mayo Clinic 110 participants Est. completion 2012-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00955435

    Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15

    Cancer Trials Ireland 60 participants Est. completion 2026-08-06 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00963729

    Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery

    Not yet reported Imperial College London 756 participants Est. completion 2011-03 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00967863

    Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

    Not yet reported UNICANCER 500 participants Est. completion 2026-10 25 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00990886

    The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women

    Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC 148 participants Est. completion 2005-01
    Other conditions: Menopause, Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT00999804

    Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy

    Not yet reported Baylor Breast Care Center 128 participants Est. completion 2026-01 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01006564

    Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer

    Not yet reported Royal Marsden NHS Foundation Trust 30 participants Est. completion 2011-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01013506

    Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2009-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01016665

    Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

    Not yet reported Federal University of São Paulo 71 participants Est. completion 2008-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01023061

    Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

    Not yet reported University of Washington 24 participants Est. completion 2015-09 2 sites
    Other conditions: Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01023802

    The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer

    Mayo Clinic 20 participants Est. completion 2011-02 1 site
    Other conditions: Neoadjuvant Therapy, Chemotherapy, Hormone Replacement Therapy, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01025349

    Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

    Not yet reported Taipei Medical University Hospital 20 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01046643

    Early Menopause Hormone Treatment and Cognition

    Not yet reported University of Michigan 30 participants Est. completion 2012-03 1 site
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Completed NCT NCT01065220

    Sex Steroids and the Serotonin Transporter

    Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Completed NCT NCT01066052

    Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

    Not yet reported Merck KGaA, Darmstadt, Germany 115 participants Est. completion 2010-08-31 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT01070485

    BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease

    Not yet reported Bayer 23 participants Est. completion 2012-01 4 sites
    Other conditions: Breast Cancer, Bone Metastases
    View official trial listing →
  • Status unknown NCT NCT01072318

    Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene

    Not yet reported Korean Breast Cancer Study Group 495 participants Est. completion 2014-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01076335

    Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01081613

    Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

    University Medical Center Groningen 7 participants Est. completion 2012-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01122121

    Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

    Not yet reported Takeda 273 participants Est. completion 2009-06 1 site
    Other conditions: Prostatic Neoplasms, Locally Advanced
    View official trial listing →
  • Completed NCT NCT01124773

    Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm

    Wake Forest University Health Sciences 1362 participants Est. completion 2016-06 1 site
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT01129336

    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

    Not yet reported Novartis Pharmaceuticals 44 participants Est. completion 2012-08 33 sites Stand-alone
    Other conditions: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis
    View official trial listing →
  • Completed NCT NCT01138345

    Biomarkers in Blood Samples From Older Breast Cancer Survivors

    UNC Lineberger Comprehensive Cancer Center 246 participants Est. completion 2014-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01151215

    Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

    Not yet reported AstraZeneca 482 participants Est. completion 2013-01 60 sites
    Other conditions: Neoplasms, Breast Neoplasms, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01176916

    Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

    Not yet reported Pfizer 564 participants Est. completion 2018-11-30 53 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01194271

    Neoadjuvant Ipilimumab in Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 19 participants Est. completion 2015-10 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01202591

    Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients

    Not yet reported, Not yet reported AstraZeneca 127 participants Est. completion 2014-10 21 sites
    Other conditions: FGFR Inhibition, Pharmacokinetics, Biomarkers, ER+ Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01205685

    Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 11 participants Est. completion 2011-07 3 sites
    Other conditions: Hormone-sensitive Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01239251

    GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy

    Memorial Sloan Kettering Cancer Center 8 participants Est. completion 2011-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01240928

    MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01240941

    Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2012-12
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01246427

    Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer

    Not yet reported Centre Leon Berard 138 participants Est. completion 2014-11 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01248494

    PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 72 participants Est. completion 2016-05 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01250717

    Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

    Not yet reported Beth Israel Deaconess Medical Center 28 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01259778

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea

    Merck KGaA, Darmstadt, Germany 224 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01263457

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

    Merck KGaA, Darmstadt, Germany 191 participants Est. completion 2015-12-31 6 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01263717

    Effects of Growth Hormone Releasing Hormone in HIV

    Not yet reported Massachusetts General Hospital 54 participants Est. completion 2014-02 1 site
    Other conditions: HIV, HIV Lipodystrophy
    View official trial listing →
  • Completed NCT NCT01265654

    Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer

    AstraZeneca 234 participants Est. completion 2011-11 37 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01267526

    A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment

    Merck KGaA, Darmstadt, Germany 205 participants Est. completion 2015-12-31 9 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT01272037

    Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

    Not yet reported National Cancer Institute (NCI) 5018 participants Est. completion 2027-01-08 1568 sites
    Other conditions: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Synchronous Bilateral Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT01281137

    Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07

    ETOP IBCSG Partners Foundation 104 participants Est. completion 2019-05-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01291394

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France

    Merck KGaA, Darmstadt, Germany 223 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01292785

    Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity

    Medical University of Vienna 80 participants Est. completion 2015-04 1 site
    Other conditions: Gender Identity Disorder
    View official trial listing →
  • Completed NCT NCT01293032

    Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

    Not yet reported Virginia Commonwealth University 59 participants Est. completion 2016-03 8 sites Stand-alone
    Other conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01296555

    A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

    Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sites
    Other conditions: Solid Cancers, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01300351

    Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

    Not yet reported AstraZeneca 249 participants Est. completion 2014-03 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01302041

    A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

    Not yet reported Astellas Pharma Inc 67 participants Est. completion 2017-04-27 12 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01302652

    Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment

    Massachusetts General Hospital 20 participants Est. completion 2015-02 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01307059

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden

    Merck KGaA, Darmstadt, Germany 152 participants Est. completion 2015-12-31 3 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01309555

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia

    Merck KGaA, Darmstadt, Germany 33 participants Est. completion 2016-10-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01309672

    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

    Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2024-04-11 205 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01320046

    Vulvar Contact Dermatitis Resulting From Urine Incontinence

    Meir Medical Center Est. completion 2012-03 1 site
    Other conditions: Urinary Incontinence, Vulvar Pruritus, Vulvar Contact Dermatitis
    View official trial listing →
  • Active, not recruiting NCT NCT01327781

    Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2026-10-30 3 sites
    Other conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01329757

    Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury

    Not yet reported Hospital Nacional de Parapléjicos de Toledo 76 participants Est. completion 2015-11 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT01344564

    Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide

    Not yet reported Urology of Virginia 50 participants Est. completion 2012-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01350180

    Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

    Dr. Tamim Niazi Est. completion 2022-12-01 8 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT01351844

    The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

    Not yet reported George Washington University 12 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer, Arthralgia
    View official trial listing →
  • Status unknown NCT NCT01352091

    Adjuvant AI Combined With Zoladex

    Not yet reported Fudan University 670 participants Est. completion 2018-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01368263

    Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

    Not yet reported Washington University School of Medicine 8 participants Est. completion 2013-05 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01374087

    Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

    Not yet reported Ipsen 32 participants Est. completion 2014-12 11 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01376921

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain

    Merck KGaA, Darmstadt, Germany 300 participants Est. completion 2015-03-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01384526

    Investigating the Impact of Tamoxifen Therapy on Ovarian Aging

    University of California, San Francisco 266 participants Est. completion 2015-03 1 site
    Other conditions: Breast Cancer, Fertility
    View official trial listing →
  • Completed NCT NCT01385280

    Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

    Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01392586

    Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer

    Not yet reported Jeroen Bosch Ziekenhuis 10 participants Est. completion 2014-01 26 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01397500

    Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

    Not yet reported Max-Planck-Institute of Psychiatry 54 participants Est. completion 2015-03 1 site
    Other conditions: Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01400984

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia

    Merck KGaA, Darmstadt, Germany 92 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01400997

    Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

    Merck KGaA, Darmstadt, Germany 206 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01402999

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary

    Merck KGaA, Darmstadt, Germany 83 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01419197

    A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

    Not yet reported Hoffmann-La Roche 602 participants Est. completion 2015-08 184 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01419249

    First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study

    Not yet reported Merck KGaA, Darmstadt, Germany 458 participants Est. completion 2012-10 31 sites
    Other conditions: Idiopathic Growth Hormone Deficiency, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01420250

    Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20 participants Est. completion 2020-07-21 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01421589

    Growth Hormone Treatment on Phosphocreatine Recovery in Obesity

    Not yet reported Massachusetts General Hospital 15 participants Est. completion 2013-03 1 site
    Other conditions: Obese, Growth Hormone Secretion Abnormality
    View official trial listing →
  • Completed NCT NCT01422408

    Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

    Not yet reported OHSU Knight Cancer Institute 34 participants Est. completion 2015-10 1 site
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT01423890

    A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

    Not yet reported Ontario Clinical Oncology Group (OCOG) 1011 participants Est. completion 2014-02 35 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01431391

    Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

    Not yet reported Dendreon 68 participants Est. completion 2014-12 14 sites
    Other conditions: Prostatic Neoplasm, Prostate Cancer, Prostatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01432028

    Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

    Not yet reported Denusa Wiltgen 90 participants Est. completion 2011-04 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT01438528

    Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

    Merck KGaA, Darmstadt, Germany 75 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01439061

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy

    Merck KGaA, Darmstadt, Germany 220 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01441713

    Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer

    Copenhagen University Hospital at Herlev 178 participants Est. completion 2012-06 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT01444820

    Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

    Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 329 participants Est. completion 2026-01 12 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01446159

    Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

    Not yet reported MedImmune LLC 188 participants Est. completion 2019-06-28 71 sites
    Other conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01471288

    Effect of Carum Carvi on Thyroid Hormones and TSH Level

    Not yet reported, Not yet reported Mashhad University of Medical Sciences 40 participants 1 site
    Other conditions: Thyroid Cancer Patients
    View official trial listing →
  • Terminated NCT NCT01477060

    Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer

    Not yet reported Fondazione Michelangelo 32 participants Est. completion 2013-12 11 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01481090

    Electro-acupuncture and Assisted Reproductive Technology

    Not yet reported National University of Health Sciences 16 participants Est. completion 2012-03 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01491854

    Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

    Not yet reported Sandoz 130 participants Est. completion 2018-10-31 23 sites
    Other conditions: Short Children Born Small for Gestational Age (SGA)
    View official trial listing →
  • Completed NCT NCT01493310

    Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

    Not yet reported University of Chicago 9 participants Est. completion 2018-05 2 sites
    Other conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01500486

    Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

    Novo Nordisk A/S 84 participants Est. completion 2009-03 4 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children, Delivery Systems
    View official trial listing →
  • Status unknown NCT NCT01503905

    Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2021-12 17 sites
    Other conditions: Breast Cancer Nos Premenopausal
    View official trial listing →
  • Terminated NCT NCT01528345

    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

    Not yet reported Novartis Pharmaceuticals 97 participants Est. completion 2015-04 67 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01531205

    Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 2 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01546623

    A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy

    Not yet reported Takeda 160 participants Est. completion 2014-04 16 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01548677

    Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1317 participants Est. completion 2017-03 80 sites
    Other conditions: Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Circulating Tumor Cells
    View official trial listing →
  • Withdrawn NCT NCT01549288

    Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy

    Not yet reported, Not yet reported Lady Hardinge Medical College Est. completion 2013-12 1 site
    Other conditions: Infantile Spasms
    View official trial listing →
  • Completed NCT NCT01553903

    Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not

    Not yet reported Institut Claudius Regaud 29 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01555528

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico

    Merck KGaA, Darmstadt, Germany 193 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01556243

    Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 270 participants Est. completion 2023-04-15 350 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01580605

    French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

    Novo Nordisk A/S 331 participants Est. completion 2011-11-28 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01602380

    A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

    Not yet reported AstraZeneca 462 participants Est. completion 2026-01-16 118 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01605071

    Timing Estrogen After MenoPaUSe

    Not yet reported University of Colorado, Denver 53 participants Est. completion 2017-01 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01612871

    Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

    Not yet reported Institut Claudius Regaud 39 participants Est. completion 2016-01-28 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01613131

    Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

    Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-06 1 site
    Other conditions: Menopausal and Other Perimenopausal Disorders
    View official trial listing →
  • Withdrawn NCT NCT01614171

    Growth Hormone for Osteoporosis Pseudoglioma Syndrome

    Not yet reported University of Maryland, Baltimore Est. completion 2015-12 1 site
    Other conditions: Osteoporosis Pseudoglioma Syndrome
    View official trial listing →
  • Completed NCT NCT01614210

    Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance

    Not yet reported University of Utah 52 participants Est. completion 2016-11 1 site
    Other conditions: Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
    View official trial listing →
  • Completed NCT NCT01615120

    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

    Not yet reported GTx 77 participants Est. completion 2016-11-09 26 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT01616758

    Phase II Study of GTx024 in Women With Metastatic Breast Cancer

    Not yet reported GTx 22 participants Est. completion 2016-03 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01619111

    DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs

    Not yet reported Prof. Wolfgang Janni 105 participants Est. completion 2022-01 1 site
    Other conditions: HER2-negative Metastatic Breast Cancer, HER2-positive Circulating Tumor Cells
    View official trial listing →
  • Status unknown NCT NCT01622361

    Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

    Not yet reported Asan Medical Center 290 participants Est. completion 2016-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01630590

    Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2021-04-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01674140

    S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

    Not yet reported SWOG Cancer Research Network 1939 participants Est. completion 2030-01 1458 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01694225

    Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

    Not yet reported University of Louisville 87 participants Est. completion 2018-01-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01697644

    Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

    Not yet reported Novo Nordisk A/S 75 participants Est. completion 2005-05 2 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Terminated NCT NCT01698944

    Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 7 participants Est. completion 2002-11-18 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01712230

    Females, Aging, Metabolism, and Exercise

    Not yet reported University of Colorado, Denver 47 participants Est. completion 2017-10 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01720602

    Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

    Not yet reported University of Washington 15 participants Est. completion 2020-01 1 site
    Other conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01722851

    Circulating miRNAs.

    Cancer Trials Ireland 255 participants Est. completion 2021-12 7 sites
    Other conditions: Breast Cancer, Newly Diagnosed Breast Cancer, Recurrent Breast Cancer
    View official trial listing →
  • Completed NCT NCT01729676

    Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

    Ferring Pharmaceuticals 315 participants Est. completion 2014-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01736163

    A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours

    Genzyme, a Sanofi Company 144 participants Est. completion 2012-08 9 sites
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Withdrawn NCT NCT01738685

    Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy

    Not yet reported University of Pittsburgh Est. completion 2015-12 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT01741883

    Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients

    Not yet reported Philipps University Marburg 165 participants Est. completion 2020-08 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT01745965

    A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.

    Not yet reported Women's Cancer Study Group GmbH 380 participants Est. completion 2025-01-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01750398

    Bipolar Androgen-based Therapy for Prostate Cancer (BAT)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2015-06 1 site
    Other conditions: Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01753297

    A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

    Not yet reported Ipsen 226 participants Est. completion 2019-09-09 18 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01758146

    Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 412 participants Est. completion 2020-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01765049

    Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor

    Seoul National University Hospital 260 participants Est. completion 2025-12-15 1 site
    Other conditions: Invasive Breast Cancer, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01773551

    Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response

    University of California, Irvine Est. completion 2018-04 4 sites
    Other conditions: Accessory; Breast Tissue
    View official trial listing →
  • Completed NCT NCT01780220

    Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery

    Not yet reported, Not yet reported UNICANCER 47 participants Est. completion 2022-01-07 5 sites
    Other conditions: Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
    View official trial listing →
  • Completed NCT NCT01781338

    Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer

    Not yet reported, Not yet reported Women's Cancer Study Group GmbH 4936 participants Est. completion 2025-01-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01791478

    BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 46 participants Est. completion 2022-10-06 2 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01796197

    Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

    Not yet reported Dana-Farber Cancer Institute 23 participants Est. completion 2026-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01800058

    Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy

    Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 68 participants Est. completion 2018-12-21 3 sites
    Other conditions: Patients With High-risk Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01805271

    Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

    Not yet reported UNICANCER 1278 participants Est. completion 2030-06 2 sites
    Other conditions: Primary Non-metastatic Breast Cancer, Who Remain Disease-free
    View official trial listing →
  • Status unknown NCT NCT01814449

    Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer

    Fudan University 130 participants Est. completion 2014-05 1 site
    Other conditions: Breast Cancer, Hypoxia
    View official trial listing →
  • Completed NCT NCT01822288

    The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

    Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 site
    Other conditions: Menopausal Syndromes
    View official trial listing →
  • Withdrawn NCT NCT01826838

    Study of Dasatinib, Androgen Deprivation Therapy and Radiation

    Not yet reported Brown University Est. completion 2013-04
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01831076

    Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

    Not yet reported University of Colorado, Denver 36 participants Est. completion 2022-01-06 1 site
    Other conditions: Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    View official trial listing →
  • Completed NCT NCT01867424

    Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2016-12-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01896050

    Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer

    University of Michigan Rogel Cancer Center 115 participants Est. completion 2014-08 1 site
    Other conditions: Breast Cancer, Arthralgia, Obesity
    View official trial listing →
  • Terminated NCT NCT01897441

    Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

    Not yet reported Albert Einstein College of Medicine 31 participants Est. completion 2023-10-25 1 site
    Other conditions: Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01904734

    Clomid in Men With Low Testosterone With and Without Prior Treatment

    Not yet reported Phoenix VA Health Care System 42 participants Est. completion 2018-10-31 1 site
    Other conditions: Hypogonadism, Male
    View official trial listing →
  • Terminated NCT NCT01907009

    A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)

    Not yet reported, Not yet reported Barts & The London NHS Trust 29 participants Est. completion 2016-12-22 1 site
    Other conditions: Castrate Resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01937052

    Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 329 participants Est. completion 2024-11-25 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01942135

    Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

    Not yet reported Pfizer 521 participants Est. completion 2022-09-28 247 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01946165

    Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

    Not yet reported M.D. Anderson Cancer Center 69 participants Est. completion 2017-07-28 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01963481

    Exemestane and Cyclophosphamide for Metastatic Breast Cancer

    Not yet reported NYU Langone Health 23 participants Est. completion 2017-10-01 1 site
    Other conditions: Metastatic Beast Cancer
    View official trial listing →
  • Completed NCT NCT01973660

    PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer

    Not yet reported SOLTI Breast Cancer Research Group 151 participants Est. completion 2017-12 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01990196

    Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 45 participants Est. completion 2026-09-30 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01994239

    Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

    Not yet reported UNICANCER 120 participants Est. completion 2025-03 39 sites Stand-alone
    Other conditions: Adenocarcinoma of Prostate
    View official trial listing →
  • Completed NCT NCT01996046

    FDG PET/CT in Breast Cancer Bone Mets

    University of Pennsylvania 26 participants Est. completion 2026-07-31 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer, Bone Metastases
    View official trial listing →
  • Terminated NCT NCT02000596

    1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

    Not yet reported University of Maryland, Baltimore 2 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02015273

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

    Merck KGaA, Darmstadt, Germany 82 participants Est. completion 2015-12-31 6 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT02015559

    Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

    Not yet reported Jonsson Comprehensive Cancer Center 61 participants Est. completion 2018-11-30 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02023463

    Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

    Not yet reported Thomas Jefferson University 25 participants Est. completion 2040-01-01 1 site
    Other conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02035813

    DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

    Not yet reported Prof. Wolfgang Janni 116 participants Est. completion 2024-01-10 1 site
    Other conditions: HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal Female Patients
    View official trial listing →
  • Completed NCT NCT02040857

    Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 162 participants Est. completion 2024-12-27 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02049671

    Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet

    The Leeds Teaching Hospitals NHS Trust 150 participants Est. completion 2020-07-30 1 site
    Other conditions: Hypopituitary Adults
    View official trial listing →
  • Completed NCT NCT02057029

    Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

    Not yet reported Yale University 96 participants Est. completion 2015-06 1 site
    Other conditions: Breast Cancer, Early Stage Estrogen Receptor (ER) Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02064582

    Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

    Not yet reported University of Texas Southwestern Medical Center 7 participants Est. completion 2018-06-09 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02078531

    A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients

    National University Hospital, Singapore 130 participants Est. completion 2020-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02088710

    Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer

    Philipps University Marburg 138 participants Est. completion 2020-02 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02089854

    Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

    Not yet reported Peking Union Medical College Hospital 800 participants 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT02090114

    RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 112 participants Est. completion 2021-11-11 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02097459

    Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

    Not yet reported Peking Union Medical College Hospital 600 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02102490

    A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

    Not yet reported Eli Lilly and Company 132 participants Est. completion 2018-10-22 36 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02107287

    Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer

    Not yet reported Sergio Faria 105 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: High Risk Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02107391

    Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

    Not yet reported SOTIO a.s. 63 participants Est. completion 2016-06 9 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02122198

    Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

    Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sites
    Cardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT02132949

    A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

    Not yet reported Hoffmann-La Roche 401 participants Est. completion 2020-08-25 80 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02137083

    A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

    Not yet reported Fudan University 22 participants Est. completion 2017-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02140437

    Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

    Not yet reported Fudan University Est. completion 2016-06
    Other conditions: Carcinoma Breast Stage IV
    View official trial listing →
  • Completed NCT NCT02141659

    A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

    Not yet reported Takeda 43 participants Est. completion 2017-04-20 6 sites
    Other conditions: Hormone Treatment-naïve Participants With Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02204098

    Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

    Not yet reported Washington University School of Medicine 27 participants Est. completion 2028-08-31 1 site
    Other conditions: Breast Cancer, Breast Carcinoma, Malignant Neoplasm of Breast
    View official trial listing →
  • Status unknown NCT NCT02213991

    Intraoperative Radiotherapy for Korean Patients With Breast Cancer

    Not yet reported Gangnam Severance Hospital 215 participants Est. completion 2020-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02214004

    Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women

    Not yet reported Gangnam Severance Hospital 132 participants Est. completion 2019-06 14 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02216162

    PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program

    Not yet reported Hospices Civils de Lyon 12 participants Est. completion 2019-02-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02221999

    Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

    Not yet reported, Not yet reported RenJi Hospital 250 participants Est. completion 2029-01 12 sites
    Other conditions: Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
    View official trial listing →
  • Completed NCT NCT02224313

    Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women

    Not yet reported Intira Sriprasert 20 participants Est. completion 2018-08 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02228681

    Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

    Not yet reported GOG Foundation 74 participants Est. completion 2024-08-22 26 sites
    Other conditions: Advanced, Persistent, or Recurrent Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT02238509

    Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies

    Not yet reported Consorzio Oncotech 154 participants Est. completion 2017-10 36 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02256670

    Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

    Not yet reported Yale University 100 participants Est. completion 2016-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02258464

    Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Bayer 99 participants Est. completion 2019-08-13 71 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02264743

    Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sites
    Other conditions: Venous Thrombosis, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT02269670

    Phase II Study of Everolimus Beyond Progression

    Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT02269813

    PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)

    Women's Cancer Study Group GmbH 452 participants Est. completion 2016-09-30 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02269982

    Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

    Duke University 120 participants Est. completion 2019-04-30 5 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02274779

    Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

    Not yet reported Institut Cancerologie de l'Ouest 74 participants Est. completion 2024-07-22 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02284581

    Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments

    Consorzio Oncotech 10000 participants Est. completion 2025-12 35 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02300675

    Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy

    Not yet reported Institut de Cancérologie de la Loire 352 participants Est. completion 2017-08 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02308020

    A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

    Not yet reported Eli Lilly and Company 162 participants Est. completion 2019-11-08 44 sites
    Other conditions: Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Brain Metastases
    View official trial listing →
  • Active, not recruiting NCT NCT02308085

    Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 518 participants Est. completion 2028-12 211 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02338310

    Trial of Perioperative Endocrine Therapy - Individualising Care

    Not yet reported Institute of Cancer Research, United Kingdom 4486 participants Est. completion 2034-04 128 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02344472

    Detect V / CHEVENDO (Chemo vs. Endo)

    Not yet reported Prof. Wolfgang Janni 271 participants Est. completion 2025-01-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02345772

    Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy

    Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: HER2-positive Breast Cancer, ER-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02347449

    The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

    Not yet reported Sunnybrook Health Sciences Centre 100 participants Est. completion 2016-09-30 1 site
    Other conditions: Hormone Receptor Positive Malignant Neoplasm of Breast
    View official trial listing →
  • Active, not recruiting NCT NCT02352883

    MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

    Not yet reported ECOG-ACRIN Cancer Research Group 368 participants Est. completion 2027-11 76 sites
    Other conditions: Ductal Breast Carcinoma In Situ
    View official trial listing →
  • Completed NCT NCT02366494

    Micro RNAs to Predict Response to Androgen Deprivation Therapy

    Medical College of Wisconsin 42 participants Est. completion 2021-05-11 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT02376413

    Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Est. completion 2022-12
    Other conditions: Local Recurrence of Malignant Tumor of Breast
    View official trial listing →
  • Completed NCT NCT02384408

    Hormone Replacement Therapy on the Postmenopausal Endometrium

    Not yet reported Universidade do Vale do Sapucai 100 participants Est. completion 2015-07 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02388308

    Evaluation of Clarity Ultrasound Guidance for Prostate Therapy

    Institute of Cancer Research, United Kingdom 61 participants Est. completion 2018-06-18 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT02395627

    Reversing Therapy Resistance With Epigenetic-Immune Modification

    Not yet reported University of California, San Francisco 38 participants Est. completion 2019-06-08 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02398773

    FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Not yet reported National Cancer Institute (NCI) 99 participants Est. completion 2026-12-31 25 sites
    Other conditions: HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02400060

    Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 39 participants Est. completion 2020-06-30 4 sites
    Other conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage 0 Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02400190

    The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

    Not yet reported University of Michigan Rogel Cancer Center 202 participants Est. completion 2028-05 13 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02401685

    POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer

    Not yet reported University Hospitals of Derby and Burton NHS Foundation Trust 1900 participants Est. completion 2026-12-31 50 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02406794

    Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors

    Not yet reported, Not yet reported University of Malaga 156 participants Est. completion 2017-03 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02408536

    Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer

    National Cancer Institute, Naples 150 participants Est. completion 2024-07 1 site
    Other conditions: Low-grade Serous Ovarian Carcinoma, Recurrent Invasive Borderline Serous Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT02414776

    Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy

    Not yet reported Western Regional Medical Center 3 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02420353

    Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears

    Not yet reported University of Michigan 20 participants Est. completion 2018-10 1 site
    Other conditions: Rupture of Anterior Cruciate Ligament
    View official trial listing →
  • Completed NCT NCT02440230

    Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients

    Not yet reported Shanghai Jiao Tong University School of Medicine 110 participants Est. completion 2021-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02444390

    Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

    Not yet reported UNICANCER 150 participants Est. completion 2022-07-01 12 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02448420

    Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer

    Not yet reported SOLTI Breast Cancer Research Group 73 participants Est. completion 2023-11-30 35 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02449837

    Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy

    UNC Lineberger Comprehensive Cancer Center 162 participants Est. completion 2022-02-20 1 site
    Other conditions: Circulating Tumor Cells
    View official trial listing →
  • Completed NCT NCT02456571

    CTC Immune Checkpoint

    Duke University 38 participants Est. completion 2019-06-13 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02458716

    Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

    Not yet reported Rutgers, The State University of New Jersey 26 participants Est. completion 2020-01-14 3 sites
    Other conditions: Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the Bone
    View official trial listing →
  • Completed NCT NCT02479997

    Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

    Not yet reported National Cancer Center, Korea 130 participants Est. completion 2018-03-27 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02480218

    Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women

    Sunnybrook Health Sciences Centre 47 participants Est. completion 2017-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02483871

    Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy

    Not yet reported Duke University Est. completion 2017-05-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02492607

    Management of Low-risk (Grade I and II) DCIS

    Not yet reported The Netherlands Cancer Institute 2500 participants Est. completion 2034-02-01 60 sites
    Other conditions: DCIS
    View official trial listing →
  • Terminated NCT NCT02494713

    Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

    Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-09-14 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02503371

    The Effect of In Vitro Fertilization on Coagulation Parameters as Measured by Thromboelastogram

    Rabin Medical Center 46 participants Est. completion 2014-09 1 site
    Other conditions: Fertilization in Vitro and Blood Coagulation Factors
    View official trial listing →
  • Completed NCT NCT02509871

    Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)

    Not yet reported Centre Jean Perrin 33 participants Est. completion 2016-11 1 site
    Other conditions: Hormonal Therapy, Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02513394

    PALbociclib CoLlaborative Adjuvant Study

    Not yet reported Alliance Foundation Trials, LLC. 5796 participants Est. completion 2028-12 437 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02530177

    Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

    Memorial Sloan Kettering Cancer Center 546 participants Est. completion 2026-08 1 site
    Other conditions: Non-Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02531516

    An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

    Not yet reported Aragon Pharmaceuticals, Inc. 1503 participants Est. completion 2028-12-29 263 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Terminated NCT NCT02532400

    Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

    Not yet reported Ruijin Hospital 21 participants Est. completion 2019-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02549430

    To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

    Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02549729

    Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy

    Not yet reported University of Sao Paulo 88 participants Est. completion 2016-08 1 site
    Other conditions: Weak; Pelvic Floor, Weak; Muscle, Urinary Incontinence
    View official trial listing →
  • Terminated NCT NCT02560051

    Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

    Not yet reported The University of Texas Health Science Center, Houston 19 participants Est. completion 2017-09-14 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02563691

    Stereotactic Radiotherapy for Oligometastatic Prostate Cancer

    Not yet reported, Not yet reported Sunnybrook Health Sciences Centre 90 participants Est. completion 2022-12 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02564848

    Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65

    Not yet reported Cedars-Sinai Medical Center 200 participants Est. completion 2029-03 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02580045

    Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer

    Duke University 3 participants Est. completion 2018-02-22 1 site
    Other conditions: Metastatic Cancer Patients on an Anti-cancer Therapy, Advanced Cancer, Brain Metastasis
    View official trial listing →
  • Status unknown NCT NCT02597868

    A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

    Not yet reported Zhejiang Cancer Hospital 132 participants Est. completion 2017-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02598310

    Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

    Not yet reported Osaka Medical College 30 participants Est. completion 2018-11-30 1 site
    Other conditions: Breast Cancer, Estrogen Receptor Negative Neoplasm, HER-2 Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02615223

    Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 120 participants Est. completion 2018-12 1 site
    Other conditions: Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02616562

    Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 76 participants Est. completion 2024-09-26 89 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Status unknown NCT NCT02617108

    Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11 Stand-alone
    Other conditions: Uterine Septum
    View official trial listing →
  • Active, not recruiting NCT NCT02623972

    A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 22 participants Est. completion 2026-12 2 sites
    Other conditions: Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT02627079

    ICanSTEP : Increasing Physical Activity With Text Messaging

    Not yet reported Duke University 30 participants Est. completion 2018-05-21 1 site
    Other conditions: A Diagnosis of Any Hematologic or Solid Malignancy
    View official trial listing →
  • Status unknown NCT NCT02646735

    Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 148 participants Est. completion 2020-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02651896

    Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer

    Hospital Sirio-Libanes 130 participants Est. completion 2019-12 2 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02653755

    The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 671 participants Est. completion 2030-05-15 6 sites
    Other conditions: Breast Cancer Radiation
    View official trial listing →
  • Completed NCT NCT02654119

    Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

    Not yet reported University of Nebraska 20 participants Est. completion 2025-12-08 3 sites Stand-alone
    Other conditions: HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02669576

    Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy

    Not yet reported Universität Duisburg-Essen 68 participants Est. completion 2022-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02676986

    Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer

    Not yet reported Queen Mary University of London 221 participants Est. completion 2016-12-31 41 sites
    Other conditions: Primary Breast Cancer ER+ve, Primary Breast Cancer AR+ve TNBN
    View official trial listing →
  • Withdrawn NCT NCT02678520

    Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients

    Not yet reported University of Kansas Medical Center Est. completion 2016-02 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02685397

    Management of Castration-Resistant Prostate Cancer with Oligometastases

    Not yet reported, Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 102 participants Est. completion 2041-08 11 sites
    Other conditions: Castration-resistant Prostate Cancer Patients with Oligometastases
    View official trial listing →
  • Status unknown NCT NCT02690480

    Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

    Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT02693002

    Estrogen Diastolic Heart Failure

    Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT02712723

    Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer

    Not yet reported Qamar Khan 121 participants Est. completion 2026-12 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02716974

    A Study of Definitive Therapy to Treat Prostate Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26 participants Est. completion 2022-04 3 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT02719990

    Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

    Not yet reported Versartis Inc. 36 participants Est. completion 2018-01-11
    Other conditions: Adult Growth Hormone Deficiency (AGHD)
    View official trial listing →
  • Completed NCT NCT02720770

    Growth Hormone Treatment in Children With Hypophosphatemic Rickets

    Not yet reported, Not yet reported Bicetre Hospital 19 participants Est. completion 2011-01
    Other conditions: X Linked Hypophosphatemic Rickets
    View official trial listing →
  • Terminated NCT NCT02734615

    Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

    Not yet reported Novartis Pharmaceuticals 199 participants Est. completion 2021-09-13 10 sites
    Other conditions: Advanced or Metastatic ER+ Breast Cancer
    View official trial listing →
  • Completed NCT NCT02742051

    A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40 participants Est. completion 2020-03-14 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02753686

    Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

    Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sites
    Other conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02755038

    Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)

    Bnai Zion Medical Center 40 participants Est. completion 2017-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02758756

    Pilot Study on Energy Therapy or Massage to Reduce Fatigue

    Not yet reported University of Rochester 87 participants Est. completion 2019-05 1 site
    Other conditions: Fatigue
    View official trial listing →
  • Completed NCT NCT02760030

    Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

    Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sites
    Other conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02778685

    Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

    Not yet reported City of Hope Medical Center 47 participants Est. completion 2026-03-30 7 sites
    Other conditions: Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02785861

    Step by Step After Cancer

    Not yet reported Centre Hospitalier Universitaire, Amiens 17 participants Est. completion 2026-02-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02791750

    5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma

    Institut de Cancérologie de Lorraine 150 participants Est. completion 2017-06-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02823262

    A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

    Not yet reported Beth Israel Deaconess Medical Center 65 participants Est. completion 2022-03 2 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT02841137

    Efficacy Study of Progesterone Tablet in Post-menopausal Women

    Not yet reported IBSA Institut Biochimique SA 80 participants Est. completion 2018-04-25 1 site
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT02855632

    The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Sir Run Run Shaw Hospital 240 participants Est. completion 2019-12 1 site
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT02858063

    Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her Partner

    Centre Oscar Lambret 1045 participants Est. completion 2013-11-27 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02876848

    A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 120 participants Est. completion 2018-09 1 site
    Other conditions: Breast Neoplasms, Medication Adherence
    View official trial listing →
  • Completed NCT NCT02878057

    Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)

    Not yet reported Peking University Cancer Hospital & Institute 30 participants Est. completion 2020-09-02
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02889874

    EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer

    Not yet reported Breast Cancer Trials, Australia and New Zealand 1167 participants Est. completion 2028-04 68 sites
    Other conditions: Early Stage Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT02894398

    Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant

    Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Status unknown NCT NCT02896504

    Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients

    Kessler Foundation 60 participants Est. completion 2018-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02907372

    Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

    Not yet reported Centre Francois Baclesse 163 participants Est. completion 2022-12 6 sites
    Other conditions: Metastatic Castration-resistant Prostate Cancer (CRPCa)
    View official trial listing →
  • Status unknown NCT NCT02913859

    Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

    Not yet reported University Hospital Sestre Milosrdnice 60 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02926911

    Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

    Not yet reported Alliance Foundation Trials, LLC. 997 participants Est. completion 2030-07 141 sites
    Other conditions: DCIS, Ductal Carcinoma in Situ
    View official trial listing →
  • Status unknown NCT NCT02931591

    Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 24 participants Est. completion 2020-06
    Other conditions: Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT02935920

    A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy

    Not yet reported Vejle Hospital 134 participants Est. completion 2019-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02941926

    Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

    Not yet reported Novartis Pharmaceuticals 3246 participants Est. completion 2022-11-09 495 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02947685

    Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

    Not yet reported Alliance Foundation Trials, LLC. 518 participants Est. completion 2030-12-31 108 sites
    Other conditions: HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02950207

    Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100

    Fondazione del Piemonte per l'Oncologia 180 participants Est. completion 2019-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02971748

    Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

    Not yet reported M.D. Anderson Cancer Center 36 participants Est. completion 2027-12-31 1 site
    Other conditions: Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT02977091

    Fitness Level in Short Stature Children and After Growth Hormone Treatment

    Meir Medical Center 50 participants Est. completion 2019-03-01 1 site
    Other conditions: Fitness
    View official trial listing →
  • Status unknown NCT NCT02982421

    The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors

    Not yet reported Rabin Medical Center 20 participants Est. completion 2017-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02992730

    Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer

    Georgetown University 630 participants Est. completion 2019-12 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT02995772

    Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

    Not yet reported Dharmais National Cancer Center Hospital 122 participants Est. completion 2018-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02997995

    Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure

    Not yet reported UNICANCER 61 participants Est. completion 2020-08-28 29 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor, Menopause, Hormone Antagonist
    View official trial listing →
  • Status unknown NCT NCT03005561

    Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment

    Not yet reported Prof. Eli Hershkovitz 200 participants Est. completion 2018-03
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT03007992

    Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer

    Not yet reported Johannes Gutenberg University Mainz 9 participants Est. completion 2019-03-02 8 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03016741

    Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

    Not yet reported Northwestern University 100 participants Est. completion 2029-08 5 sites
    Other conditions: Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer, Hormone-Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03033121

    Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

    Not yet reported University of Palermo 32 participants Est. completion 2017-01-01 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT03043807

    A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26 participants Est. completion 2022-10-17 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03045653

    Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

    Not yet reported Sun Yat-sen University 30 participants Est. completion 2019-02-21 1 site
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Withdrawn NCT NCT03058939

    Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

    Not yet reported University of Chicago Est. completion 2019-06 1 site
    Other conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III
    View official trial listing →
  • Completed NCT NCT03065010

    Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer

    Not yet reported Biocad 6 participants Est. completion 2018-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03065621

    Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)

    Not yet reported Jules Bordet Institute 100 participants Est. completion 2023-02-01 5 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Terminated NCT NCT03066154

    Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer

    Not yet reported The Netherlands Cancer Institute 24 participants Est. completion 2022-08 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT03078036

    International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study

    AstraZeneca 873 participants Est. completion 2019-05-20 98 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03081234

    Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals Est. completion 2025-11-17
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03092635

    AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

    Not yet reported Medical University of South Carolina 9 participants Est. completion 2022-04-22 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03099200

    An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer

    Hoffmann-La Roche 300 participants Est. completion 2017-03-17 14 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT03119857

    Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

    Not yet reported Göteborg University 349 participants Est. completion 2023-04 5 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Terminated NCT NCT03147040

    AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer

    Not yet reported The Netherlands Cancer Institute 23 participants Est. completion 2022-07-01 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03147287

    Palbociclib After CDK and Endocrine Therapy (PACE)

    Not yet reported Dana-Farber Cancer Institute 220 participants Est. completion 2026-12-30 22 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03161353

    Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.

    Not yet reported MedSIR 377 participants Est. completion 2026-11-01 56 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03162172

    Growth Hormone (GH) in Congenital Adrenal Hyperplasia

    Hospices Civils de Lyon 25 participants Est. completion 2016-03-15 1 site
    Other conditions: Adrenal Hyperplasia, Congenital
    View official trial listing →
  • Completed NCT NCT03162523

    Experiences With HDR-brachytherapy in Norway

    Oslo University Hospital 325 participants Est. completion 2016-10-15 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03176238

    Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 235 participants Est. completion 2019-01-29 55 sites
    Other conditions: Post Menopausal Breast Cancer
    View official trial listing →
  • Completed NCT NCT03184090

    Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

    Not yet reported MedSIR 33 participants Est. completion 2020-10-27 15 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03186599

    Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer

    Not yet reported Gachon University 200 participants Est. completion 2018-10-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03195192

    Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer

    Not yet reported Side-Out Foundation 28 participants Est. completion 2020-06-30 8 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03204734

    Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

    Not yet reported Zhejiang Cancer Hospital 132 participants Est. completion 2021-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03213925

    Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer

    Not yet reported Instituto do Cancer do Estado de São Paulo 1 participants Est. completion 2025-07-01 1 site
    Other conditions: Breast Cancer, Radiation Therapy
    View official trial listing →
  • Completed NCT NCT03227328

    CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

    Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 52 participants Est. completion 2022-07-01 20 sites
    Other conditions: Hormone Receptor Positive Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03235427

    The CAROLE (CArdiac Related Oncologic Late Effects) Study

    Northwell Health 201 participants Est. completion 2018-06-26 1 site
    Cardiovascular disease Other conditions: Cardiac Disease, Cardiac Toxicity, Radiation, Radiation Therapy, Atherosclerotic Heart Disease, Cardiotoxicity, Breast Cancer, Lung Cancer, Lymphoma, Cancer, Carcinoma, Intraductal, Noninfiltrating
    View official trial listing →
  • Completed NCT NCT03236545

    Menopause Effects on Vascular Function

    Not yet reported University of Delaware 48 participants Est. completion 2022-11-01 1 site
    Other conditions: Cardiovascular Risk Factor
    View official trial listing →
  • Completed NCT NCT03238196

    Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 35 participants Est. completion 2024-03-20 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03238703

    Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2025-03-14 1 site
    Other conditions: HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal, Stage 0 Breast Cancer, Stage IA Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03241537

    COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer

    Not yet reported Samsung Medical Center 61 participants Est. completion 2026-12-14 1 site
    Other conditions: Prostate Neoplasm
    View official trial listing →
  • Completed NCT NCT03259711

    Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase

    Groupe Hospitalier Pitie-Salpetriere 20000 participants Est. completion 2017-08-14 1 site
    Other conditions: Cardiac Affections
    View official trial listing →
  • Completed NCT NCT03270969

    A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

    Not yet reported University of Nebraska 15 participants Est. completion 2018-09-10 1 site
    Other conditions: HIV Prevention
    View official trial listing →
  • Active, not recruiting NCT NCT03281902

    Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

    Mayo Clinic 68 participants Est. completion 2028-03-04 3 sites
    Other conditions: Advanced Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Active, not recruiting NCT NCT03285412

    CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer

    Not yet reported Massachusetts General Hospital 120 participants Est. completion 2026-10 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03288103

    Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2023-08-31 1 site
    Other conditions: Short Stature
    View official trial listing →
  • Status unknown NCT NCT03294122

    Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer

    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 400 participants Est. completion 2019-12-31 1 site
    Other conditions: Prostate Cancer, Head and Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT03301389

    Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)

    Yonsei University 2000 participants Est. completion 2025-01 1 site
    Other conditions: Chemotherapy Induced Cardiotoxicity
    View official trial listing →
  • Completed NCT NCT03308201

    Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer

    Not yet reported Tianjin Hemay Pharmaceutical Co., Ltd 55 participants Est. completion 2023-03-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03327207

    Exploring Interactions Between Growth Hormone and the Microbiome

    Rambam Health Care Campus 200 participants Est. completion 2021-11 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03355157

    A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03361735

    Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

    Not yet reported City of Hope Medical Center 25 participants Est. completion 2027-01-06 1 site
    Other conditions: Prostate Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03373708

    Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

    Not yet reported, Not yet reported Zhiyong Yu 200 participants Est. completion 2019-12-20
    Other conditions: Breast Cancer, Chemotherapy, Endocrine Breast Diseases
    View official trial listing →
  • Status unknown NCT NCT03395327

    Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer

    Centre Hospitalier Departemental Vendee 50 participants Est. completion 2020-05-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03420105

    Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep

    Not yet reported Centre Francois Baclesse 75 participants Est. completion 2020-03-06 2 sites
    Other conditions: Breast Cancer, Memory Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT03425838

    Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

    Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sites
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Terminated NCT NCT03430466

    Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer

    Not yet reported Kyoto Breast Cancer Research Network 1 participants Est. completion 2018-07-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03432780

    Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer

    Not yet reported Spanish Oncology Genito-Urinary Group 134 participants Est. completion 2023-11-14
    Other conditions: Prostate Cancer Stage III, Prostate Cancer Stage IV
    View official trial listing →
  • Active, not recruiting NCT NCT03439735

    Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45 participants Est. completion 2027-11-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03442504

    Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

    Not yet reported Institut Cancerologie de l'Ouest 57 participants Est. completion 2024-06 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03447886

    Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

    Dana-Farber Cancer Institute 17 participants Est. completion 2018-08-27 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03458559

    Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

    Not yet reported Amsterdam UMC, location VUmc 402 participants Est. completion 2024-05-16 1 site
    Other conditions: Prostate Cancer Metastatic to Bone
    View official trial listing →
  • Completed NCT NCT03462251

    Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line

    Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03489473

    FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment

    Radboud University Medical Center 40 participants Est. completion 2021-12-01
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT03493854

    A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

    Not yet reported Hoffmann-La Roche 500 participants Est. completion 2023-06-02 107 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT03494400

    Aerobic Training in Treatment for Breast Cancer

    Not yet reported Universidade Estadual Paulista Júlio de Mesquita Filho 6 participants Est. completion 2020-11-30 1 site
    Other conditions: Cancer of Breast, Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT03503799

    Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

    North Eastern German Society of Gynaecological Oncology 1191 participants Est. completion 2032-10-01 40 sites
    Other conditions: Primary Invasive Breast Cancer, Estrogen Receptor Positive Tumor, Human Epidermal Growth Factor Receptor 2 Negative Tumor
    View official trial listing →
  • Completed NCT NCT03514654

    MIAMI Safe Surgery for Multiple Breast Cancers

    Not yet reported University College, London 4 participants Est. completion 2020-10-31 7 sites
    Other conditions: Breast Cancer, Unilateral
    View official trial listing →
  • Terminated NCT NCT03519178

    A Study of PF-06873600 in People With Cancer

    Not yet reported, Not yet reported Pfizer 155 participants Est. completion 2024-10-30 54 sites
    Other conditions: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
    View official trial listing →
  • Completed NCT NCT03523351

    Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 78 participants Est. completion 2024-04-18 9 sites
    Other conditions: Metastatic Solid Tumors of Metastatic Disease
    View official trial listing →
  • Completed NCT NCT03523572

    Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

    Not yet reported Daiichi Sankyo 86 participants Est. completion 2023-09-12 29 sites Stand-alone
    Other conditions: Breast Cancer, Urothelial Carcinoma
    View official trial listing →
  • Completed NCT NCT03530215

    Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)

    Groupe Hospitalier Pitie-Salpetriere 500000 participants Est. completion 2023-04-08 1 site
    Other conditions: Cardiac Disease, Cancer
    View official trial listing →
  • Status unknown NCT NCT03549663

    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108 participants Est. completion 2021-10 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Terminated NCT NCT03553602

    HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer

    Not yet reported, Not yet reported Loyola University 3 participants Est. completion 2024-07-26 1 site Stand-alone
    Other conditions: Prostate Cancer - Recurrent
    View official trial listing →
  • Completed NCT NCT03554044

    T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

    Not yet reported University of California, San Francisco 20 participants Est. completion 2023-12-31 1 site
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT03554265

    Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

    Not yet reported The University of Texas Medical Branch, Galveston 72 participants Est. completion 2023-10-04 1 site
    Other conditions: Traumatic Brain Injury, Fatigue, Cognitive Impairment, COVID-19
    View official trial listing →
  • Completed NCT NCT03555877

    Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

    Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2022-07-21 1 site
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Status unknown NCT NCT03556800

    Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

    Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT03556904

    FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

    Not yet reported University of Michigan Rogel Cancer Center 14 participants Est. completion 2023-07-28 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03557268

    Pubertal Blockade and Hormone Therapy in Transgender Youth

    University of Colorado, Denver 19 participants Est. completion 2020-09-09 1 site
    Other conditions: Gender Identity, Gender Dysphoria, Gender Identity Disorder in Adolescence and Adulthood
    View official trial listing →
  • Active, not recruiting NCT NCT03561961

    Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)

    Not yet reported Tata Memorial Centre 526 participants Est. completion 2035-03 1 site Stand-alone
    Other conditions: Prostate Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03568149

    Pelvic Congestion Syndrome and Endometriosis

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 160 participants Est. completion 2019-08 1 site
    Other conditions: Pelvic Congestive Syndrome, Endometriosis
    View official trial listing →
  • Active, not recruiting NCT NCT03573648

    Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2027-03-30 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03579680

    De-implementation of Low Value Castration for Men With Prostate Cancer

    Not yet reported University of Michigan 60 participants Est. completion 2023-04-06 1 site
    Other conditions: Cancer of Prostate
    View official trial listing →
  • Status unknown NCT NCT03587285

    A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer

    Not yet reported, Not yet reported Guangzhou University of Traditional Chinese Medicine 11 participants Est. completion 2021-07-31 1 site Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT03609047

    Adjuvant Palbociclib in Elderly Patients With Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 366 participants Est. completion 2026-09-30 73 sites
    Other conditions: Breast Cancer Stage II, Breast Cancer Stage III
    View official trial listing →
  • Completed NCT NCT03620734

    Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women

    Thai Red Cross AIDS Research Centre 40 participants Est. completion 2019-10-01 1 site
    Other conditions: PrEP and ART
    View official trial listing →
  • Terminated NCT NCT03636776

    Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer

    Not yet reported Institut Cancerologie de l'Ouest 60 participants Est. completion 2022-01-11 2 sites
    Other conditions: Metastatic Breast Cancer, Positive Hormonal Receptors
    View official trial listing →
  • Completed NCT NCT03644186

    To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

    Not yet reported ETOP IBCSG Partners Foundation 147 participants Est. completion 2023-04-14 54 sites Stand-alone
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03651427

    Cross-sex Hormone Therapy and Neuronal Plasticity

    Not yet reported Hospital de Clinicas de Porto Alegre 30 participants Est. completion 2019-03-30 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT03652623

    Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study

    Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 site
    Other conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
    View official trial listing →
  • Completed NCT NCT03654638

    Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 25 participants Est. completion 2022-03-09 1 site
    Other conditions: Prostate Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03665077

    Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

    Not yet reported University of Arizona 28 participants Est. completion 2022-06-15 1 site Stand-alone
    Other conditions: Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS), Breast Cancer
    View official trial listing →
  • Completed NCT NCT03672396

    Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

    Not yet reported UNC Lineberger Comprehensive Cancer Center 22 participants Est. completion 2019-12-31 2 sites
    Other conditions: Castration-resistant Prostate Cancer, Androgen Deprivation Therapy
    View official trial listing →
  • Completed NCT NCT03672617

    Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

    Novo Nordisk A/S 321 participants Est. completion 2019-04-25 1 site
    Other conditions: Growth Hormone Deficiency in Children
    View official trial listing →
  • Completed NCT NCT03676257

    Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

    Institut Bergonié 20033 participants Est. completion 2023-12-01 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03685331

    HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 Mutation
    View official trial listing →
  • Completed NCT NCT03690765

    Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis

    Abbott 350 participants Est. completion 2020-05-29 21 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03691493

    Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

    Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT03695341

    500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI

    Fudan University 130 participants Est. completion 2019-05-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03697200

    Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings

    Not yet reported Johns Hopkins University 102 participants Est. completion 2020-12-30 1 site
    Other conditions: Aromatase Inhibitor, Musculoskeletal Symptoms, Postmenopausal Breast Cancer Survivors
    View official trial listing →
  • Active, not recruiting NCT NCT03701334

    A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals 5101 participants Est. completion 2030-05-29 387 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT03718260

    PSMA-PET Registry for Recurrent Prostate Cancer

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 9684 participants Est. completion 2026-06-15 7 sites
    Other conditions: Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03719495

    Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

    Duke University 68 participants Est. completion 2023-07-31 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT03725059

    Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

    Not yet reported Merck Sharp & Dohme LLC 1240 participants Est. completion 2031-01-24 244 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03749421

    Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer

    Dana-Farber Cancer Institute 60 participants Est. completion 2025-08-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03750396

    Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer

    Not yet reported Gangnam Severance Hospital 110 participants Est. completion 2025-07-31 1 site
    Other conditions: Breast Cancer, Recurrent Breast Cancer, Stereotactic Body Radiotherapy, Estrogen Receptor Positive Tumor, Her2-negative Tumor, Surgery
    View official trial listing →
  • Completed NCT NCT03761420

    Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome

    St. Olavs Hospital 1411 participants Est. completion 2021-04-01 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT03767244

    A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

    Not yet reported Janssen Research & Development, LLC 2517 participants Est. completion 2028-10-13 203 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT03772353

    Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer

    Not yet reported, Not yet reported Fudan University 59 participants Est. completion 2025-12-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03776045

    PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)

    Not yet reported University of East Anglia 50 participants Est. completion 2016-02-03
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03778359

    Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis

    Taipei Veterans General Hospital, Taiwan 5000 participants Est. completion 2018-10-18 1 site
    Other conditions: Endometriosis, Adenomyosis
    View official trial listing →
  • Status unknown NCT NCT03786575

    Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

    Not yet reported Peking Union Medical College 50 participants Est. completion 2021-12-31 1 site
    Other conditions: Breast Neoplasm Female, Therapeutics, Mutation
    View official trial listing →
  • Terminated NCT NCT03795012

    Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients

    Not yet reported MedSIR 22 participants Est. completion 2021-03-31 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03798197

    Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers

    Not yet reported Donesta Bioscience 28 participants Est. completion 2019-04-06 1 site
    Other conditions: Food-effect
    View official trial listing →
  • Completed NCT NCT03809988

    PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

    Not yet reported MedSIR 198 participants Est. completion 2022-11-30 53 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Active, not recruiting NCT NCT03818100

    Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible

    CCTU- Cancer Theme 43 participants Est. completion 2026-10-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03820830

    Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 405 participants Est. completion 2029-01-01 53 sites
    Other conditions: Breast Cancer Recurrent
    View official trial listing →
  • Completed NCT NCT03822429

    Cumulative Live Birth Rate (CLBR) After a Complete IVF Cycle: a Single Center Retrospective Study

    Istituto Clinico Humanitas 6375 participants Est. completion 2015-12-31
    Other conditions: ART, Fertility Disorders
    View official trial listing →
  • Completed NCT NCT03837496

    Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors

    Not yet reported Massachusetts General Hospital 100 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Breast Cancer, Adherence, Medication
    View official trial listing →
  • Completed NCT NCT03839823

    Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 222 participants Est. completion 2023-05-10 50 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03849573

    A Web-Based Tool to Improve Breast Cancer Survivorship

    Not yet reported Northwestern University 84 participants Est. completion 2022-05-01 1 site
    Other conditions: Breast Cancer, Hormone Dependent Neoplasms, Adherence to Hormone Therapy
    View official trial listing →
  • Status unknown NCT NCT03864250

    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 124 participants Est. completion 2021-11 1 site
    Other conditions: Tacrolimus, Idiopathic Membranous Nephropathy, Clinical Trial
    View official trial listing →
  • Completed NCT NCT03870399

    Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

    Not yet reported AC Camargo Cancer Center 23 participants Est. completion 2023-05-13 2 sites
    Other conditions: Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Status unknown NCT NCT03873428

    Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES

    Not yet reported Centre Georges Francois Leclerc 25 participants Est. completion 2025-10-18 2 sites
    Other conditions: FES TEP in Detection of Estrogen Receptors
    View official trial listing →
  • Completed NCT NCT03896984

    Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).

    Bayer 346 participants Est. completion 2020-12-14 1 site
    Other conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)
    View official trial listing →
  • Active, not recruiting NCT NCT03900637

    PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

    Not yet reported Seoul National University Hospital 122 participants Est. completion 2028-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03906669

    A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

    Not yet reported St Vincent's Hospital 200 participants Est. completion 2024-04 1 site
    Other conditions: Early-stage Breast Cancer, Hormone Receptor Positive Tumor
    View official trial listing →
  • Active, not recruiting NCT NCT03917082

    Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

    Not yet reported British Columbia Cancer Agency 290 participants Est. completion 2029-05-01 1 site
    Other conditions: Breast Cancer Female, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT03928288

    Cabergoline for the Treatment of Chronic Pain Due to Endometriosis

    Not yet reported Boston Children's Hospital 129 participants Est. completion 2026-01-14 6 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT03939156

    Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer

    European Institute of Oncology 450 participants Est. completion 2023-12-31 1 site
    Other conditions: Breast Cancer, Endocrine Breast Diseases
    View official trial listing →
  • Completed NCT NCT03945812

    Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer

    Not yet reported Wael Elbanna Clinic 665 participants Est. completion 2023-03-08 1 site
    Other conditions: Infertility, Frozen Embryo Transfer (FET)
    View official trial listing →
  • Completed NCT NCT03948568

    Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

    Not yet reported Ottawa Hospital Research Institute 262 participants Est. completion 2022-04-09 1 site
    Other conditions: Early-stage Breast Cancer
    View official trial listing →
  • Completed NCT NCT03949270

    Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

    Not yet reported Yale University 400 participants Est. completion 2023-11-01 1 site
    Other conditions: Breast Cancer, Adherence, Medication, Side Effect
    View official trial listing →
  • Completed NCT NCT03955627

    REJOIN Trial for Older Breast Cancer Survivors

    Not yet reported Wake Forest University Health Sciences 12 participants Est. completion 2025-07-29 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Active, not recruiting NCT NCT03959891

    AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

    Not yet reported Massachusetts General Hospital 77 participants Est. completion 2027-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03960593

    Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological Malignancy

    Assistance Publique Hopitaux De Marseille 500 participants Est. completion 2024-05-06 1 site
    Other conditions: Cancer and / or Hematological Malignancy
    View official trial listing →
  • Enrolling by invitation NCT NCT03972345

    Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

    Novo Nordisk A/S 750 participants Est. completion 2031-06-30 1 site
    Other conditions: Growth Hormone Deficiency in Children, Born Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT03980093

    The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors

    Not yet reported University of Colorado, Boulder 88 participants Est. completion 2020-08-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03997539

    A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 256 participants Est. completion 2021-12-30
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04002570

    Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients

    Clinica Luganese Moncucco 13 participants Est. completion 2020-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04003207

    Growth Hormone Treatment in Children With Phelan McDermid Syndrome

    Not yet reported Swathi Sethuram 6 participants Est. completion 2020-06-05 1 site
    Other conditions: Phelan McDermid Syndrome
    View official trial listing →
  • Status unknown NCT NCT04012918

    Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study

    Not yet reported Ain Shams University 124 participants Est. completion 2021-02 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04024462

    A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

    Not yet reported Hoffmann-La Roche 200 participants Est. completion 2026-01-19 18 sites
    Other conditions: HER2-positive Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04045392

    Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients

    Not yet reported Gangnam Severance Hospital 78 participants Est. completion 2021-08
    Other conditions: Breast Cancer, Obesity
    View official trial listing →
  • Completed NCT NCT04048252

    Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy

    Centre Hospitalier Universitaire de Nīmes 18 participants Est. completion 2021-07-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04049747

    Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

    Not yet reported Imperial College London 100 participants Est. completion 2023-03-20 10 sites Stand-alone
    Other conditions: Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04050592

    Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life

    Not yet reported Hanna Savolainen-Peltonen 150 participants Est. completion 2022-12 1 site
    Cardiovascular disease Other conditions: Menopause, Atherosclerosis, Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT04054557

    Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

    Not yet reported Thomas Jefferson University 305 participants Est. completion 2024-12-06 5 sites
    Other conditions: Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage III Breast Cancer AJCC v7
    View official trial listing →
  • Active, not recruiting NCT NCT04055493

    Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

    Not yet reported Women's Cancer Study Group GmbH 1684 participants Est. completion 2027-07-31 86 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Terminated NCT NCT04059484

    Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

    Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT04066283

    Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women

    University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Active, not recruiting NCT NCT04070209

    Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

    Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 66 participants Est. completion 2030-11 11 sites Stand-alone
    Other conditions: Metastatic Prostate Cancer, Castration-resistant Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04071236

    Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

    Not yet reported, Not yet reported National Cancer Institute (NCI) 90 participants Est. completion 2027-04-30 32 sites
    Other conditions: Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04077138

    Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development

    Hektoen Institute for Medical Research 80 participants Est. completion 2023-11-30 3 sites
    Other conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
    View official trial listing →
  • Completed NCT NCT04077151

    Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Demonstration Project

    Not yet reported Hektoen Institute for Medical Research 51 participants Est. completion 2023-11-30 1 site
    Other conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
    View official trial listing →
  • Status unknown NCT NCT04086875

    A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer

    Not yet reported Thomas Jefferson University 332 participants Est. completion 2024-09-24 7 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Positive Tumor, Progesterone Receptor Positive Tumor, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04095390

    A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer

    Not yet reported Jinming Yu 60 participants Est. completion 2022-08-30 1 site
    Other conditions: Metastatic Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04097756

    A Phase I Study of LX-039 Tablets

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 44 participants Est. completion 2023-02-07 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04109066

    Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

    Not yet reported Bristol-Myers Squibb 521 participants Est. completion 2023-12-27 240 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04116827

    Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

    Samsung Medical Center 20 participants Est. completion 2020-12-31 1 site
    Other conditions: Sleep Disorder, Breast Cancer
    View official trial listing →
  • Completed NCT NCT04128488

    Effects of Gender-Affirming Hormone Therapy Among Transgender Women

    Massachusetts General Hospital 33 participants Est. completion 2024-03-28 1 site
    Cardiovascular disease Other conditions: Transgender Women, HIV/AIDS, Metabolic Disease, Coagulopathy
    View official trial listing →
  • Active, not recruiting NCT NCT04134598

    ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer

    Not yet reported Azienda Ospedaliero-Universitaria Careggi 926 participants Est. completion 2030-03-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04139772

    Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.

    Not yet reported National Cancer Institute, Naples 18 participants Est. completion 2024-07-01 1 site
    Other conditions: Metastatic Castration-resistent Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT04152057

    Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

    Not yet reported, Not yet reported West China Hospital 20 participants Est. completion 2021-04 1 site
    Other conditions: Breast Cancer, HER2 Positive, Combination Chemotherapy
    View official trial listing →
  • Completed NCT NCT04168814

    Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study

    Universidad Pontificia Comillas 586 participants Est. completion 2020-12-15 11 sites
    Other conditions: Malnutrition, Oncologic Complications, Oncology, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT04176809

    Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer

    Not yet reported Centre Georges Francois Leclerc 342 participants Est. completion 2025-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04188275

    CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION

    Azienda Ospedaliero-Universitaria Careggi 46 participants Est. completion 2022-06-30 1 site
    Other conditions: D011471, D064129, D035683, D009360, D014408
    View official trial listing →
  • Completed NCT NCT04200001

    Evaluation of Sexual Quality of Life for Breast Cancer

    Institut du Cancer de Montpellier - Val d'Aurelle 45 participants Est. completion 2020-07-31 1 site
    Other conditions: Breast Cancer, Cancer, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT04212702

    ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments

    National Taiwan University Hospital 123 participants Est. completion 2021-12-31 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04220398

    Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

    Not yet reported RenJi Hospital 475 participants Est. completion 2024-12-31
    Other conditions: Prostate Cancer, Chemotherapy Effect, Hormone Sensitive Prostate Cancer, Locally Advanced Prostate Carcinoma
    View official trial listing →
  • Completed NCT NCT04237467

    Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men

    University of Colorado, Denver 16 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT04244123

    Web-based Adherence Information Integrated Nurse-led Monitoring Clinic

    Manchester University NHS Foundation Trust 43 participants Est. completion 2023-01-05 1 site
    Other conditions: Short Stature, Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT04246606

    Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer

    UNICANCER 155 participants Est. completion 2023-11-01 1 site
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Status unknown NCT NCT04247633

    High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)

    Not yet reported Samsung Medical Center 578 participants Est. completion 2025-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04258163

    Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 760 participants Est. completion 2019-07-01 3 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04272801

    Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer

    Not yet reported Shayna Showalter, MD 84 participants Est. completion 2026-06-01 2 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT04276272

    D4 Choline Breast PET/CT

    Imperial College London 6 participants Est. completion 2023-11-03 1 site
    Other conditions: HER2-negative Breast Cancer, ER Positive Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04282031

    A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

    Not yet reported, Not yet reported Beta Pharma (Suzhou) Co., Ltd. 224 participants Est. completion 2025-06-30 1 site
    Other conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04282876

    Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer

    Aarhus University Hospital 60 participants Est. completion 2025-10-31 1 site
    Other conditions: Bladder Cancer, Radiation Therapy Complication, Quality of Life
    View official trial listing →
  • Completed NCT NCT04283656

    Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women

    Not yet reported Thomas Jefferson University 8 participants Est. completion 2022-12-30 1 site
    Other conditions: Transgender Health, Gender Dysphoria, Transgender Women, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT04300790

    Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

    Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT04301375

    Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)

    Not yet reported David Garcia Cinca 27 participants Est. completion 2027-07-15 1 site
    Other conditions: Mammary Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04302454

    Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy

    Not yet reported University Medical Center Groningen 280 participants Est. completion 2027-12-01 13 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04305093

    Data Mining: Precision Analytical Retrospective Data Correlation

    Precision Analytical, Inc. 144561 participants Est. completion 2023-03-28 1 site
    Other conditions: Obesity; Endocrine, Hormone Disturbance
    View official trial listing →
  • Terminated NCT NCT04305236

    Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer

    Not yet reported University of California, Irvine 1 participants Est. completion 2022-02-16 1 site
    Other conditions: Breast Neoplasm, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT04309760

    Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria

    Not yet reported Hôpital le Vinatier Est. completion 2022-03-15
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT04315012

    Training With Mobile Application in Breast Cancer

    Not yet reported Izmir Bakircay University 64 participants Est. completion 2018-04-17 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04318223

    Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

    Not yet reported Consorzio Oncotech 168 participants Est. completion 2023-07-31 19 sites
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04340713

    The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal Therapy

    Not yet reported Fudan University 95 participants Est. completion 2020-02-29 1 site Stand-alone
    Other conditions: Information Support
    View official trial listing →
  • Completed NCT NCT04341324

    Effect of ADT in Chinese Male With Prostate Cancer

    Chinese University of Hong Kong 60 participants Est. completion 2019-12-04
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04354896

    The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism

    Not yet reported Insel Gruppe AG, University Hospital Bern 322 participants Est. completion 2018-05-04 5 sites
    Other conditions: Subclinical Hypothyroidism, Sarcopenia
    View official trial listing →
  • Status unknown NCT NCT04355858

    Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

    Not yet reported Fudan University 319 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Withdrawn NCT NCT04374279

    Trial to Promote Recovery From COVID-19 With Endocrine Therapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2022-01 1 site
    Other conditions: COVID-19, SARS-CoV 2
    View official trial listing →
  • Active, not recruiting NCT NCT04379570

    Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 1167 participants Est. completion 2027-10-04 526 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2 Negative Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8
    View official trial listing →
  • Active, not recruiting NCT NCT04383275

    Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)

    Not yet reported Fudan University 367 participants Est. completion 2031-07-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04389424

    Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

    Instituto Jalisciense de Cancerologia 300 participants Est. completion 2022-01-30 1 site
    Other conditions: Breast Cancer, Endocrine Therapy, Endocrine Therapy Adverse Reaction, Vitamin D Deficiency, Nutrition Disorders, Obesity
    View official trial listing →
  • Status unknown NCT NCT04400942

    Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy

    Ospedale Policlinico San Martino 600 participants Est. completion 2021-12-01 1 site
    Other conditions: Uterine Fibroids, Uterine Myomas
    View official trial listing →
  • Status unknown NCT NCT04409691

    SCMC Trial on KHE With KMP (V.2020)

    Not yet reported Shanghai Children's Medical Center 20 participants Est. completion 2023-06-30 1 site
    Other conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
    View official trial listing →
  • Completed NCT NCT04420481

    Growth Hormone in Ischemic Heart Failure

    Not yet reported Göteborg University 37 participants Est. completion 2012-02-25
    Heart failure Other conditions: Ischemic Heart Disease Chronic
    View official trial listing →
  • Completed NCT NCT04420598

    DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease

    Not yet reported MedSIR 41 participants Est. completion 2023-04-04 16 sites
    Other conditions: Advanced Breast Cancer, HER2-positive Breast Cancer, Brain Metastases, Leptomeningeal Metastasis
    View official trial listing →
  • Completed NCT NCT04424108

    Hormone Therapy on Serum Ischemia Modified Albumin in Menopausal Women

    Karadeniz Technical University 30 participants Est. completion 2010-05-20
    Other conditions: Hormone Therapy Induced Morphologic Change, Surgical Menopause
    View official trial listing →
  • Completed NCT NCT04424173

    Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

    Karadeniz Technical University 45 participants Est. completion 2008-08-30
    Other conditions: CRP, Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT04446117

    Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

    Not yet reported Exelixis 575 participants Est. completion 2026-10-16 280 sites
    Other conditions: Metastatic Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04453332

    Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters

    Not yet reported Hospital de Clinicas de Porto Alegre 60 participants Est. completion 2021-12 1 site
    Other conditions: Menopause, Hormone Replacement Therapy
    View official trial listing →
  • Completed NCT NCT04459650

    A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2025-08-14 1 site
    Other conditions: Alopecia
    View official trial listing →
  • Completed NCT NCT04460898

    RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

    Pfizer 195 participants Est. completion 2019-06-24 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04465097

    Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer

    Not yet reported First Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2023-10-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04478760

    Trans & Non-binary Reference Intervals While on Hormone Therapy Study

    King's College Hospital NHS Trust 250 participants Est. completion 2024-05-14 1 site
    Other conditions: Transgender Persons, Hormone Replacement Therapy, Reference Values
    View official trial listing →
  • Active, not recruiting NCT NCT04484818

    Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

    Not yet reported ECOG-ACRIN Cancer Research Group 27 participants Est. completion 2028-05-31 115 sites
    Other conditions: Prostate Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04498793

    Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55 participants Est. completion 2022-12 2 sites
    Other conditions: HER2-negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04501003

    Investigation of U1-A Uterine Anomalies Implantation Markers From the Lateral Walls of the Endometrium

    Not yet reported Ufuk University 35 participants Est. completion 2021-05 1 site
    Other conditions: T-Shaped Uterus, Infertility, Female, Genital Tract Anomalies
    View official trial listing →
  • Terminated NCT NCT04515472

    Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

    Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2025-03-17 1 site
    Other conditions: Transgender Persons
    View official trial listing →
  • Completed NCT NCT04515888

    Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer

    Institut du Cancer de Montpellier - Val d'Aurelle 246 participants Est. completion 2021-07-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04524325

    Mechanisms of Blood Pressure Dysfunction in Transmen Receiving Testosterone

    Not yet reported Yale University Est. completion 2024-06-30
    Other conditions: Transgender Men, Blood Pressure, Hyperandrogenism
    View official trial listing →
  • Completed NCT NCT04524728

    Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy

    Istituti Clinici Scientifici Maugeri SpA 191 participants Est. completion 2020-06 1 site
    Other conditions: Breast, Neoplasm Malignant, Female
    View official trial listing →
  • Completed NCT NCT04531943

    Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

    Emory University 285 participants Est. completion 2024-04-04 1 site
    Other conditions: HIV Prevention
    View official trial listing →
  • Status unknown NCT NCT04539496

    A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors

    Not yet reported, Not yet reported Sihuan Pharmaceutical Holdings Group Ltd. 402 participants Est. completion 2025-12-31 1 site
    Other conditions: Metastasis Solid Tumors, Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04554927

    Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

    Not yet reported Centre Francois Baclesse 438 participants Est. completion 2026-12-31 1 site
    Other conditions: Web-application, Breast Cancer, Hormono Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT04565054

    Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC

    Not yet reported Women's Cancer Study Group GmbH 1260 participants Est. completion 2029-07 85 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT04567446

    Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach

    Gustave Roussy, Cancer Campus, Grand Paris 1100 participants Est. completion 2024-12 9 sites
    Other conditions: Cancer
    View official trial listing →
  • Terminated NCT NCT04578106

    Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy

    Not yet reported Fundacio Clinic Barcelona 5 participants Est. completion 2024-07-16 1 site
    Other conditions: HER2-positive Breast Cancer, Stage I Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04584853

    PreOperative Endocrine Therapy for Individualised Care With Abemaciclib

    Not yet reported Institute of Cancer Research, United Kingdom 123 participants Est. completion 2030-10 62 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Active, not recruiting NCT NCT04590417

    Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

    Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04591548

    Biomarkers in Endometriosis

    University Medical Centre Ljubljana 100 participants Est. completion 2021-01-01
    Other conditions: Endometriosis
    View official trial listing →
  • Active, not recruiting NCT NCT04593680

    Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men

    Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Active, not recruiting NCT NCT04597580

    Personalised Disease Monitoring in Metastatic Breast Cancer

    The Christie NHS Foundation Trust 97 participants Est. completion 2030-01-31 7 sites
    Other conditions: Breast Cancer Metastatic, Estrogen Receptor-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04600336

    Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 88 participants Est. completion 2024-03-11 103 sites
    Other conditions: Prostate Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04646564

    Radiotherapy for Extracranial Oligometastatic Breast Cancer

    Not yet reported Chinese Academy of Medical Sciences 170 participants Est. completion 2026-04-30 2 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT04647474

    Mental Wellbeing and Quality of Life in Prostate Cancer

    King's College London 300 participants Est. completion 2023-03-29 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04659551

    Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients

    Not yet reported Istituto Oncologico Veneto IRCCS 43 participants Est. completion 2020-05-25 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04666805

    Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

    First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04675814

    Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA)

    Institut Cancerologie de l'Ouest 37 participants Est. completion 2021-03-14 1 site
    Other conditions: Sports Physical Therapy
    View official trial listing →
  • Completed NCT NCT04676607

    SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 6 participants Est. completion 2023-06-12 1 site
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04681768

    Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients

    Technical University of Munich 95 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer/ Metastatic Breast Cancer
    View official trial listing →
  • Suspended NCT NCT04684628

    68Ga-PSMA PET/CT in Prostate Cancer

    Not yet reported University of Saskatchewan 500 participants Est. completion 2025-12 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT04696250

    Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR)

    University Hospital, Caen 5000000 participants Est. completion 2025-01-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT04707196

    A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

    Not yet reported Eli Lilly and Company 200 participants Est. completion 2023-01-09 15 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Active, not recruiting NCT NCT04733118

    Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer

    Not yet reported MedSIR 393 participants Est. completion 2028-03 41 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT04735549

    Vulvovaginal Atrophy Correction Using Neodymium Laser

    Not yet reported MeLSyTech, Ltd 120 participants Est. completion 2023-10-20 1 site
    Other conditions: Postmenopausal Period, Vaginal Atrophy, Female Urogenital Diseases
    View official trial listing →
  • Completed NCT NCT04736576

    Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy

    Not yet reported Pfizer 99 participants Est. completion 2023-03-24 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04736797

    Transition in Transgender

    RWTH Aachen University 200 participants Est. completion 2023-08-01 2 sites
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Terminated NCT NCT04738292

    Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sites
    Other conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT04742491

    Pre-Exposure Prophylaxis for Transgender Women in the US and South America

    Not yet reported, Not yet reported HIV Prevention Trials Network 304 participants Est. completion 2024-08-16 5 sites Stand-alone
    Other conditions: HIV Prevention
    View official trial listing →
  • Terminated NCT NCT04752332

    A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

    Not yet reported Eli Lilly and Company 111 participants Est. completion 2024-06-26 115 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT04753177

    The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

    Not yet reported, Not yet reported Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120 participants Est. completion 2024-01-28 1 site
    Other conditions: The Neoadjuvant Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT04762979

    Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

    Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sites
    Other conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04767594

    First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

    Pfizer 1407 participants Est. completion 2028-04-30 192 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT04798976

    Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

    Center of Personalized Medicine, Pirogova 3000 participants Est. completion 2021-05-30 1 site
    Other conditions: Breast Cancer-specific Survival
    View official trial listing →
  • Completed NCT NCT04812665

    Digital Health for Caregivers Emotional and Self-management Support

    Adhera Health, Inc. 65 participants Est. completion 2022-08-12 1 site
    Other conditions: Emotional Adjustment, Mood Disturbance
    View official trial listing →
  • Status unknown NCT NCT04824339

    Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.

    Not yet reported University of British Columbia 132 participants Est. completion 2023-12-31 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT04842617

    Phase III Study :SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 5274 participants Est. completion 2031-10-31 1 site
    Other conditions: Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04856371

    Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

    Not yet reported Haihe Biopharma Co., Ltd. 228 participants Est. completion 2022-12
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04861896

    A Research Study for Latina Women With Breast Cancer

    Not yet reported Northwestern University 58 participants Est. completion 2023-11-07 1 site
    Other conditions: Cancer, Breast, Cancer-related Problem/Condition, Quality of Life, Hormone Dependent Neoplasms, Adherence, Medication
    View official trial listing →
  • Completed NCT NCT04864405

    Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance

    Not yet reported Ottawa Hospital Research Institute 245 participants Est. completion 2023-07-29 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04875351

    Breast Cancer Index (BCI) Registry

    Biotheranostics, Inc. 3465 participants Est. completion 2028-12 105 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04883398

    A Study of Attention and Memory Processes in Breast Cancer Survivors

    Memorial Sloan Kettering Cancer Center 65 participants Est. completion 2027-05 1 site
    Other conditions: Breast Cancer Survivors
    View official trial listing →
  • Completed NCT NCT04887701

    Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women

    Not yet reported Madorra 25 participants Est. completion 2022-08-22 3 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT04892914

    Embr Thermal Device for Hot Flash Management in Prostate Cancer

    Not yet reported Embr Labs, Inc. 57 participants Est. completion 2021-12-05 1 site
    Other conditions: Prostate Cancer, Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT04906395

    Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

    Not yet reported Tolmar Inc. 250 participants Est. completion 2027-01-30 59 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04915508

    Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

    Not yet reported Jonsson Comprehensive Cancer Center 165 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIIC Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04922008

    Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)

    Not yet reported Fudan University 356 participants Est. completion 2026-06-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04930055

    Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

    Indiana University 2206 participants Est. completion 2022-03-08 2 sites
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT04938466

    Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy

    University of Minnesota 19 participants Est. completion 2024-10-30 1 site
    Other conditions: Growth Hormone Deficiency, Growth Hormone Treatment
    View official trial listing →
  • Completed NCT NCT04943497

    A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

    Novartis Pharmaceuticals 2390 participants Est. completion 2025-07-28 57 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04961996

    A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 4170 participants Est. completion 2033-09-30 621 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04971447

    Extracellular Vesicles and Endothelial Function in Transgender Subjects

    Not yet reported Central Hospital, Nancy, France 136 participants Est. completion 2024-01
    Other conditions: Transgenderism
    View official trial listing →
  • Status unknown NCT NCT04972448

    RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

    Zhejiang Cancer Hospital 500 participants Est. completion 2025-11
    Other conditions: Breast Cancer, Recurrence
    View official trial listing →
  • Active, not recruiting NCT NCT04975308

    A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

    Not yet reported Eli Lilly and Company 874 participants Est. completion 2027-08 243 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT04981275

    A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype

    Onegevity Health 81 participants Est. completion 2023-09-30 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT04995731

    Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer

    Assiut University 328 participants Est. completion 2024-07 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT05000736

    Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC

    Chinese Academy of Medical Sciences 600 participants Est. completion 2022-09-01 1 site
    Other conditions: Hormone Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05010707

    Transgender Estradiol Affirming Therapy

    Not yet reported Washington University School of Medicine 39 participants Est. completion 2024-01-01 1 site
    Other conditions: Transgenderism
    View official trial listing →
  • Status unknown NCT NCT05026073

    Vibrational Spectroscopy for Endometrial Cancer Diagnosis

    Nottingham University Hospitals NHS Trust 150 participants Est. completion 2024-11 1 site
    Other conditions: Endometrial Cancer, Endometrial Hyperplasia
    View official trial listing →
  • Active, not recruiting NCT NCT05041842

    Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer

    Not yet reported UNICANCER 53 participants Est. completion 2026-04-30 16 sites
    Other conditions: Metastatic Breast Cancer With a Isolated Brain Progression
    View official trial listing →
  • Completed NCT NCT05043506

    European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies

    Pfizer 1939 participants Est. completion 2023-11-02 64 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05050981

    Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life

    Faculdade de Medicina do ABC 74 participants Est. completion 2022-02-28 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT05054751

    GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported Genor Biopharma Co., Ltd. 275 participants Est. completion 2024-03-30 54 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05070234

    Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature

    Chunxiu Gong 150 participants Est. completion 2022-08-30
    Other conditions: Small for Gestational Age Infant, Silver-Russell Syndrome, Genetic Diseases, Inborn
    View official trial listing →
  • Completed NCT NCT05072756

    Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits

    Faculdade de Medicina do ABC 1339 participants Est. completion 2021-09-04 1 site
    Other conditions: Menopause, Opinions, Hormone Replacement Therapy
    View official trial listing →
  • Terminated NCT NCT05084859

    A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

    Not yet reported Biosplice Therapeutics, Inc. 30 participants Est. completion 2022-10-20 20 sites
    Other conditions: Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT05085678

    Co'Moon for Supporting Breast Cancer Patients on Adjuvant Endocrine Therapy

    Not yet reported Universitaire Ziekenhuizen KU Leuven 77 participants Est. completion 2022-12-31 1 site
    Other conditions: Breast Cancer, Quality of Life, Self Efficacy
    View official trial listing →
  • Active, not recruiting NCT NCT05100472

    A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 50 participants Est. completion 2027-10-19 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT05110391

    Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy

    ANDROFERT - Clinica de Andrologia e Reproducao Humana 616 participants Est. completion 2021-09-15 1 site
    Other conditions: Non-obstructive Azoospermia, Hormone Deficiency, Hypogonadism, Male, Male Infertility
    View official trial listing →
  • Completed NCT NCT05122377

    RWE About QOL and Compliance of Patients With OFS in China

    Fudan University 562 participants Est. completion 2025-05-01 1 site
    Other conditions: Breast Cancer, Quality of Life, Hormone Receptor-positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05131893

    Neoadjuvant Treatment of Breast Cancer

    National Institute of Oncology, Hungary 300 participants Est. completion 2031-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05138510

    Sexual Health in Breast Cancer Patients

    University of Colorado, Denver 93 participants Est. completion 2025-10-23 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05150652

    Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

    Not yet reported Irada Ibrahim-zada 8 participants Est. completion 2026-06-10 1 site
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer, Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05156814

    Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women

    Not yet reported Scientific Research Institute of Public Health, Russian Federation 150 participants Est. completion 2023-05 1 site
    Other conditions: Perimenopausal Disorder, Hot Flashes
    View official trial listing →
  • Completed NCT NCT05159778

    Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

    Not yet reported HiberCell, Inc. 26 participants Est. completion 2023-04-12 16 sites
    Other conditions: Malignant Neoplasm of Breast
    View official trial listing →
  • Terminated NCT NCT05176080

    Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

    Not yet reported, Not yet reported Henan Cancer Hospital 46 participants Est. completion 2024-07-03 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05186545

    An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

    Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sites
    Other conditions: Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT05195437

    Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size

    Assistance Publique - Hôpitaux de Paris 36 participants Est. completion 2024-10-12 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Active, not recruiting NCT NCT05204927

    177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Curium US LLC 439 participants Est. completion 2029-02 52 sites
    Other conditions: Metastasis From Malignant Tumor of Prostate
    View official trial listing →
  • Status unknown NCT NCT05205200

    Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02

    Not yet reported Fudan University 338 participants Est. completion 2026-08-01 1 site
    Other conditions: Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Terminated NCT NCT05207709

    Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype

    Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05238467

    Immunological Responses of COVID-19 Vaccination

    University Hospitals Cleveland Medical Center 42 participants Est. completion 2023-02-13 1 site
    Other conditions: Cancer; Chemotherapy
    View official trial listing →
  • Active, not recruiting NCT NCT05251714

    CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer

    Not yet reported, Not yet reported Treadwell Therapeutics, Inc 44 participants Est. completion 2026-08 4 sites
    Other conditions: Advanced Solid Tumor, Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05264649

    Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer

    Not yet reported Show Chwan Memorial Hospital 72 participants Est. completion 2023-03-03 1 site
    Other conditions: Arthralgia
    View official trial listing →
  • Status unknown NCT NCT05277935

    Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

    Not yet reported Beneficência Portuguesa de São Paulo 68 participants Est. completion 2025-03-01 4 sites
    Other conditions: Breast Neoplasm Female, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT05279118

    Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome

    Not yet reported, Not yet reported All India Institute of Medical Sciences 80 participants Est. completion 2024-07-28 2 sites
    Other conditions: Ketogenic Diet, West Syndrome, Infantile Spasm, ACTH
    View official trial listing →
  • Not yet recruiting NCT NCT05285332

    Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy

    Not yet reported Changhai Hospital 362 participants Est. completion 2031-05-01
    Other conditions: Breast Neoplasms, Treatment, Metastatic Breast Cancer, Survival
    View official trial listing →
  • Completed NCT NCT05324020

    eHealth Intervention for Medication Adherence in Breast Cancer Survivors

    Not yet reported Luxembourg Institute of Health 3 participants Est. completion 2022-11-30 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05343117

    Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

    Chinese Academy of Medical Sciences 400 participants Est. completion 2024-06-01 9 sites
    Other conditions: Hormone Receptor Positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05346445

    Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

    Not yet reported Hospital Regional 1o de Octubre 91 participants Est. completion 2021-12-20 1 site
    Other conditions: Postmenopause, Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT05392608

    SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

    Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sites
    Other conditions: Neoplasm, Breast, Congenital, Familial and Genetic Disorders
    View official trial listing →
  • Completed NCT NCT05392985

    Detection and Analysis of MBC With Heterogeneous ER Expression

    Fudan University 51 participants Est. completion 2022-12-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05411380

    Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

    Not yet reported wang shusen 73 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05415930

    Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.

    Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 100 participants Est. completion 2025-02-28
    Other conditions: Transgenderism
    View official trial listing →
  • Status unknown NCT NCT05433480

    A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

    Not yet reported Betta Pharmaceuticals Co., Ltd. 274 participants Est. completion 2025-07-31 64 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05437679

    Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

    Angle plc 9 participants Est. completion 2023-08-22 2 sites
    Other conditions: High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma, Castration-resistant Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT05452213

    Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

    Not yet reported Institut fuer Frauengesundheit 1000 participants Est. completion 2026-10 52 sites
    Other conditions: Breast Cancer, Breast Neoplasms, Breast Neoplasm Female, Breast Cancer Female, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05460819

    Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

    Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-07-31 1 site
    Other conditions: Hot Flashes, Breast Cancer, Acupuncture
    View official trial listing →
  • Completed NCT NCT05465408

    Culturally Aware AET Non-Initiation Intervention

    Not yet reported Massachusetts General Hospital 35 participants Est. completion 2024-11-20 11 sites
    Other conditions: Breast Cancer, Survivorship, Treatment Compliance, Treatment Adherence, Treatment Refusal
    View official trial listing →
  • Completed NCT NCT05469204

    Effect of Estrogen Treatment on Drug Metabolism and Transport

    Not yet reported University of Washington 22 participants Est. completion 2025-07-30 1 site
    Other conditions: Transgender Persons
    View official trial listing →
  • Completed NCT NCT05483621

    Hormonal Stimulation of Spermatogenesis

    Not yet reported Egymedicalpedia 100 participants Est. completion 2022-03-01 1 site Stand-alone
    Other conditions: Azoospermia, Nonobstructive
    View official trial listing →
  • Active, not recruiting NCT NCT05486182

    Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer

    Not yet reported GE Healthcare 153 participants Est. completion 2026-01 11 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05488145

    A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy

    Not yet reported Emory University 21 participants Est. completion 2025-12-10 4 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05503160

    Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application

    Not yet reported Technical University of Munich 400 participants Est. completion 2026-06 1 site
    Other conditions: New Healthcare Approach
    View official trial listing →
  • Status unknown NCT NCT05504213

    A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 224 participants Est. completion 2025-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05512416

    Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer

    Not yet reported The Affiliated Hospital of Qingdao University 35 participants Est. completion 2024-05
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05514054

    A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

    Not yet reported Eli Lilly and Company 8000 participants Est. completion 2032-03 672 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT05525481

    Tamoxifen Prediction Study in Patients With ER+ Breast Cancer

    Not yet reported Erasmus Medical Center 100 participants Est. completion 2024-02-28 1 site
    Other conditions: ER+ Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05529862

    Trans-RosaLEE Study: a Biomarker-directed, Translational Study

    Not yet reported Institut Paoli-Calmettes 115 participants Est. completion 2028-11-01 1 site
    Other conditions: Advanced or Metastatic Breast Cancer (BC)
    View official trial listing →
  • Completed NCT NCT05544227

    Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Williams Cancer Foundation 15 participants Est. completion 2025-06-01 1 site
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT05550090

    Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC

    Zhejiang Cancer Hospital 40 participants Est. completion 2025-12-30 1 site
    Other conditions: Metastatic Breast Cancer in the Liver
    View official trial listing →
  • Completed NCT NCT05562518

    GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

    Not yet reported University Hospital, Ghent 31 participants Est. completion 2026-03-02 1 site
    Other conditions: Vulvovaginal Atrophy, Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05568472

    Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study

    Not yet reported SWOG Cancer Research Network 565 participants Est. completion 2028-05-01 490 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT05568940

    Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids

    McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2026-04 1 site
    Other conditions: Endometriosis, Fibroids
    View official trial listing →
  • Active, not recruiting NCT NCT05569811

    NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial

    Not yet reported SOLTI Breast Cancer Research Group 120 participants Est. completion 2030-07-31 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05583058

    Sex Hormone Overdose and Misuse in Chinese Transgender and Gender Non-conforming Population

    Xiamen University 260 participants Est. completion 2029-03-30 1 site
    Other conditions: Gender Incongruence, Gender Dysphoria
    View official trial listing →
  • Active, not recruiting NCT NCT05587296

    A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

    Not yet reported Bayer 474 participants Est. completion 2028-06-05 102 sites
    Other conditions: Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT05607004

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

    Not yet reported Atossa Therapeutics, Inc. 87 participants Est. completion 2027-04 14 sites
    Other conditions: Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05612100

    Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

    Mayo Clinic 169 participants Est. completion 2028-07-09 23 sites
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT05613504

    Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

    Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-12-01 1 site
    Other conditions: Hot Flashes, Breast Cancer, Acupuncture
    View official trial listing →
  • Terminated NCT NCT05617885

    Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

    Not yet reported Praful Ravi, MB BCHir, MRCP 9 participants Est. completion 2026-06-01 1 site Stand-alone
    Other conditions: Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT05640778

    Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2025-10-31 1 site
    Other conditions: Luminal B/HER2-negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05643131

    Hyivy Device as Non-hormonal Therapy in Endometriosis

    Not yet reported Hyivy Health Inc 20 participants Est. completion 2026-12 1 site
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Enrolling by invitation NCT NCT05645536

    Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

    Not yet reported Tolmar Inc. 250 participants Est. completion 2030-03 46 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05654623

    A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

    Not yet reported Pfizer 624 participants Est. completion 2028-05-15 312 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05663892

    Drug-Drug Interaction Study in Trans Women Living With HIV

    Not yet reported Maple Leaf Research 45 participants Est. completion 2025-01 1 site
    Other conditions: Hiv, Transgenderism
    View official trial listing →
  • Withdrawn NCT NCT05664893

    Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

    Not yet reported, Not yet reported Centre Antoine Lacassagne Est. completion 2026-03-26 1 site
    Other conditions: HER2 Negative Breast Cancer Not Immediately Operated
    View official trial listing →
  • Active, not recruiting NCT NCT05669664

    Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

    Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2026-11-30 27 sites
    Other conditions: Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Unresectable Salivary Gland Carcinoma
    View official trial listing →
  • Completed NCT NCT05678192

    Effect of Menopausal Hormone Therapy on Immune System Parameters

    Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 40 participants Est. completion 2023-03-01 1 site
    Other conditions: Last Period Not Earlier Than 6 Months Ago
    View official trial listing →
  • Status unknown NCT NCT05680194

    Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients

    Peking Union Medical College Hospital 1000 participants Est. completion 2025-12-01 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT05690295

    Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer

    Not yet reported Universidad de La Frontera 26 participants Est. completion 2024-05-15 1 site
    Other conditions: Breast Cancer Survivors, Postmenopause, Resistance Training
    View official trial listing →
  • Active, not recruiting NCT NCT05697146

    Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

    Novartis Pharmaceuticals 1019 participants Est. completion 2028-06-30 82 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05700006

    Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

    University of Michigan 94 participants Est. completion 2026-02-26 1 site
    Other conditions: Breast Neoplasm Female, Arthralgia, Aging
    View official trial listing →
  • Status unknown NCT NCT05717634

    Endometrial Changes in Breast Cancer Women.

    Regina Elena Cancer Institute 829 participants Est. completion 2024-01-26 1 site
    Other conditions: Endometrial Cancer, Endometrial Hyperplasia With Atypia, Breast Cancer, TAM
    View official trial listing →
  • Active, not recruiting NCT NCT05730647

    Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients

    Consorzio Oncotech 600 participants Est. completion 2032-07-31 40 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05754528

    Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance

    Not yet reported Ottawa Hospital Research Institute 240 participants Est. completion 2030-02 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05755581

    Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

    Not yet reported Sohag University 100 participants Est. completion 2025-08-01 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05766410

    A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2026-09-30 2 sites
    Other conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT05780567

    Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 1946 participants Est. completion 2027-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05789771

    Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.

    Blokhin's Russian Cancer Research Center 136 participants Est. completion 2022-12-01 1 site
    Other conditions: HR+/HER2- Breast Cancer, Metastatic Disease, Аdvanced Disease
    View official trial listing →
  • Status unknown NCT NCT05800197

    Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

    Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 site
    Other conditions: Breast Cancer, Neoadjuvant Endocrine Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT05827081

    Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals 1466 participants Est. completion 2030-09-20 214 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT05865262

    Protocol TRANS and QT Repolarization

    University Hospital, Bordeaux 120 participants Est. completion 2023-01-01 1 site
    Other conditions: Transgender Individuals, QTc Interval
    View official trial listing →
  • Active, not recruiting NCT NCT05870579

    [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2032-05-27 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05887102

    Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors

    Not yet reported CHU de Quebec-Universite Laval 66 participants Est. completion 2025-03 1 site
    Other conditions: Breast Neoplasms, Breast Cancer
    View official trial listing →
  • Completed NCT NCT05887297

    Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence

    Not yet reported University of Strathclyde 35 participants Est. completion 2024-04-23 1 site
    Other conditions: Insomnia, Breast Cancer, Adherence, Medication, Quality of Life, Survivorship
    View official trial listing →
  • Status unknown NCT NCT05889871

    A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer

    Not yet reported Fudan University 916 participants Est. completion 2026-06-01
    Other conditions: HR+/HER2-breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05890287

    A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-10-01 1 site
    Other conditions: HR Positive HER2 Negative Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05891795

    Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

    Not yet reported, Not yet reported Stanford University 18 participants Est. completion 2026-06 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Terminated NCT NCT05894876

    A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

    Novo Nordisk A/S 43 participants Est. completion 2025-03-21 4 sites
    Other conditions: Idiopathic Short Stature
    View official trial listing →
  • Completed NCT NCT05894954

    Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

    Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sites
    Other conditions: Mild Cognitive Impairment, Dementia, Mild
    View official trial listing →
  • Completed NCT NCT05896605

    Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

    Not yet reported First Affiliated Hospital of Guangxi Medical University 63 participants Est. completion 2023-04-01 1 site
    Other conditions: NMO Spectrum Disorder, Azathioprine Adverse Reaction
    View official trial listing →
  • Active, not recruiting NCT NCT05914792

    Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

    University of Pittsburgh 49 participants Est. completion 2026-07-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05927779

    Study of TFX06 in Women With Advanced Breast Cancer.

    Not yet reported, Not yet reported Zhejiang Yangli Pharmaceutical Technology Co., Ltd. 74 participants Est. completion 2025-04-30 2 sites
    Other conditions: ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05934877

    ASK-PrEP (Assistance Services Knowledge-PrEP)

    Not yet reported Friends Research Institute, Inc. 152 participants Est. completion 2025-03-19 1 site
    Substance use disorder Other conditions: HIV
    View official trial listing →
  • Active, not recruiting NCT NCT05952557

    An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

    Not yet reported AstraZeneca 5511 participants Est. completion 2037-05-06 661 sites
    Other conditions: Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05966584

    A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 1 participants Est. completion 2024-08-02 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05969184

    Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

    Not yet reported Peking University Cancer Hospital & Institute 94 participants Est. completion 2026-06-25 2 sites
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Status unknown NCT NCT05979480

    The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study)

    University Hospital Birmingham 25 participants Est. completion 2025-11-30 1 site
    Other conditions: Adult Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT05982470

    Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI

    Not yet reported Beijing Tiantan Hospital 328 participants Est. completion 2025-10-01 1 site
    Other conditions: Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment, White Matter Hyperintensity
    View official trial listing →
  • Not yet recruiting NCT NCT05986071

    I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers

    Not yet reported, Not yet reported Institut Paoli-Calmettes 57 participants Est. completion 2027-10-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06001762

    TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 90 participants Est. completion 2027-01-01 12 sites
    Other conditions: Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT06009627

    Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

    Not yet reported, Not yet reported Tianjin Medical University Cancer Institute and Hospital 119 participants Est. completion 2025-09-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06016738

    OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

    Not yet reported Olema Pharmaceuticals, Inc. 510 participants Est. completion 2028-02-29 233 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06018337

    A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

    Not yet reported DualityBio Inc. 541 participants Est. completion 2028-08 258 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06027541

    Young Patients With Early Breast Cancer

    Peking Union Medical College Hospital 1000 participants Est. completion 2028-02-01 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT06040593

    Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

    Daiichi Sankyo 927 participants Est. completion 2024-02-23 1 site
    Other conditions: Hormone-receptor-positive Breast Cancer, HER2-low Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT06049797

    A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

    Astellas Pharma Global Development, Inc. 999 participants Est. completion 2026-05-07 48 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Status unknown NCT NCT06061666

    Treatment of Insomnia in Patients With Breast Cancer

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80 participants Est. completion 2024-06-30 1 site
    Other conditions: Breast Cancer, Insomnia
    View official trial listing →
  • Completed NCT NCT06064851

    Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

    Not yet reported Five Liters, Inc. 29 participants Est. completion 2025-04-18 1 site Stand-alone
    Other conditions: Von Willebrand Disease, Type 1, Heavy Menstrual Bleeding
    View official trial listing →
  • Active, not recruiting NCT NCT06065748

    A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06072196

    A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

    Pfizer 3017 participants Est. completion 2024-12-18 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT06075758

    A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

    Novartis Pharmaceuticals 175 participants Est. completion 2025-06-30 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06080620

    The Choice of Treatment Methods and Efficacy of LABC

    Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2026-08-01 1 site
    Other conditions: Locally Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06105632

    A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

    Not yet reported Pfizer 333 participants Est. completion 2028-01-21 48 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06116201

    Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women

    Not yet reported Chulalongkorn University 60 participants Est. completion 2021-07-31 1 site
    Other conditions: Transgender Women
    View official trial listing →
  • Terminated NCT NCT06126003

    Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

    BioCorteX Inc 2 participants Est. completion 2024-07-31 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06131424

    NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients

    AstraZeneca 1151 participants Est. completion 2025-05-19 31 sites
    Other conditions: HER2-negative
    View official trial listing →
  • Completed NCT NCT06133465

    Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management

    Istituto Oncologico Veneto IRCCS 1063 participants Est. completion 2025-01-31 1 site
    Other conditions: Pleomorphic Lobular Breast Carcinoma in Situ, Breast Florid Lobular Carcinoma in Situ
    View official trial listing →
  • Active, not recruiting NCT NCT06148506

    A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

    Novartis Pharmaceuticals 376 participants Est. completion 2027-06-30 20 sites
    Other conditions: HR+HER2- Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06149065

    Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study

    Mahidol University 247 participants Est. completion 2023-06-06 1 site
    Other conditions: Acne, Transgenderism
    View official trial listing →
  • Completed NCT NCT06151418

    A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

    Pfizer 2313 participants Est. completion 2024-04-23 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT06154590

    Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

    DR. DIANE CHISESI NFS. MD. PHD. 100 participants Est. completion 2026-09 1 site
    Other conditions: Metastatic Breast Cancer, Tumor, Muscle Neoplasms, Chronic Pain
    View official trial listing →
  • Completed NCT NCT06168890

    Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.

    IRCCS San Raffaele 195 participants Est. completion 2014-02-25
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT06172088

    Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy

    Not yet reported University Hospital Tuebingen 54 participants Est. completion 2025-09-30 2 sites
    Other conditions: Breast Cancer Patients Treated With Aromatase Inhibitors
    View official trial listing →
  • Status unknown NCT NCT06192446

    Factors Influencing Adherence to Adjuvant Endocrine Therapy

    University of Zagreb 1000 participants Est. completion 2024-09-20 1 site
    Other conditions: Adherence, Treatment
    View official trial listing →
  • Status unknown NCT NCT06195202

    Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)

    Sun Yat-sen University 2000 participants Est. completion 2026-08-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06201897

    Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation

    Not yet reported, Not yet reported All India Institute of Medical Sciences 40 participants Est. completion 2026-06 1 site
    Other conditions: West Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06223698

    Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer

    Not yet reported Region Örebro County 3832 participants Est. completion 2035-05-02 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06229366

    [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

    Not yet reported Eli Lilly and Company 142 participants Est. completion 2032-12 7 sites
    Other conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Oligometastatic Prostate Carcinoma, Hormone Sensitive Prostate Cancer
    View official trial listing →
  • Completed NCT NCT06246084

    INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy

    Not yet reported Dana-Farber Cancer Institute 76 participants Est. completion 2024-12-23 1 site
    Other conditions: Breast Cancer, Breast Cancer Female, Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06247995

    A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

    Not yet reported, Not yet reported Novartis Pharmaceuticals 20 participants Est. completion 2027-04-14 28 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06306404

    Sleeping Through Menopause

    Not yet reported VU University of Amsterdam 222 participants Est. completion 2030-01-01
    Other conditions: Menopause, Insomnia
    View official trial listing →
  • Completed NCT NCT06311383

    A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment

    Novartis Pharmaceuticals 2610 participants Est. completion 2025-03-10 265 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06338644

    Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.

    Helwan University 100 participants Est. completion 2026-09-01
    Other conditions: Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06343987

    The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity

    Not yet reported Aarhus University Hospital 21 participants Est. completion 2025-04-24 1 site
    Other conditions: Metastatic Breast Cancer, Estrogen-receptor-positive Breast Cancer, Adiposity
    View official trial listing →
  • Completed NCT NCT06344793

    Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

    Fudan University 608 participants Est. completion 2025-02-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06355401

    Maintenance Hormonal Therapy and DLBCL

    Not yet reported, Not yet reported Sohag University 100 participants Est. completion 2029-03
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT06369909

    Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis

    Peking Union Medical College Hospital 180 participants Est. completion 2026-01-31 1 site
    Other conditions: Autoimmune Pancreatitis
    View official trial listing →
  • Completed NCT NCT06375707

    First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 74 participants Est. completion 2026-05-30 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06379659

    Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer

    Not yet reported, Not yet reported Isfahan University of Medical Sciences 54 participants Est. completion 2024-09-14 1 site
    Other conditions: Thin Endometrium, Infertility Female, Infertility
    View official trial listing →
  • Completed NCT NCT06388304

    THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence

    Not yet reported Joanna Arch 39 participants Est. completion 2025-04-18 1 site
    Other conditions: Breast Cancer, DCIS
    View official trial listing →
  • Not yet recruiting NCT NCT06407401

    Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 399 participants Est. completion 2028-11-30
    Other conditions: ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Drug-Related Side Effects and Adverse Reactions, Musculoskeletal Pain
    View official trial listing →
  • Terminated NCT NCT06408168

    Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2025-12-08 1 site
    Other conditions: Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06415162

    Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality

    Not yet reported Saglik Bilimleri Universitesi 64 participants Est. completion 2024-07-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06428396

    Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

    Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06440967

    A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

    Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT06447623

    Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

    Not yet reported Fudan University 184 participants Est. completion 2029-02-01 1 site
    Other conditions: Advanced Breast Cancer, HR+/HER2- Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06448195

    Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery

    Not yet reported Shanghai Zhongshan Hospital 40 participants Est. completion 2025-12-31 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Status unknown NCT NCT06455956

    Use of miRNAs in Growth Hormone Deficiency (GHD)

    University of Parma 400 participants Est. completion 2026-03-01 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Status unknown NCT NCT06458764

    Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study

    Candiolo Cancer Institute - IRCCS 150 participants Est. completion 2025-12-01 1 site
    Other conditions: Breast Cancer Female, Sexual Dysfunction, Premenopausal Breast Cancer
    View official trial listing →
  • Completed NCT NCT06464341

    Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study

    University Hospital, Basel, Switzerland 583 participants Est. completion 2024-12-31 62 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06470672

    Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer

    Not yet reported Fudan University 32 participants Est. completion 2026-07 1 site
    Other conditions: Advanced Breast Cancer, Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Enrolling by invitation NCT NCT06472765

    Vaginal Ecosystem and Network in the United States Study

    Vaginal Biome Science 3250 participants Est. completion 2028-05-15 21 sites
    Other conditions: Bacterial Vaginosis, Candidiasis, Urinary Tract Infections, Genitourinary Syndrome of Menopause, Lichen Sclerosus, Lichen Planus, Vulvodynia, Endometriosis, Ureaplasma Infections, Cancer, Desquamative Inflammatory Vaginitis
    View official trial listing →
  • Status unknown NCT NCT06481553

    RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences 480 participants Est. completion 2024-07-31 1 site
    Other conditions: Breast Cancer Stage IV
    View official trial listing →
  • Enrolling by invitation NCT NCT06481956

    T-DM1 Combined With CDK4/6 Inhibitor Ribociclib

    Not yet reported Zheng Yabing 40 participants Est. completion 2027-10-10 1 site
    Other conditions: HER2-positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06482385

    Transmasculine Quality of Life and Sexual Function at Pre and Post Gender-affirming Hormonal Therapy

    Chulalongkorn University 40 participants Est. completion 2024-05-31 1 site
    Other conditions: Transgender Men
    View official trial listing →
  • Active, not recruiting NCT NCT06492616

    A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    Not yet reported Stemline Therapeutics, Inc. 4556 participants Est. completion 2032-10 555 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06494150

    Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)

    Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 site
    Other conditions: Low Grade Ovarian Serous Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT06500741

    Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

    Astellas Pharma Global Development, Inc. 374 participants Est. completion 2025-04-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT06504953

    Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy

    Not yet reported Centre Hospitalier Universitaire de Nice 72 participants Est. completion 2026-06-17 1 site
    Other conditions: Women, Tibial Translation, Hormone
    View official trial listing →
  • Status unknown NCT NCT06505278

    The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy

    Not yet reported Sun Yat-sen University 70 participants Est. completion 2025-12 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT06508788

    Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients

    Hospital Universitari de Bellvitge 30 participants Est. completion 2026-07-01 1 site
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Status unknown NCT NCT06510647

    Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.

    University of Cagliari 247 participants Est. completion 2026-05-31 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT06538818

    Ultra Phonophoresis With a Hyaluronic Acid-Containing Gel on Carpal Tunnel Syndrome Post Mastectomy.

    Not yet reported Cairo University 60 participants Est. completion 2024-11-01 1 site
    Other conditions: Mastectomy, Carpal Tunnel Syndrome (CTS)
    View official trial listing →
  • Status unknown NCT NCT06544577

    Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

    SciClone Pharmaceuticals 350 participants Est. completion 2026-08-01 1 site
    Other conditions: ESR1 Gene Mutation, Advanced Breast Cancer, Safety
    View official trial listing →
  • Not yet recruiting NCT NCT06556862

    Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

    Not yet reported Beijing 302 Hospital 155 participants Est. completion 2028-12-31 1 site
    Other conditions: HR+/HER2- Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06570031

    ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

    Not yet reported Ono Pharmaceutical Co., Ltd. 46 participants Est. completion 2026-04-30 13 sites
    Other conditions: Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06583460

    Systematic Intervention to Improve Sexual Dysfunction

    Not yet reported Center Eugene Marquis 60 participants Est. completion 2028-06-09 1 site
    Other conditions: Breast Cancer Female, Localized Cancer
    View official trial listing →
  • Withdrawn NCT NCT06585969

    A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

    Not yet reported Danish Breast Cancer Cooperative Group Est. completion 2026-01-01
    Other conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, Luminal B, Her2 Enriched, Basal Like
    View official trial listing →
  • Active, not recruiting NCT NCT06599216

    Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer

    Not yet reported Harbin Medical University 30 participants Est. completion 2027-09-01 2 sites
    Other conditions: Breast Cancer, HR+/HER2- Breast Cancer
    View official trial listing →
  • Completed NCT NCT06603805

    Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study

    West China Hospital 974 participants Est. completion 2024-01-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06611514

    Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer

    Not yet reported European Institute of Oncology 95 participants Est. completion 2027-01-01 1 site
    Other conditions: Women With Breast Cancer
    View official trial listing →
  • Terminated NCT NCT06617455

    Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial

    Not yet reported University of Michigan Rogel Cancer Center 9 participants Est. completion 2025-11-21 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ, Localized Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06621459

    Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

    University Hospital, Brest 30 participants Est. completion 2025-10-31 1 site
    Other conditions: Brest Cancer, Abemaciclib, Adjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT06623903

    Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy

    Aarhus University Hospital 112 participants Est. completion 2025-07-31 1 site
    Other conditions: Early Breast Cancer, Metabolic Health, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06642948

    AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial

    Not yet reported Fudan University 80 participants Est. completion 2025-01-01 1 site
    Other conditions: Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase Inhibitors
    View official trial listing →
  • Enrolling by invitation NCT NCT06650748

    Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

    Not yet reported Peking University 100 participants Est. completion 2028-04-01 1 site
    Other conditions: Breast Cancer, Early-stage Breast Cancer
    View official trial listing →
  • Completed NCT NCT06655545

    18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

    Fudan University 473 participants Est. completion 2025-02-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06656624

    Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 190 participants Est. completion 2025-12-31 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06662864

    Study on Sleep, Lifestyle and Quality of Life in Women With Breast Cancer

    Institut Rafael 60 participants Est. completion 2023-12-31 1 site
    Other conditions: Breast Cancers
    View official trial listing →
  • Active, not recruiting NCT NCT06668805

    A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

    Not yet reported BioMarin Pharmaceutical 30 participants Est. completion 2041-09 38 sites
    Other conditions: Noonan Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06669273

    Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)

    Not yet reported University Hospital, Clermont-Ferrand 70 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Suspected Prostate Cancer (increased PSA Level)
    View official trial listing →
  • Suspended NCT NCT06671912

    Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

    Not yet reported Alliance for Clinical Trials in Oncology 1556 participants Est. completion 2031-11-30 732 sites
    Other conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
    View official trial listing →
  • Completed NCT NCT06690489

    An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)

    Pierre Fabre Medicament 155 participants Est. completion 2025-11-26 9 sites
    Other conditions: Early Breast Cancer, Skin Condition, Quality of Life
    View official trial listing →
  • Active, not recruiting NCT NCT06702618

    Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33 participants Est. completion 2026-12 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06711094

    Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABC

    Not yet reported Fujian Medical University 52 participants Est. completion 2028-12-30
    Other conditions: HR+/HER2- Advanced Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT06733415

    Changes in Energy Expenditure (EE) in Transsexuals Undergoing Hormonal Therapy

    Tel-Aviv Sourasky Medical Center 40 participants Est. completion 2026-12-31 1 site
    Other conditions: Transgender, Transgender Persons, M01.777.500
    View official trial listing →
  • Not yet recruiting NCT NCT06746376

    Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.

    Not yet reported Universidad Europea de Madrid 32 participants Est. completion 2025-11-01 1 site
    Other conditions: Arthralgia
    View official trial listing →
  • Active, not recruiting NCT NCT06754293

    Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol

    Not yet reported Fudan University 24 participants Est. completion 2025-02-01 1 site
    Other conditions: Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase Inhibitors
    View official trial listing →
  • Active, not recruiting NCT NCT06760637

    Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

    Not yet reported Pfizer 1035 participants Est. completion 2037-12-29 460 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06763094

    Efficacy of Calcium Dobesilate Versus Tranexamic Acid for Treating Heavy Menstrual Bleeding

    Not yet reported University of Health Sciences Lahore 100 participants Est. completion 2025-12
    Other conditions: Menorrhagia, Abnormal Uterine Bleeding
    View official trial listing →
  • Enrolling by invitation NCT NCT06765707

    Symptom Monitoring Using Patient-Report to Improve Medication Use

    Not yet reported Medical College of Wisconsin 225 participants Est. completion 2029-08 4 sites
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), Endocrine Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT06787118

    Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 130 participants Est. completion 2027-05 1 site
    Other conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, HR+ Breast Cancer, AI-related Musculoskeletal Pain
    View official trial listing →
  • Completed NCT NCT06806072

    BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY

    Not yet reported Parc de Salut Mar 84 participants Est. completion 2026-07-01 2 sites
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Not yet recruiting NCT NCT06810492

    The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

    Not yet reported Hongmei Zheng, PhD 40 participants Est. completion 2027-12-01
    Other conditions: Breast Cancer Stage III, Breast Cancer Stage II
    View official trial listing →
  • Completed NCT NCT06830486

    Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)

    University of Colorado, Denver 40 participants Est. completion 2023-10-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06855589

    Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

    Not yet reported Charles LeMoyne Hospital 400 participants Est. completion 2034-03 5 sites
    Other conditions: Prostate Cancer (Adenocarcinoma)
    View official trial listing →
  • Not yet recruiting NCT NCT06905886

    Resting Energy Expenditure in Postmenopausal Women

    Insel Gruppe AG, University Hospital Bern 37 participants Est. completion 2027-02 1 site
    Other conditions: Postmenopause, Energy Expenditure, Hormone Replacement Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT06957379

    Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 78 participants Est. completion 2025-12 1 site
    Other conditions: HR+/HER2- Advanced/Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06976593

    Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors

    University of Extremadura 30 participants Est. completion 2025-05-31 1 site
    Other conditions: Breast Cancer Survivorship, Muscle Oxygenation, Near-infrared Spectroscopy, Exercise, Quality of Life, Functional Capacity, Hormonal Therapy
    View official trial listing →
  • Completed NCT NCT07013422

    The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer

    Not yet reported Sultan Qaboos Comprehensive Cancer Center 58 participants Est. completion 2024-04-18 1 site Stand-alone
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Not yet recruiting NCT NCT07028242

    Ultrasound and Histology in AEH and Early EEC Treated Conservatively

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50 participants Est. completion 2027-06-30 1 site
    Other conditions: Fertility-Sparing Treatment (FST), Atypical Endometrial Hyperplasia, Early Endometrial Cancer (EEC)
    View official trial listing →
  • Not yet recruiting NCT NCT07061717

    Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 474 participants Est. completion 2029-07-01 1 site
    Other conditions: Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT07076680

    A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer

    SciClone Pharmaceuticals Est. completion 2027-07-01 1 site
    Other conditions: Breast Cancer Metastatic, HR+/HER2- Advanced Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07078435

    Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis

    Not yet reported University Hospital, Grenoble 40 participants Est. completion 2027-09-30 1 site
    Other conditions: Endometriosis, Immunity, Microbiota
    View official trial listing →
  • Not yet recruiting NCT NCT07101159

    Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

    Not yet reported Fujian Cancer Hospital 200 participants Est. completion 2031-12
    Other conditions: Early Breast Cancer, Adjuvant Therapy, Hormone Receptor Positive / HER2-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT07103603

    MHT and Liver Function in Postmenopausal Women

    Not yet reported Ipek B. Ozcivit Erkan, MD 44 participants Est. completion 2025-12-30 1 site
    Other conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic Steatosis
    View official trial listing →
  • Enrolling by invitation NCT NCT07128771

    Cardiomodulatory Effects of Gender-Affirming Hormone Therapy

    University Hospital, Akershus 450 participants Est. completion 2030-10 1 site
    Cardiovascular disease Other conditions: Gender Incongruence
    View official trial listing →
  • Active, not recruiting NCT NCT07130643

    Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer

    Not yet reported Xinhong Wu, PhD 40 participants Est. completion 2027-06-20 1 site
    Other conditions: HR+/HER2- Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07153757

    De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial

    Not yet reported Fudan University 2934 participants Est. completion 2033-09-01 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Not yet recruiting NCT NCT07162259

    Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer

    Not yet reported Yan Xue 40 participants Est. completion 2027-12-31 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT07164794

    Memantine Hydrochloride in Prostate Cancer Patients

    Not yet reported Bin Xu 15 participants Est. completion 2028-06
    Other conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)
    View official trial listing →
  • Not yet recruiting NCT NCT07179939

    Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

    Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07180914

    A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer

    Zhejiang Cancer Hospital 300 participants Est. completion 2029-12-31
    Other conditions: Breast Cancer Females
    View official trial listing →
  • Not yet recruiting NCT NCT07189884

    Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy

    Not yet reported, Not yet reported The First Affiliated Hospital of Xiamen University 33 participants Est. completion 2028-12-31
    Other conditions: Locally Advanced Breast Cancer (LABC)
    View official trial listing →
  • Not yet recruiting NCT NCT07190651

    Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50 participants Est. completion 2026-09-30
    Other conditions: Breast Cancer, CDK4/6 Inhibitor
    View official trial listing →
  • Completed NCT NCT07199556

    Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.

    Not yet reported Arafarma Group, S.A. 30 participants Est. completion 2025-09-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07213206

    CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer

    Not yet reported Fudan University 1500 participants Est. completion 2035-09-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07235618

    A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 site
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07245316

    Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

    Not yet reported Jeong Eon Lee 340 participants Est. completion 2032-12-31 1 site
    Other conditions: Ductal Carcinoma in Situ of the Breast
    View official trial listing →
  • Not yet recruiting NCT NCT07269691

    RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

    Not yet reported Pengfei Qiu 194 participants Est. completion 2027-12-01 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07305246

    Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

    Not yet reported First Hospital of China Medical University 120 participants Est. completion 2027-09
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07311122

    Endocrine Therapy Base on 21-gene RS

    Gangnam Severance Hospital 4000 participants Est. completion 2028-12-31
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07313202

    Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

    Not yet reported Fujian Cancer Hospital 72 participants Est. completion 2028-12-26
    Other conditions: Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
    View official trial listing →
  • Completed NCT NCT07334626

    Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy

    Not yet reported Benha University 60 participants Est. completion 2026-07-20 1 site
    Other conditions: Breast Cancer, Breast Cancer Survivors, Aromatase Inhibitors, Osteoporosis or Osteopenia, Pilates Exercise
    View official trial listing →
  • Completed NCT NCT07346287

    ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

    Not yet reported Stratpharma AG 11 participants Est. completion 2026-02-19 1 site Stand-alone
    Other conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Active, not recruiting NCT NCT07352748

    Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

    Universita di Verona 30 participants Est. completion 2026-10-17 1 site
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07358897

    Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study

    Imperial College London 500 participants Est. completion 2029-01-07
    Other conditions: Transgender
    View official trial listing →
  • Completed NCT NCT07363434

    A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib

    Novartis Pharmaceuticals 335 participants Est. completion 2024-07-26 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07368192

    Community-Based Exercise Oncology: Real-World Evidence of High Adherence, Improved Quality of Life and Cost-Effectiveness Across the Cancer Continuum

    University of Castilla-La Mancha 492 participants Est. completion 2026-07-31 1 site
    Other conditions: Cancer, Neoplams
    View official trial listing →
  • Not yet recruiting NCT NCT07368543

    Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer

    Not yet reported Fudan University 216 participants Est. completion 2028-12-01
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07376057

    Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150 participants Est. completion 2028-12-31 1 site
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Not yet recruiting NCT NCT07387861

    PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study

    Assiut University 70 participants Est. completion 2028-03
    Other conditions: Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT07389174

    Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

    Not yet reported Shanghai Changzheng Hospital 40 participants Est. completion 2027-06 1 site
    Other conditions: mHSPC, mHNPC, Prostate Cancer Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07394049

    A Prospective Multicenter Cohort Study of Contemporary Menopausal Hormone Therapy and Cardiovascular Outcomes

    Heinrich-Heine University, Duesseldorf 3408 participants Est. completion 2041-03 2 sites
    Cardiovascular disease Other conditions: Hormone Replacement Therapy, Hormone Replacement Therapy, Post-Menopausal, Menopause
    View official trial listing →
  • Not yet recruiting NCT NCT07394400

    Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults.

    Milagros Rocha Barajas 94 participants Est. completion 2029-12-31 1 site
    Other conditions: Transgender Individuals
    View official trial listing →
  • Not yet recruiting NCT NCT07394946

    Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.

    Not yet reported Cancer Care Hospital & Research Centre Foundation, Lahore 126 participants Est. completion 2029-07 1 site
    Other conditions: Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT07422727

    Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy

    Not yet reported Sligo General Hospital 40 participants Est. completion 2026-04-01 1 site
    Other conditions: Hot Flashes, Sleep, Hormonal, Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07423611

    ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer

    Not yet reported Fudan University 388 participants Est. completion 2030-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07447024

    Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy

    Not yet reported Cairo University 60 participants Est. completion 2026-06-15 1 site Stand-alone
    Other conditions: Mastectomy
    View official trial listing →
  • Not yet recruiting NCT NCT07462663

    SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer

    Not yet reported Hospital Universitari de Bellvitge 80 participants Est. completion 2035-01 Stand-alone
    Other conditions: Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Obesity & Overweight, BMI>40, Obesity, Obesity Grade III
    View official trial listing →
  • Completed NCT NCT07481942

    Body Composition Assessment in Transgender Population.

    Celia Bañuls 70 participants Est. completion 2025-10-31 1 site
    Other conditions: Transgender
    View official trial listing →
  • Completed NCT NCT07487129

    Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt

    Not yet reported Beni-Suef University 206 participants Est. completion 2025-12-20 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07490509

    Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

    Not yet reported Poitiers University Hospital 235 participants Est. completion 2029-09
    Other conditions: Abemaciclib, Abemaciclib-related Diarrhea, Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07497191

    AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

    Shengjing Hospital 300 participants Est. completion 2030-03-05
    Other conditions: Breast Cancer, Perimenopause, Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT07519213

    Guangdong Endometriosis Retrospective Clinical Cohort

    Guangdong Women and Children Hospital 1121 participants Est. completion 2026-01-01 1 site
    Other conditions: Ovarian Endometrioma, Endometriosis
    View official trial listing →
  • Not yet recruiting NCT NCT07529353

    Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .

    Not yet reported University of Rochester 20 participants Est. completion 2028-10 1 site
    Other conditions: Breast Cancer, Cancer Related Fatigue
    View official trial listing →
  • Active, not recruiting NCT NCT07541703

    Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

    Spotlight Medical 2200 participants Est. completion 2028-03-31 1 site
    Other conditions: Breast Cancer, Early Breast Cancer, ER-Positive HER2-Negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07542964

    Transgender Analysis of Nephrological Studies Focused on Renal Metrics

    Amsterdam UMC, location VUmc 60 participants Est. completion 2028-09 1 site
    Other conditions: Kidney Disease, Kidney Injury, Transgender Individuals
    View official trial listing →
  • Not yet recruiting NCT NCT07545486

    Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment

    Chirec 1235 participants Est. completion 2036-06-01 12 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Not yet recruiting NCT NCT07562399

    Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda

    Not yet reported Dana-Farber Cancer Institute 224 participants Est. completion 2028-12-31 4 sites
    Other conditions: Medication Adherence, Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT07570966

    Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals Est. completion 2031-08-01
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer (mCRPC)
    View official trial listing →
  • Not yet recruiting NCT NCT07572981

    Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal Women

    Not yet reported University Hospital, Toulouse 94 participants Est. completion 2027-12-31 1 site
    Other conditions: Menopause
    View official trial listing →
  • Enrolling by invitation NCT NCT07586319

    Effectiveness of Surgery for Improving Survival in Oligometastatic Breast Cancer Patients

    Not yet reported Sharif Medical Research Center 110 participants Est. completion 2031-06-01 1 site
    Other conditions: Survival Outcomes
    View official trial listing →
  • Not yet recruiting NCT NCT07590583

    Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-12-02 2 sites
    Other conditions: Advanced Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Hormone Receptor-Positive Breast Carcinoma, Unresectable Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07610733

    Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.

    Not yet reported Fudan University 100 participants Est. completion 2030-06-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07619066

    A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.

    Not yet reported MedSIR 25 participants Est. completion 2028-11-28
    Other conditions: Advanced Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer, HER2 Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT07621289

    Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe

    University Hospital, Caen 10000 participants Est. completion 2030-12-31
    Cardiovascular disease Other conditions: Cancer, Anticancer Treatment, Hematological Malignancies
    View official trial listing →
  • Not yet recruiting NCT NCT07645326

    RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

    Not yet reported Georgetown University 108 participants Est. completion 2032-08 1 site
    Other conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
    View official trial listing →
  • Not yet recruiting NCT NCT07668427

    The Impact of a Web-based Empowerment Program on Intolerance of Uncertainty and Maintenance Burden.

    Not yet reported Necmettin Erbakan University 62 participants Est. completion 2027-05-17
    Other conditions: Intolerance of Uncertainty, Caregiving Burden
    View official trial listing →
  • Not yet recruiting NCT NCT07677956

    Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer

    The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2036-12-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07687225

    Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases

    Not yet reported West China Hospital 216 participants Est. completion 2036-12-31
    Other conditions: Breast Cancer, Stage IV Breast Cancer, Bone Metastases
    View official trial listing →
  • Not yet recruiting NCT NCT07697768

    Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment

    Not yet reported Patricia Lordelo 150 participants Est. completion 2028-05-20 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis, Vulvovaginal Candidiasis (VVC)
    View official trial listing →
  • Not yet recruiting NCT NCT07716046

    Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer

    Not yet reported Fudan University 240 participants Est. completion 2032-12-31
    Other conditions: Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer, HR+/HER2+ Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07729046

    Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer

    Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 site
    Other conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07730580

    Study of XNW5004 Tablets in Advanced Prostate Cancer

    Not yet reported Evopoint Biosciences Inc. 242 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: Advanced Prostate Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07738341

    GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

    Not yet reported, Not yet reported Eddingpharm (Zhuhai) Co., Ltd. 270 participants Est. completion 2030-08-01
    Other conditions: Breast Cancer (Locally Advanced or Metastatic)
    View official trial listing →
  • Not yet recruiting NCT NCT07745257

    Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases

    Not yet reported Sun Yat-sen University 40 participants Est. completion 2028-07-28 9 sites
    Other conditions: HR-positive, HER2-negative Metastatic Breast Cancer With Brain Metastases
    View official trial listing →
  • Not yet recruiting NCT NCT07754292

    Off-Label Treatment With Immune Checkpoint Inhibitor Blockade

    Not yet reported Medical College of Wisconsin 231 participants Est. completion 2036-11-01 1 site Stand-alone
    Other conditions: Malignancy
    View official trial listing →
  • Not yet recruiting NCT NCT07759947

    Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy

    Not yet reported Massachusetts General Hospital 400 participants Est. completion 2031-06-01 2 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07767448

    Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

    Not yet reported Stanford University 50 participants Est. completion 2029-02 1 site
    Other conditions: Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07773662

    Age of Puberty Onset Among Girls in Asyut, Egypt

    Assiut University 600 participants Est. completion 2027-10
    Other conditions: Puberty
    View official trial listing →
  • Not yet recruiting NCT NCT07782840

    QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy

    Not yet reported Hebei Medical University Fourth Hospital 40 participants Est. completion 2028-12-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07786051

    DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)

    Not yet reported The Netherlands Cancer Institute 80 participants Est. completion 2028-11-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07787520

    A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors

    Not yet reported Laekna Limited 150 participants Est. completion 2029-12 6 sites
    Other conditions: Patients With Advanced Solid Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT07817446

    Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study

    Chulalongkorn University 500 participants Est. completion 2027-12-31 1 site
    Other conditions: Headache, Migraine
    View official trial listing →
  • Not yet recruiting NCT NCT07833501

    Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer

    D'Or Institute for Research and Education 172 participants Est. completion 2027-05-30
    Other conditions: Hormone Receptor-Positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07837063

    Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either Hormone Sensitive Metastatic Prostate Cancer or Disease Progression on Treatment.

    The Clatterbridge Cancer Centre NHS Foundation Trust 40 participants Est. completion 2030-09-03 1 site
    Other conditions: Cancer, Urology
    View official trial listing →
  • Not yet recruiting NCT NCT07840534

    Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)

    Not yet reported University College Cork 30 participants Est. completion 2028-06-01 1 site
    Other conditions: Breast Cancer, Breast Cancer Survivorship, Cancer Survivorship, Endocrine Therapy, Early Stage Breast Cancer
    View official trial listing →
  • Completed NCT NCT07843121

    Supervised Exercise in Women With Breast Cancer

    Not yet reported University of Extremadura 16 participants Est. completion 2025-09-23 1 site
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT07844759

    SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers

    Not yet reported Renaissance Institute of Precision Oncology and Radiosurgery 30 participants Est. completion 2032-01-01 1 site
    Other conditions: Breast Cancer, Early-Stage Breast Carcinoma, Hormone Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07849127

    wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65

    Not yet reported Women's Heart Austria 800 participants Est. completion 2034-03-31 1 site
    Cardiovascular disease Other conditions: Atheroscleroses
    View official trial listing →
  • Not yet recruiting NCT NCT07850609

    A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)

    Not yet reported Merck Sharp & Dohme LLC 80 participants Est. completion 2027-12-02
    Other conditions: HIV
    View official trial listing →
  • Not yet recruiting NCT NCT07859319

    Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting

    Not yet reported Hospices Civils de Lyon 105 participants Est. completion 2028-03 3 sites
    Other conditions: Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint Pain
    View official trial listing →
  • Not yet recruiting NCT NCT07861932

    A Phase 1/2a Study of K-1728 in Advanced Solid Tumors

    Not yet reported, Not yet reported KymaThera, Inc. 110 participants Est. completion 2029-03
    Other conditions: Breast Neoplasms, Solid Tumors, PIK3CA Gene Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT07867262

    A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally Advanced or Metastatic Hormone Receptor-Positive, HER2-Negatve Breast Cancer

    Not yet reported Genentech, Inc. 165 participants Est. completion 2030-08-15
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07871396

    Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females on Hormone Therapy

    Not yet reported University of Virginia 24 participants Est. completion 2028-01-30 1 site
    Other conditions: Postmenopausal Female Patients, Vasomotor Symptoms, Menopausal Hormone Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07905001

    A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

    Not yet reported Prelude Therapeutics Incorporated 242 participants Est. completion 2029-10-31
    Other conditions: Breast Cancer, Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, HR-positive Breast Cancer, HR+/HER2- Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07907653

    Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 37 participants Est. completion 2035-01 1 site
    Other conditions: Prostate Cancer (Adenocarcinoma)
    View official trial listing →
  • Active, not recruiting NCT NCT07909785

    AKU Study - Acupuncture for Aromatase Inhibitor-Induced Musculoskeletal Syndrome

    Not yet reported Masaryk Memorial Cancer Institute 200 participants Est. completion 2028-03-31 1 site
    Other conditions: Aromatase Inhibitor-Associated Musculoskeletal Syndrome, Arthralgia Syndrome, Early Breast Cancer (EBC)
    View official trial listing →
  • Not yet recruiting NCT NCT07911839

    Agentic AI App and Home Bioimpedance Monitoring for Endocrine Therapy Adherence and Lymphedema in Breast Cancer Survivors

    Not yet reported Chang-Ik Yoon 264 participants Est. completion 2028-12-31 1 site
    Other conditions: Breast Neoplasm Malignant Primary, Lymphedema Arm, Medication Adherence, Ductal Carcinoma In Situ
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.